cancer_type	qtl_type	tag_SNP	LD	SNP_id	gene_id	gene_symbol	t-stat	p-value	beta	r	Traits	SNP_position	Gene_position
COAD	cis	rs75358501	0.636	rs2241347	MIMAT0014995	hsa-miR-3130-5p	-17.1	2.77e-44	-0.91	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206783257	chr2:206783276~206783296:-
COAD	cis	rs75358501	0.636	rs2241347	MIMAT0014995_1	hsa-miR-3130-5p	-17.1	2.77e-44	-0.91	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206783257	chr2:206783246~206783266:+
COAD	cis	rs75358501	0.636	rs7576591	MIMAT0014995	hsa-miR-3130-5p	-16.73	5.32e-43	-0.91	-0.72	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784502	chr2:206783276~206783296:-
COAD	cis	rs75358501	0.636	rs7576591	MIMAT0014995_1	hsa-miR-3130-5p	-16.73	5.32e-43	-0.91	-0.72	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784502	chr2:206783246~206783266:+
COAD	cis	rs75358501	0.636	rs2287628	MIMAT0014995	hsa-miR-3130-5p	-16.73	5.32e-43	-0.91	-0.72	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785809	chr2:206783276~206783296:-
COAD	cis	rs75358501	0.636	rs2287628	MIMAT0014995_1	hsa-miR-3130-5p	-16.73	5.32e-43	-0.91	-0.72	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785809	chr2:206783246~206783266:+
COAD	cis	rs75358501	0.636	rs12471008	MIMAT0014995	hsa-miR-3130-5p	-16.73	5.4e-43	-0.9	-0.72	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206775059	chr2:206783276~206783296:-
COAD	cis	rs75358501	0.636	rs12471008	MIMAT0014995_1	hsa-miR-3130-5p	-16.73	5.4e-43	-0.9	-0.72	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206775059	chr2:206783246~206783266:+
COAD	cis	rs75358501	0.636	rs768533	MIMAT0014995	hsa-miR-3130-5p	-16.73	5.4e-43	-0.9	-0.72	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776113	chr2:206783276~206783296:-
COAD	cis	rs75358501	0.636	rs768533	MIMAT0014995_1	hsa-miR-3130-5p	-16.73	5.4e-43	-0.9	-0.72	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776113	chr2:206783246~206783266:+
COAD	cis	rs75358501	0.636	rs888621	MIMAT0014995	hsa-miR-3130-5p	16.67	8.6e-43	0.9	0.72	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784626	chr2:206783276~206783296:-
COAD	cis	rs75358501	0.636	rs888621	MIMAT0014995_1	hsa-miR-3130-5p	16.67	8.6e-43	0.9	0.72	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784626	chr2:206783246~206783266:+
COAD	cis	rs75358501	0.636	rs10199766	MIMAT0014995	hsa-miR-3130-5p	-16.53	2.73e-42	-0.9	-0.72	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206777144	chr2:206783276~206783296:-
COAD	cis	rs75358501	0.636	rs10199766	MIMAT0014995_1	hsa-miR-3130-5p	-16.53	2.73e-42	-0.9	-0.72	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206777144	chr2:206783246~206783266:+
COAD	cis	rs75358501	0.636	rs13427002	MIMAT0014995	hsa-miR-3130-5p	-16.53	2.73e-42	-0.9	-0.72	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206778949	chr2:206783276~206783296:-
COAD	cis	rs75358501	0.636	rs13427002	MIMAT0014995_1	hsa-miR-3130-5p	-16.53	2.73e-42	-0.9	-0.72	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206778949	chr2:206783246~206783266:+
COAD	cis	rs75358501	0.636	rs11895370	MIMAT0014995	hsa-miR-3130-5p	-16.35	1.08e-41	-0.89	-0.71	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206789990	chr2:206783276~206783296:-
COAD	cis	rs75358501	0.636	rs11895370	MIMAT0014995_1	hsa-miR-3130-5p	-16.35	1.08e-41	-0.89	-0.71	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206789990	chr2:206783246~206783266:+
COAD	cis	rs75358501	0.636	rs725980	MIMAT0014995	hsa-miR-3130-5p	-16.34	1.17e-41	-0.9	-0.71	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206773856	chr2:206783276~206783296:-
COAD	cis	rs75358501	0.636	rs725980	MIMAT0014995_1	hsa-miR-3130-5p	-16.34	1.17e-41	-0.9	-0.71	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206773856	chr2:206783246~206783266:+
COAD	cis	rs75358501	0.688	rs2287629	MIMAT0014995	hsa-miR-3130-5p	16.33	1.34e-41	0.88	0.71	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785690	chr2:206783276~206783296:-
COAD	cis	rs75358501	0.688	rs2287629	MIMAT0014995_1	hsa-miR-3130-5p	16.33	1.34e-41	0.88	0.71	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785690	chr2:206783246~206783266:+
COAD	cis	rs75358501	0.636	rs16838834	MIMAT0014995	hsa-miR-3130-5p	-16.01	1.68e-40	-0.89	-0.71	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765071	chr2:206783276~206783296:-
COAD	cis	rs75358501	0.636	rs16838834	MIMAT0014995_1	hsa-miR-3130-5p	-16.01	1.68e-40	-0.89	-0.71	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765071	chr2:206783246~206783266:+
COAD	cis	rs75358501	0.636	rs3815686	MIMAT0014995	hsa-miR-3130-5p	-15.45	1.57e-38	-0.87	-0.69	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206768278	chr2:206783276~206783296:-
COAD	cis	rs75358501	0.636	rs3815686	MIMAT0014995_1	hsa-miR-3130-5p	-15.45	1.57e-38	-0.87	-0.69	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206768278	chr2:206783246~206783266:+
COAD	cis	rs6841433	1	rs13133286	MIMAT0003242	hsa-miR-577	14.78	3.28e-36	0.74	0.68	Hemoglobin concentration;	chr4:114701654	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.948	rs35736852	MIMAT0003242	hsa-miR-577	14.68	7.44e-36	0.72	0.68	Hemoglobin concentration;	chr4:114687255	chr4:114656774~114656794:+
COAD	cis	rs6841433	1	rs34115976	MIMAT0003242	hsa-miR-577	14.64	1.08e-35	0.73	0.67	Hemoglobin concentration;	chr4:114656841	chr4:114656774~114656794:+
COAD	cis	rs6841433	1	rs13133899	MIMAT0003242	hsa-miR-577	14.53	2.47e-35	0.72	0.67	Hemoglobin concentration;	chr4:114661153	chr4:114656774~114656794:+
COAD	cis	rs6841433	1	rs34546485	MIMAT0003242	hsa-miR-577	14.45	4.97e-35	0.73	0.67	Hemoglobin concentration;	chr4:114693882	chr4:114656774~114656794:+
COAD	cis	rs6841433	1	rs7677294	MIMAT0003242	hsa-miR-577	14.35	1.11e-34	0.72	0.67	Hemoglobin concentration;	chr4:114633283	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.948	rs34110012	MIMAT0003242	hsa-miR-577	14.13	6.33e-34	0.72	0.66	Hemoglobin concentration;	chr4:114710498	chr4:114656774~114656794:+
COAD	cis	rs75358501	0.584	rs11894165	MIMAT0014995	hsa-miR-3130-5p	-14	1.81e-33	-0.89	-0.66	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206759688	chr2:206783276~206783296:-
COAD	cis	rs75358501	0.584	rs11894165	MIMAT0014995_1	hsa-miR-3130-5p	-14	1.81e-33	-0.89	-0.66	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206759688	chr2:206783246~206783266:+
COAD	cis	rs75358501	0.688	rs1862087	MIMAT0014995	hsa-miR-3130-5p	-13.92	3.34e-33	-0.87	-0.66	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206760843	chr2:206783276~206783296:-
COAD	cis	rs75358501	0.688	rs1862087	MIMAT0014995_1	hsa-miR-3130-5p	-13.92	3.34e-33	-0.87	-0.66	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206760843	chr2:206783246~206783266:+
COAD	cis	rs75358501	0.636	rs7580138	MIMAT0014995	hsa-miR-3130-5p	-13.37	2.69e-31	-0.87	-0.64	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206750560	chr2:206783276~206783296:-
COAD	cis	rs75358501	0.636	rs7580138	MIMAT0014995_1	hsa-miR-3130-5p	-13.37	2.69e-31	-0.87	-0.64	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206750560	chr2:206783246~206783266:+
COAD	cis	rs6841433	1	rs35217170	MIMAT0003242	hsa-miR-577	13.25	6.87e-31	0.64	0.64	Hemoglobin concentration;	chr4:114672701	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.948	rs13135834	MIMAT0003242	hsa-miR-577	13.25	6.87e-31	0.64	0.64	Hemoglobin concentration;	chr4:114678835	chr4:114656774~114656794:+
COAD	cis	rs6841433	1	rs55875005	MIMAT0003242	hsa-miR-577	13.22	8.91e-31	0.64	0.64	Hemoglobin concentration;	chr4:114691920	chr4:114656774~114656794:+
COAD	cis	rs75358501	0.636	rs1862089	MIMAT0014995	hsa-miR-3130-5p	-13.14	1.66e-30	-0.85	-0.63	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206755794	chr2:206783276~206783296:-
COAD	cis	rs75358501	0.636	rs1862089	MIMAT0014995_1	hsa-miR-3130-5p	-13.14	1.66e-30	-0.85	-0.63	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206755794	chr2:206783246~206783266:+
COAD	cis	rs75358501	0.636	rs10932164	MIMAT0014995	hsa-miR-3130-5p	-13.13	1.74e-30	-0.84	-0.63	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206751601	chr2:206783276~206783296:-
COAD	cis	rs75358501	0.636	rs10932164	MIMAT0014995_1	hsa-miR-3130-5p	-13.13	1.74e-30	-0.84	-0.63	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206751601	chr2:206783246~206783266:+
COAD	cis	rs6841433	1	rs35271056	MIMAT0003242	hsa-miR-577	13.11	1.99e-30	0.64	0.63	Hemoglobin concentration;	chr4:114642195	chr4:114656774~114656794:+
COAD	cis	rs6841433	1	rs10011293	MIMAT0003242	hsa-miR-577	13.1	2.22e-30	0.64	0.63	Hemoglobin concentration;	chr4:114656225	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.848	rs13328022	MIMAT0003242	hsa-miR-577	13.07	2.8e-30	0.64	0.63	Hemoglobin concentration;	chr4:114700701	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.948	rs7671477	MIMAT0003242	hsa-miR-577	13.04	3.65e-30	0.64	0.63	Hemoglobin concentration;	chr4:114632518	chr4:114656774~114656794:+
COAD	cis	rs6841433	1	rs6533803	MIMAT0003242	hsa-miR-577	13.01	4.73e-30	0.64	0.63	Hemoglobin concentration;	chr4:114637085	chr4:114656774~114656794:+
COAD	cis	rs6841433	1	rs10049660	MIMAT0003242	hsa-miR-577	13.01	4.73e-30	0.64	0.63	Hemoglobin concentration;	chr4:114637758	chr4:114656774~114656794:+
COAD	cis	rs6841433	1	rs10008981	MIMAT0003242	hsa-miR-577	12.82	2.07e-29	0.63	0.62	Hemoglobin concentration;	chr4:114650189	chr4:114656774~114656794:+
COAD	cis	rs6841433	1	rs6828127	MIMAT0003242	hsa-miR-577	12.76	3.14e-29	0.61	0.62	Hemoglobin concentration;	chr4:114689927	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.95	rs28696112	MIMAT0003242	hsa-miR-577	12.74	3.67e-29	0.63	0.62	Hemoglobin concentration;	chr4:114601833	chr4:114656774~114656794:+
COAD	cis	rs6841433	1	rs28390138	MIMAT0003242	hsa-miR-577	12.7	5.42e-29	0.62	0.62	Hemoglobin concentration;	chr4:114687320	chr4:114656774~114656794:+
COAD	cis	rs6841433	1	rs6841433	MIMAT0003242	hsa-miR-577	12.62	9.71e-29	0.62	0.62	Hemoglobin concentration;	chr4:114647874	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.904	rs4130705	MIMAT0003242	hsa-miR-577	12.55	1.66e-28	0.62	0.62	Hemoglobin concentration;	chr4:114609479	chr4:114656774~114656794:+
COAD	cis	rs6841433	1	rs34403669	MIMAT0003242	hsa-miR-577	12.46	3.41e-28	0.62	0.61	Hemoglobin concentration;	chr4:114703735	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.948	rs9884805	MIMAT0003242	hsa-miR-577	12.43	4.21e-28	0.62	0.61	Hemoglobin concentration;	chr4:114697040	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.706	rs13147491	MIMAT0003242	hsa-miR-577	9.7	3.67e-19	0.67	0.52	Hemoglobin concentration;	chr4:114696462	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.706	rs13134858	MIMAT0003242	hsa-miR-577	9.54	1.16e-18	0.67	0.51	Hemoglobin concentration;	chr4:114601150	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.706	rs35571359	MIMAT0003242	hsa-miR-577	9.5	1.54e-18	0.66	0.51	Hemoglobin concentration;	chr4:114606130	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.706	rs35759252	MIMAT0003242	hsa-miR-577	9.5	1.54e-18	0.66	0.51	Hemoglobin concentration;	chr4:114608520	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.904	rs11731984	MIMAT0003242	hsa-miR-577	-8.81	1.95e-16	-0.42	-0.48	Hemoglobin concentration;	chr4:114663873	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.699	rs12643031	MIMAT0003242	hsa-miR-577	8.8	2.03e-16	0.48	0.48	Hemoglobin concentration;	chr4:114541449	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.607	rs34695716	MIMAT0003242	hsa-miR-577	-8.75	2.81e-16	-0.41	-0.48	Hemoglobin concentration;	chr4:114658285	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.75	rs6857337	MIMAT0003242	hsa-miR-577	8.53	1.27e-15	0.39	0.47	Hemoglobin concentration;	chr4:114667805	chr4:114656774~114656794:+
COAD	cis	rs6753739	0.745	rs6436104	MIMAT0014996	hsa-miR-3131	8.42	2.68e-15	0.57	0.46	Height;	chr2:219051045	chr2:219058725~219058747:-
COAD	cis	rs6753739	0.745	rs4674356	MIMAT0014996	hsa-miR-3131	8.4	3.02e-15	0.57	0.46	Height;	chr2:219049911	chr2:219058725~219058747:-
COAD	cis	rs6841433	0.718	rs7656139	MIMAT0003242	hsa-miR-577	-8.36	3.92e-15	-0.4	-0.46	Hemoglobin concentration;	chr4:114672622	chr4:114656774~114656794:+
COAD	cis	rs6753739	0.871	rs6436113	MIMAT0014996	hsa-miR-3131	8.35	4.32e-15	0.54	0.46	Height;	chr2:219120176	chr2:219058725~219058747:-
COAD	cis	rs6841433	0.687	rs12640227	MIMAT0003242	hsa-miR-577	-8.35	4.32e-15	-0.4	-0.46	Hemoglobin concentration;	chr4:114700788	chr4:114656774~114656794:+
COAD	cis	rs6753739	0.745	rs1378640	MIMAT0014996	hsa-miR-3131	8.14	1.74e-14	0.55	0.45	Height;	chr2:219052910	chr2:219058725~219058747:-
COAD	cis	rs6841433	0.632	rs7699896	MIMAT0003242	hsa-miR-577	8.1	2.21e-14	0.38	0.45	Hemoglobin concentration;	chr4:114617357	chr4:114656774~114656794:+
COAD	cis	rs6753739	0.784	rs7578383	MIMAT0014996	hsa-miR-3131	8.04	3.39e-14	0.55	0.45	Height;	chr2:219066129	chr2:219058725~219058747:-
COAD	cis	rs6753739	0.871	rs6436109	MIMAT0014996	hsa-miR-3131	8	4.35e-14	0.53	0.45	Height;	chr2:219115759	chr2:219058725~219058747:-
COAD	cis	rs6753739	0.871	rs1869802	MIMAT0014996	hsa-miR-3131	7.98	4.97e-14	0.52	0.45	Height;	chr2:219112311	chr2:219058725~219058747:-
COAD	cis	rs6753739	0.784	rs6730783	MIMAT0014996	hsa-miR-3131	7.92	7.34e-14	0.55	0.44	Height;	chr2:219058113	chr2:219058725~219058747:-
COAD	cis	rs6753739	0.826	rs897477	MIMAT0014996	hsa-miR-3131	7.9	8.24e-14	0.53	0.44	Height;	chr2:219076341	chr2:219058725~219058747:-
COAD	cis	rs6753739	0.784	rs10168527	MIMAT0014996	hsa-miR-3131	7.88	9.19e-14	0.53	0.44	Height;	chr2:219107653	chr2:219058725~219058747:-
COAD	cis	rs6753739	0.871	rs2030450	MIMAT0014996	hsa-miR-3131	7.84	1.21e-13	0.52	0.44	Height;	chr2:219132157	chr2:219058725~219058747:-
COAD	cis	rs6753739	0.826	rs10171368	MIMAT0014996	hsa-miR-3131	7.78	1.81e-13	0.53	0.44	Height;	chr2:219069055	chr2:219058725~219058747:-
COAD	cis	rs6753739	0.826	rs6732562	MIMAT0014996	hsa-miR-3131	7.77	1.91e-13	0.52	0.44	Height;	chr2:219102140	chr2:219058725~219058747:-
COAD	cis	rs6841433	0.632	rs7679995	MIMAT0003242	hsa-miR-577	-7.73	2.45e-13	-0.37	-0.43	Hemoglobin concentration;	chr4:114665137	chr4:114656774~114656794:+
COAD	cis	rs6753739	0.826	rs6711613	MIMAT0014996	hsa-miR-3131	7.69	3.09e-13	0.51	0.43	Height;	chr2:219082969	chr2:219058725~219058747:-
COAD	cis	rs6753739	0.784	rs11690649	MIMAT0014996	hsa-miR-3131	7.69	3.09e-13	0.51	0.43	Height;	chr2:219083049	chr2:219058725~219058747:-
COAD	cis	rs6753739	0.826	rs7599778	MIMAT0014996	hsa-miR-3131	7.67	3.52e-13	0.52	0.43	Height;	chr2:219096938	chr2:219058725~219058747:-
COAD	cis	rs6753739	0.871	rs6436114	MIMAT0014996	hsa-miR-3131	7.66	3.9e-13	0.51	0.43	Height;	chr2:219138112	chr2:219058725~219058747:-
COAD	cis	rs6753739	0.826	rs10164493	MIMAT0014996	hsa-miR-3131	7.65	4.13e-13	0.52	0.43	Height;	chr2:219083370	chr2:219058725~219058747:-
COAD	cis	rs6753739	0.784	rs1378642	MIMAT0014996	hsa-miR-3131	7.62	4.86e-13	0.51	0.43	Height;	chr2:219085388	chr2:219058725~219058747:-
COAD	cis	rs6753739	0.871	rs10932796	MIMAT0014996	hsa-miR-3131	7.55	7.38e-13	0.49	0.43	Height;	chr2:219156790	chr2:219058725~219058747:-
COAD	cis	rs6841433	0.615	rs35789595	MIMAT0003242	hsa-miR-577	7.51	9.68e-13	0.48	0.42	Hemoglobin concentration;	chr4:114594055	chr4:114656774~114656794:+
COAD	cis	rs950880	0.71	rs1474309	MIMAT0019926	hsa-miR-4772-5p	7.5	1.03e-12	0.91	0.42	Serum protein levels (sST2);	chr2:102474542	chr2:102432300~102432321:+
COAD	cis	rs6841433	0.615	rs56149980	MIMAT0003242	hsa-miR-577	7.5	1.07e-12	0.48	0.42	Hemoglobin concentration;	chr4:114576580	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.615	rs12642541	MIMAT0003242	hsa-miR-577	7.5	1.07e-12	0.48	0.42	Hemoglobin concentration;	chr4:114579576	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.571	rs35578985	MIMAT0003242	hsa-miR-577	7.49	1.11e-12	0.48	0.42	Hemoglobin concentration;	chr4:114594500	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.615	rs34001486	MIMAT0003242	hsa-miR-577	7.49	1.11e-12	0.48	0.42	Hemoglobin concentration;	chr4:114594792	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.615	rs57930571	MIMAT0003242	hsa-miR-577	7.42	1.66e-12	0.47	0.42	Hemoglobin concentration;	chr4:114580433	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.615	rs35732213	MIMAT0003242	hsa-miR-577	7.42	1.66e-12	0.47	0.42	Hemoglobin concentration;	chr4:114581427	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.615	rs35936834	MIMAT0003242	hsa-miR-577	7.42	1.66e-12	0.47	0.42	Hemoglobin concentration;	chr4:114581520	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.615	rs6813229	MIMAT0003242	hsa-miR-577	7.42	1.66e-12	0.47	0.42	Hemoglobin concentration;	chr4:114582721	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.615	rs6813283	MIMAT0003242	hsa-miR-577	7.42	1.66e-12	0.47	0.42	Hemoglobin concentration;	chr4:114582806	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.571	rs6839189	MIMAT0003242	hsa-miR-577	7.42	1.66e-12	0.47	0.42	Hemoglobin concentration;	chr4:114582848	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.615	rs7437576	MIMAT0003242	hsa-miR-577	7.42	1.7e-12	0.48	0.42	Hemoglobin concentration;	chr4:114595467	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.561	rs13148598	MIMAT0003242	hsa-miR-577	-7.36	2.45e-12	-0.36	-0.42	Hemoglobin concentration;	chr4:114676939	chr4:114656774~114656794:+
COAD	cis	rs75358501	0.901	rs16838691	MIMAT0014995	hsa-miR-3130-5p	-7.35	2.64e-12	-0.77	-0.42	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206718128	chr2:206783276~206783296:-
COAD	cis	rs75358501	0.901	rs16838691	MIMAT0014995_1	hsa-miR-3130-5p	-7.35	2.64e-12	-0.77	-0.42	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206718128	chr2:206783246~206783266:+
COAD	cis	rs6841433	0.632	rs4585328	MIMAT0003242	hsa-miR-577	-7.35	2.71e-12	-0.35	-0.42	Hemoglobin concentration;	chr4:114613660	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.632	rs7685523	MIMAT0003242	hsa-miR-577	-7.32	3.12e-12	-0.35	-0.42	Hemoglobin concentration;	chr4:114621913	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.615	rs13144260	MIMAT0003242	hsa-miR-577	7.26	4.66e-12	0.46	0.41	Hemoglobin concentration;	chr4:114573271	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.615	rs34948407	MIMAT0003242	hsa-miR-577	7.26	4.66e-12	0.46	0.41	Hemoglobin concentration;	chr4:114575280	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.632	rs4834428	MIMAT0003242	hsa-miR-577	-7.24	5.06e-12	-0.35	-0.41	Hemoglobin concentration;	chr4:114683908	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.615	rs35082726	MIMAT0003242	hsa-miR-577	7.24	5.07e-12	0.47	0.41	Hemoglobin concentration;	chr4:114566777	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.571	rs17047238	MIMAT0003242	hsa-miR-577	7.24	5.07e-12	0.47	0.41	Hemoglobin concentration;	chr4:114568870	chr4:114656774~114656794:+
COAD	cis	rs6753739	0.745	rs7572601	MIMAT0014996	hsa-miR-3131	7.24	5.31e-12	0.48	0.41	Height;	chr2:219154762	chr2:219058725~219058747:-
COAD	cis	rs6753739	0.871	rs6724718	MIMAT0014996	hsa-miR-3131	-7.22	5.75e-12	-0.47	-0.41	Height;	chr2:219139521	chr2:219058725~219058747:-
COAD	cis	rs6841433	0.571	rs17047244	MIMAT0003242	hsa-miR-577	7.17	7.8e-12	0.46	0.41	Hemoglobin concentration;	chr4:114571532	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.615	rs17047246	MIMAT0003242	hsa-miR-577	7.17	7.8e-12	0.46	0.41	Hemoglobin concentration;	chr4:114571876	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.615	rs7434753	MIMAT0003242	hsa-miR-577	7.17	8.01e-12	0.46	0.41	Hemoglobin concentration;	chr4:114596387	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.615	rs17047239	MIMAT0003242	hsa-miR-577	7.16	8.48e-12	0.46	0.41	Hemoglobin concentration;	chr4:114570559	chr4:114656774~114656794:+
COAD	cis	rs6753739	0.627	rs2293070	MIMAT0014996	hsa-miR-3131	7.14	9.28e-12	0.47	0.41	Height;	chr2:219158882	chr2:219058725~219058747:-
COAD	cis	rs6841433	0.615	rs1380932	MIMAT0003242	hsa-miR-577	7.13	1.04e-11	0.46	0.41	Hemoglobin concentration;	chr4:114565923	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.632	rs35717197	MIMAT0003242	hsa-miR-577	-7.1	1.2e-11	-0.34	-0.41	Hemoglobin concentration;	chr4:114639584	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.632	rs13106767	MIMAT0003242	hsa-miR-577	-7.1	1.2e-11	-0.34	-0.41	Hemoglobin concentration;	chr4:114635719	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.632	rs13152031	MIMAT0003242	hsa-miR-577	-7.09	1.33e-11	-0.34	-0.4	Hemoglobin concentration;	chr4:114644503	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.632	rs6533807	MIMAT0003242	hsa-miR-577	-7.04	1.78e-11	-0.34	-0.4	Hemoglobin concentration;	chr4:114699454	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs4409025	MIMAT0003242	hsa-miR-577	-7	2.16e-11	-0.31	-0.4	Optic disc area;	chr4:114511785	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs4409026	MIMAT0003242	hsa-miR-577	-7	2.16e-11	-0.31	-0.4	Optic disc area;	chr4:114511787	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs2054306	MIMAT0003242	hsa-miR-577	-7	2.26e-11	-0.31	-0.4	Optic disc area;	chr4:114496204	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs2035059	MIMAT0003242	hsa-miR-577	-7	2.26e-11	-0.31	-0.4	Optic disc area;	chr4:114496530	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs993460	MIMAT0003242	hsa-miR-577	-6.97	2.67e-11	-0.31	-0.4	Optic disc area;	chr4:114510521	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.693	rs7686100	MIMAT0003242	hsa-miR-577	-6.97	2.67e-11	-0.31	-0.4	Optic disc area;	chr4:114511670	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.692	rs7690858	MIMAT0003242	hsa-miR-577	-6.97	2.67e-11	-0.31	-0.4	Optic disc area;	chr4:114511804	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs4295329	MIMAT0003242	hsa-miR-577	-6.97	2.67e-11	-0.31	-0.4	Optic disc area;	chr4:114511945	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.692	rs4409027	MIMAT0003242	hsa-miR-577	-6.97	2.67e-11	-0.31	-0.4	Optic disc area;	chr4:114511985	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs4413472	MIMAT0003242	hsa-miR-577	-6.97	2.67e-11	-0.31	-0.4	Optic disc area;	chr4:114512090	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs11936113	MIMAT0003242	hsa-miR-577	-6.97	2.67e-11	-0.31	-0.4	Optic disc area;	chr4:114512224	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs11936150	MIMAT0003242	hsa-miR-577	-6.97	2.67e-11	-0.31	-0.4	Optic disc area;	chr4:114512391	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.692	rs28361366	MIMAT0003242	hsa-miR-577	-6.97	2.67e-11	-0.31	-0.4	Optic disc area;	chr4:114512809	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs28656197	MIMAT0003242	hsa-miR-577	-6.97	2.67e-11	-0.31	-0.4	Optic disc area;	chr4:114512821	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.692	rs2199314	MIMAT0003242	hsa-miR-577	-6.97	2.67e-11	-0.31	-0.4	Optic disc area;	chr4:114513555	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.516	rs11098259	MIMAT0003242	hsa-miR-577	-6.96	2.77e-11	-0.44	-0.4	Hemoglobin concentration;	chr4:114598669	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.56	rs11098260	MIMAT0003242	hsa-miR-577	-6.96	2.77e-11	-0.44	-0.4	Hemoglobin concentration;	chr4:114598670	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs13102706	MIMAT0003242	hsa-miR-577	-6.95	3.09e-11	-0.31	-0.4	Optic disc area;	chr4:114492998	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs13102910	MIMAT0003242	hsa-miR-577	-6.95	3.09e-11	-0.31	-0.4	Optic disc area;	chr4:114493049	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs13127839	MIMAT0003242	hsa-miR-577	-6.95	3.09e-11	-0.31	-0.4	Optic disc area;	chr4:114493059	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs13103158	MIMAT0003242	hsa-miR-577	-6.95	3.09e-11	-0.31	-0.4	Optic disc area;	chr4:114493188	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.692	rs13127680	MIMAT0003242	hsa-miR-577	-6.95	3.09e-11	-0.31	-0.4	Optic disc area;	chr4:114493217	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.693	rs4834415	MIMAT0003242	hsa-miR-577	-6.95	3.09e-11	-0.31	-0.4	Optic disc area;	chr4:114493245	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs4833458	MIMAT0003242	hsa-miR-577	-6.95	3.09e-11	-0.31	-0.4	Optic disc area;	chr4:114493571	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs4833459	MIMAT0003242	hsa-miR-577	-6.95	3.09e-11	-0.31	-0.4	Optic disc area;	chr4:114493734	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs12501292	MIMAT0003242	hsa-miR-577	-6.95	3.09e-11	-0.31	-0.4	Optic disc area;	chr4:114493876	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.622	rs12711027	MIMAT0003242	hsa-miR-577	-6.95	3.09e-11	-0.31	-0.4	Optic disc area;	chr4:114494204	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs13148430	MIMAT0003242	hsa-miR-577	-6.95	3.09e-11	-0.31	-0.4	Optic disc area;	chr4:114494469	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs10028232	MIMAT0003242	hsa-miR-577	-6.93	3.47e-11	-0.31	-0.4	Optic disc area;	chr4:114487644	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs7671026	MIMAT0003242	hsa-miR-577	-6.93	3.47e-11	-0.31	-0.4	Optic disc area;	chr4:114487736	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.692	rs10031142	MIMAT0003242	hsa-miR-577	-6.93	3.47e-11	-0.31	-0.4	Optic disc area;	chr4:114488433	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs17678686	MIMAT0003242	hsa-miR-577	-6.93	3.47e-11	-0.31	-0.4	Optic disc area;	chr4:114489100	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs28766989	MIMAT0003242	hsa-miR-577	-6.93	3.47e-11	-0.31	-0.4	Optic disc area;	chr4:114489752	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.692	rs11722125	MIMAT0003242	hsa-miR-577	-6.93	3.47e-11	-0.31	-0.4	Optic disc area;	chr4:114490374	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.692	rs11722162	MIMAT0003242	hsa-miR-577	-6.93	3.47e-11	-0.31	-0.4	Optic disc area;	chr4:114490460	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.668	rs11722201	MIMAT0003242	hsa-miR-577	-6.93	3.47e-11	-0.31	-0.4	Optic disc area;	chr4:114490577	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs1585447	MIMAT0003242	hsa-miR-577	-6.93	3.47e-11	-0.31	-0.4	Optic disc area;	chr4:114490912	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.692	rs1585448	MIMAT0003242	hsa-miR-577	-6.93	3.47e-11	-0.31	-0.4	Optic disc area;	chr4:114491050	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs1870655	MIMAT0003242	hsa-miR-577	-6.93	3.47e-11	-0.31	-0.4	Optic disc area;	chr4:114491625	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs2219591	MIMAT0003242	hsa-miR-577	-6.93	3.47e-11	-0.31	-0.4	Optic disc area;	chr4:114491902	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs2199310	MIMAT0003242	hsa-miR-577	-6.92	3.54e-11	-0.31	-0.4	Optic disc area;	chr4:114492246	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs6839599	MIMAT0003242	hsa-miR-577	-6.92	3.62e-11	-0.31	-0.4	Optic disc area;	chr4:114494754	chr4:114656774~114656794:+
COAD	cis	rs75358501	0.901	rs79499040	MIMAT0014995	hsa-miR-3130-5p	-6.91	3.72e-11	-0.76	-0.4	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776206	chr2:206783276~206783296:-
COAD	cis	rs75358501	0.901	rs79499040	MIMAT0014995_1	hsa-miR-3130-5p	-6.91	3.72e-11	-0.76	-0.4	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776206	chr2:206783246~206783266:+
COAD	cis	rs10021731	0.692	rs2054303	MIMAT0003242	hsa-miR-577	-6.91	3.84e-11	-0.31	-0.4	Optic disc area;	chr4:114495803	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.645	rs7698524	MIMAT0003242	hsa-miR-577	-6.91	3.92e-11	-0.31	-0.4	Optic disc area;	chr4:114492417	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.668	rs7698363	MIMAT0003242	hsa-miR-577	-6.91	3.92e-11	-0.31	-0.4	Optic disc area;	chr4:114492418	chr4:114656774~114656794:+
COAD	cis	rs6753739	0.871	rs9784128	MIMAT0014996	hsa-miR-3131	-6.9	3.93e-11	-0.48	-0.4	Height;	chr2:219113916	chr2:219058725~219058747:-
COAD	cis	rs6841433	0.615	rs6849357	MIMAT0003242	hsa-miR-577	-6.9	3.93e-11	-0.43	-0.4	Hemoglobin concentration;	chr4:114598115	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.615	rs13112553	MIMAT0003242	hsa-miR-577	-6.9	3.93e-11	-0.43	-0.4	Hemoglobin concentration;	chr4:114598194	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs28736894	MIMAT0003242	hsa-miR-577	-6.88	4.52e-11	-0.31	-0.39	Optic disc area;	chr4:114514184	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs17622270	MIMAT0003242	hsa-miR-577	-6.88	4.52e-11	-0.31	-0.39	Optic disc area;	chr4:114514205	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs958771	MIMAT0003242	hsa-miR-577	-6.88	4.52e-11	-0.31	-0.39	Optic disc area;	chr4:114514506	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.668	rs66482879	MIMAT0003242	hsa-miR-577	-6.88	4.52e-11	-0.31	-0.39	Optic disc area;	chr4:114517522	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs28657376	MIMAT0003242	hsa-miR-577	-6.88	4.52e-11	-0.31	-0.39	Optic disc area;	chr4:114517650	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.668	rs7684322	MIMAT0003242	hsa-miR-577	-6.87	4.8e-11	-0.31	-0.39	Optic disc area;	chr4:114519788	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs12108520	MIMAT0003242	hsa-miR-577	-6.87	4.8e-11	-0.31	-0.39	Optic disc area;	chr4:114522087	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs13117126	MIMAT0003242	hsa-miR-577	-6.87	4.8e-11	-0.31	-0.39	Optic disc area;	chr4:114526758	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.692	rs10516602	MIMAT0003242	hsa-miR-577	-6.86	4.98e-11	-0.3	-0.39	Optic disc area;	chr4:114486174	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.615	rs10516604	MIMAT0003242	hsa-miR-577	6.86	5.04e-11	0.44	0.39	Hemoglobin concentration;	chr4:114546112	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.615	rs13135560	MIMAT0003242	hsa-miR-577	6.86	5.04e-11	0.44	0.39	Hemoglobin concentration;	chr4:114547331	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.615	rs35777558	MIMAT0003242	hsa-miR-577	6.86	5.04e-11	0.44	0.39	Hemoglobin concentration;	chr4:114548111	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.615	rs79776742	MIMAT0003242	hsa-miR-577	6.86	5.04e-11	0.44	0.39	Hemoglobin concentration;	chr4:114550195	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.615	rs57059575	MIMAT0003242	hsa-miR-577	6.86	5.04e-11	0.44	0.39	Hemoglobin concentration;	chr4:114551237	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.615	rs13147106	MIMAT0003242	hsa-miR-577	6.86	5.04e-11	0.44	0.39	Hemoglobin concentration;	chr4:114552206	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.615	rs13147485	MIMAT0003242	hsa-miR-577	6.86	5.04e-11	0.44	0.39	Hemoglobin concentration;	chr4:114552321	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.615	rs35252674	MIMAT0003242	hsa-miR-577	6.86	5.04e-11	0.44	0.39	Hemoglobin concentration;	chr4:114556583	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.615	rs12641516	MIMAT0003242	hsa-miR-577	6.86	5.04e-11	0.44	0.39	Hemoglobin concentration;	chr4:114556972	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.615	rs71606719	MIMAT0003242	hsa-miR-577	6.86	5.04e-11	0.44	0.39	Hemoglobin concentration;	chr4:114557814	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.511	rs13125495	MIMAT0003242	hsa-miR-577	6.86	5.04e-11	0.44	0.39	Hemoglobin concentration;	chr4:114558326	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.571	rs13129837	MIMAT0003242	hsa-miR-577	6.82	6.43e-11	0.44	0.39	Hemoglobin concentration;	chr4:114563925	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.615	rs17047198	MIMAT0003242	hsa-miR-577	6.81	6.91e-11	0.44	0.39	Hemoglobin concentration;	chr4:114544338	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.668	rs12512563	MIMAT0003242	hsa-miR-577	-6.81	7.06e-11	-0.31	-0.39	Optic disc area;	chr4:114493973	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.6	rs12504927	MIMAT0003242	hsa-miR-577	-6.81	7.06e-11	-0.31	-0.39	Optic disc area;	chr4:114493975	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.645	rs13147121	MIMAT0003242	hsa-miR-577	-6.81	7.06e-11	-0.31	-0.39	Optic disc area;	chr4:114493994	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.692	rs13147488	MIMAT0003242	hsa-miR-577	-6.81	7.06e-11	-0.31	-0.39	Optic disc area;	chr4:114494051	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.693	rs114243292	MIMAT0003242	hsa-miR-577	-6.8	7.2e-11	-0.31	-0.39	Optic disc area;	chr4:114516751	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.615	rs12511581	MIMAT0003242	hsa-miR-577	-6.8	7.2e-11	-0.42	-0.39	Hemoglobin concentration;	chr4:114598400	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs1460772	MIMAT0003242	hsa-miR-577	-6.78	8.07e-11	-0.3	-0.39	Optic disc area;	chr4:114487028	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.692	rs6840798	MIMAT0003242	hsa-miR-577	-6.78	8.31e-11	-0.31	-0.39	Optic disc area;	chr4:114495078	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs6817762	MIMAT0003242	hsa-miR-577	-6.78	8.31e-11	-0.31	-0.39	Optic disc area;	chr4:114495098	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.692	rs13103833	MIMAT0003242	hsa-miR-577	-6.77	8.65e-11	-0.31	-0.39	Optic disc area;	chr4:114495414	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.692	rs7662125	MIMAT0003242	hsa-miR-577	-6.77	8.65e-11	-0.31	-0.39	Optic disc area;	chr4:114495706	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs2199312	MIMAT0003242	hsa-miR-577	-6.77	8.66e-11	-0.3	-0.39	Optic disc area;	chr4:114513322	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.615	rs17047201	MIMAT0003242	hsa-miR-577	6.77	8.93e-11	0.44	0.39	Hemoglobin concentration;	chr4:114544945	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs10857032	MIMAT0003242	hsa-miR-577	-6.74	1.01e-10	-0.3	-0.39	Optic disc area;	chr4:114527831	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.631	rs11098253	MIMAT0003242	hsa-miR-577	-6.74	1.01e-10	-0.3	-0.39	Optic disc area;	chr4:114527990	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.615	rs79261962	MIMAT0003242	hsa-miR-577	6.72	1.19e-10	0.44	0.39	Hemoglobin concentration;	chr4:114539953	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.615	rs77422558	MIMAT0003242	hsa-miR-577	6.72	1.19e-10	0.44	0.39	Hemoglobin concentration;	chr4:114540944	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.571	rs12649041	MIMAT0003242	hsa-miR-577	6.72	1.19e-10	0.44	0.39	Hemoglobin concentration;	chr4:114541220	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.615	rs12649963	MIMAT0003242	hsa-miR-577	6.72	1.19e-10	0.44	0.39	Hemoglobin concentration;	chr4:114542537	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.692	rs13105714	MIMAT0003242	hsa-miR-577	-6.71	1.26e-10	-0.3	-0.39	Optic disc area;	chr4:114511171	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.615	rs12648803	MIMAT0003242	hsa-miR-577	-6.69	1.35e-10	-0.42	-0.39	Hemoglobin concentration;	chr4:114546228	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs1460771	MIMAT0003242	hsa-miR-577	6.68	1.43e-10	0.29	0.38	Optic disc area;	chr4:114486755	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs7683270	MIMAT0003242	hsa-miR-577	6.68	1.49e-10	0.3	0.38	Optic disc area;	chr4:114532438	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs13103719	MIMAT0003242	hsa-miR-577	6.68	1.49e-10	0.3	0.38	Optic disc area;	chr4:114532620	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.681	rs13109008	MIMAT0003242	hsa-miR-577	6.68	1.49e-10	0.3	0.38	Optic disc area;	chr4:114532769	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs13109803	MIMAT0003242	hsa-miR-577	6.68	1.49e-10	0.3	0.38	Optic disc area;	chr4:114532837	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs7440658	MIMAT0003242	hsa-miR-577	6.68	1.49e-10	0.3	0.38	Optic disc area;	chr4:114533303	chr4:114656774~114656794:+
COAD	cis	rs1712517	0.525	rs2271751	MIMAT0005951	hsa-miR-1307-3p	-6.66	1.61e-10	-0.26	-0.38	Migraine;	chr10:103415374	chr10:103394301~103394322:-
COAD	cis	rs10021731	0.718	rs2126028	MIMAT0003242	hsa-miR-577	-6.58	2.64e-10	-0.29	-0.38	Optic disc area;	chr4:114533453	chr4:114656774~114656794:+
COAD	cis	rs1163656	0.502	rs7310000	MIMAT0003287	hsa-miR-618	-6.57	2.7e-10	-0.57	-0.38	Dental caries;	chr12:80933498	chr12:80935796~80935818:-
COAD	cis	rs10021731	0.718	rs10857031	MIMAT0003242	hsa-miR-577	-6.56	2.89e-10	-0.29	-0.38	Optic disc area;	chr4:114527690	chr4:114656774~114656794:+
COAD	cis	rs6753739	0.784	rs437512	MIMAT0014996	hsa-miR-3131	6.56	2.92e-10	0.5	0.38	Height;	chr2:219061446	chr2:219058725~219058747:-
COAD	cis	rs6753739	0.871	rs6436110	MIMAT0014996	hsa-miR-3131	6.56	2.99e-10	0.43	0.38	Height;	chr2:219116231	chr2:219058725~219058747:-
COAD	cis	rs1163656	0.502	rs11114658	MIMAT0003287	hsa-miR-618	-6.54	3.35e-10	-0.56	-0.38	Dental caries;	chr12:80933378	chr12:80935796~80935818:-
COAD	cis	rs10021731	0.718	rs13104656	MIMAT0003242	hsa-miR-577	-6.53	3.5e-10	-0.3	-0.38	Optic disc area;	chr4:114495547	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.692	rs13104685	MIMAT0003242	hsa-miR-577	-6.53	3.5e-10	-0.3	-0.38	Optic disc area;	chr4:114495590	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.692	rs13104693	MIMAT0003242	hsa-miR-577	-6.53	3.5e-10	-0.3	-0.38	Optic disc area;	chr4:114495600	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.615	rs33914856	MIMAT0003242	hsa-miR-577	6.52	3.6e-10	0.4	0.38	Hemoglobin concentration;	chr4:114564668	chr4:114656774~114656794:+
COAD	cis	rs1163656	0.502	rs17007711	MIMAT0003287	hsa-miR-618	6.51	3.86e-10	0.54	0.38	Dental caries;	chr12:80934305	chr12:80935796~80935818:-
COAD	cis	rs10021731	0.809	rs12650546	MIMAT0003242	hsa-miR-577	6.51	3.95e-10	0.3	0.38	Optic disc area;	chr4:114578518	chr4:114656774~114656794:+
COAD	cis	rs7072216	0.763	rs10736129	MIMAT0005878	hsa-miR-1287-5p	-6.49	4.41e-10	-0.46	-0.38	Metabolite levels;	chr10:98411814	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.763	rs12763326	MIMAT0005878	hsa-miR-1287-5p	-6.48	4.59e-10	-0.44	-0.37	Metabolite levels;	chr10:98407639	chr10:98395271~98395292:-
COAD	cis	rs1163656	0.502	rs10862209	MIMAT0003287	hsa-miR-618	-6.45	5.53e-10	-0.55	-0.37	Dental caries;	chr12:80933176	chr12:80935796~80935818:-
COAD	cis	rs10021731	0.718	rs1824490	MIMAT0003242	hsa-miR-577	6.44	5.78e-10	0.29	0.37	Optic disc area;	chr4:114529766	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs1824489	MIMAT0003242	hsa-miR-577	6.44	5.78e-10	0.29	0.37	Optic disc area;	chr4:114529776	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs7669767	MIMAT0003242	hsa-miR-577	6.44	5.78e-10	0.29	0.37	Optic disc area;	chr4:114530264	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs2100782	MIMAT0003242	hsa-miR-577	6.44	5.78e-10	0.29	0.37	Optic disc area;	chr4:114530452	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs12508960	MIMAT0003242	hsa-miR-577	6.44	5.78e-10	0.29	0.37	Optic disc area;	chr4:114531061	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.681	rs11098254	MIMAT0003242	hsa-miR-577	6.44	5.78e-10	0.29	0.37	Optic disc area;	chr4:114531300	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs11098255	MIMAT0003242	hsa-miR-577	6.44	5.78e-10	0.29	0.37	Optic disc area;	chr4:114531393	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs7655989	MIMAT0003242	hsa-miR-577	-6.42	6.36e-10	-0.29	-0.37	Optic disc area;	chr4:114528134	chr4:114656774~114656794:+
COAD	cis	rs7072216	0.69	rs113195335	MIMAT0005878	hsa-miR-1287-5p	6.4	7.19e-10	0.45	0.37	Metabolite levels;	chr10:98415775	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.727	rs3750603	MIMAT0005878	hsa-miR-1287-5p	6.4	7.19e-10	0.45	0.37	Metabolite levels;	chr10:98415779	chr10:98395271~98395292:-
COAD	cis	rs6841433	0.571	rs1903365	MIMAT0003242	hsa-miR-577	6.4	7.29e-10	0.4	0.37	Hemoglobin concentration;	chr4:114561897	chr4:114656774~114656794:+
COAD	cis	rs7072216	0.763	rs3814142	MIMAT0005878	hsa-miR-1287-5p	6.4	7.51e-10	0.45	0.37	Metabolite levels;	chr10:98411347	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.691	rs3829853	MIMAT0005878	hsa-miR-1287-5p	6.4	7.51e-10	0.45	0.37	Metabolite levels;	chr10:98411417	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.727	rs10748728	MIMAT0005878	hsa-miR-1287-5p	6.4	7.51e-10	0.45	0.37	Metabolite levels;	chr10:98411441	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.763	rs10748729	MIMAT0005878	hsa-miR-1287-5p	6.4	7.51e-10	0.45	0.37	Metabolite levels;	chr10:98411614	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.763	rs10748730	MIMAT0005878	hsa-miR-1287-5p	6.4	7.51e-10	0.45	0.37	Metabolite levels;	chr10:98411683	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.763	rs7910014	MIMAT0005878	hsa-miR-1287-5p	6.4	7.51e-10	0.45	0.37	Metabolite levels;	chr10:98412353	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.763	rs7910247	MIMAT0005878	hsa-miR-1287-5p	6.4	7.51e-10	0.45	0.37	Metabolite levels;	chr10:98412495	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.727	rs7913541	MIMAT0005878	hsa-miR-1287-5p	6.4	7.51e-10	0.45	0.37	Metabolite levels;	chr10:98412722	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.763	rs6584204	MIMAT0005878	hsa-miR-1287-5p	6.4	7.51e-10	0.45	0.37	Metabolite levels;	chr10:98413823	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.763	rs6584205	MIMAT0005878	hsa-miR-1287-5p	6.4	7.51e-10	0.45	0.37	Metabolite levels;	chr10:98414049	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.763	rs3750601	MIMAT0005878	hsa-miR-1287-5p	6.4	7.51e-10	0.45	0.37	Metabolite levels;	chr10:98414804	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.763	rs2147900	MIMAT0005878	hsa-miR-1287-5p	6.4	7.51e-10	0.45	0.37	Metabolite levels;	chr10:98414964	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.763	rs2274246	MIMAT0005878	hsa-miR-1287-5p	6.4	7.51e-10	0.45	0.37	Metabolite levels;	chr10:98415303	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.763	rs2274245	MIMAT0005878	hsa-miR-1287-5p	6.4	7.51e-10	0.45	0.37	Metabolite levels;	chr10:98415325	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.763	rs2274244	MIMAT0005878	hsa-miR-1287-5p	6.4	7.51e-10	0.45	0.37	Metabolite levels;	chr10:98415461	chr10:98395271~98395292:-
COAD	cis	rs10021731	0.718	rs62309866	MIMAT0003242	hsa-miR-577	-6.39	7.63e-10	-0.29	-0.37	Optic disc area;	chr4:114479583	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.809	rs9884212	MIMAT0003242	hsa-miR-577	6.39	7.95e-10	0.3	0.37	Optic disc area;	chr4:114580888	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.744	rs2388976	MIMAT0003242	hsa-miR-577	6.39	7.95e-10	0.3	0.37	Optic disc area;	chr4:114581250	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs2054305	MIMAT0003242	hsa-miR-577	-6.39	7.96e-10	-0.29	-0.37	Optic disc area;	chr4:114496175	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.744	rs6814022	MIMAT0003242	hsa-miR-577	-6.38	8.27e-10	-0.29	-0.37	Optic disc area;	chr4:114528667	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.615	rs13127912	MIMAT0003242	hsa-miR-577	6.37	8.47e-10	0.4	0.37	Hemoglobin concentration;	chr4:114546019	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.615	rs10516603	MIMAT0003242	hsa-miR-577	6.37	8.47e-10	0.4	0.37	Hemoglobin concentration;	chr4:114546303	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.615	rs34685786	MIMAT0003242	hsa-miR-577	6.37	8.47e-10	0.4	0.37	Hemoglobin concentration;	chr4:114549280	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.615	rs13120552	MIMAT0003242	hsa-miR-577	6.37	8.47e-10	0.4	0.37	Hemoglobin concentration;	chr4:114552518	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.615	rs13101831	MIMAT0003242	hsa-miR-577	6.37	8.47e-10	0.4	0.37	Hemoglobin concentration;	chr4:114552771	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.66	rs13127941	MIMAT0003242	hsa-miR-577	6.37	8.47e-10	0.4	0.37	Hemoglobin concentration;	chr4:114553520	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.615	rs13147198	MIMAT0003242	hsa-miR-577	6.37	8.47e-10	0.4	0.37	Hemoglobin concentration;	chr4:114553935	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.615	rs34403145	MIMAT0003242	hsa-miR-577	6.37	8.47e-10	0.4	0.37	Hemoglobin concentration;	chr4:114554629	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.615	rs12643074	MIMAT0003242	hsa-miR-577	6.37	8.47e-10	0.4	0.37	Hemoglobin concentration;	chr4:114555226	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.615	rs2100783	MIMAT0003242	hsa-miR-577	6.37	8.47e-10	0.4	0.37	Hemoglobin concentration;	chr4:114555821	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.615	rs12650115	MIMAT0003242	hsa-miR-577	6.37	8.47e-10	0.4	0.37	Hemoglobin concentration;	chr4:114560232	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.615	rs12644238	MIMAT0003242	hsa-miR-577	6.37	8.47e-10	0.4	0.37	Hemoglobin concentration;	chr4:114560598	chr4:114656774~114656794:+
COAD	cis	rs1712517	0.525	rs7911488	MIMAT0005951	hsa-miR-1307-3p	-6.36	9.33e-10	-0.25	-0.37	Migraine;	chr10:103394332	chr10:103394301~103394322:-
COAD	cis	rs6841433	0.615	rs13110751	MIMAT0003242	hsa-miR-577	6.33	1.08e-09	0.4	0.37	Hemoglobin concentration;	chr4:114563572	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.615	rs13105144	MIMAT0003242	hsa-miR-577	6.33	1.08e-09	0.4	0.37	Hemoglobin concentration;	chr4:114563873	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs7698790	MIMAT0003242	hsa-miR-577	6.33	1.12e-09	0.29	0.37	Optic disc area;	chr4:114492647	chr4:114656774~114656794:+
COAD	cis	rs7072216	0.763	rs942805	MIMAT0005878	hsa-miR-1287-5p	6.31	1.2e-09	0.44	0.37	Metabolite levels;	chr10:98408615	chr10:98395271~98395292:-
COAD	cis	rs10021731	0.668	rs1599317	MIMAT0003242	hsa-miR-577	-6.31	1.21e-09	-0.29	-0.37	Optic disc area;	chr4:114503010	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.692	rs6834235	MIMAT0003242	hsa-miR-577	-6.31	1.23e-09	-0.28	-0.37	Optic disc area;	chr4:114531582	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs1599320	MIMAT0003242	hsa-miR-577	-6.31	1.23e-09	-0.28	-0.37	Optic disc area;	chr4:114532227	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs7685549	MIMAT0003242	hsa-miR-577	-6.3	1.27e-09	-0.28	-0.37	Optic disc area;	chr4:114479772	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs7686774	MIMAT0003242	hsa-miR-577	-6.3	1.27e-09	-0.28	-0.37	Optic disc area;	chr4:114480357	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs7687413	MIMAT0003242	hsa-miR-577	-6.3	1.27e-09	-0.28	-0.37	Optic disc area;	chr4:114480417	chr4:114656774~114656794:+
COAD	cis	rs6753739	0.871	rs12694452	MIMAT0014996	hsa-miR-3131	-6.29	1.35e-09	-0.42	-0.37	Height;	chr2:219162677	chr2:219058725~219058747:-
COAD	cis	rs6841433	0.615	rs35594431	MIMAT0003242	hsa-miR-577	6.28	1.45e-09	0.39	0.36	Hemoglobin concentration;	chr4:114554497	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs1585446	MIMAT0003242	hsa-miR-577	-6.27	1.55e-09	-0.29	-0.36	Optic disc area;	chr4:114490871	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs13127822	MIMAT0003242	hsa-miR-577	-6.27	1.55e-09	-0.29	-0.36	Optic disc area;	chr4:114493024	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.668	rs2199311	MIMAT0003242	hsa-miR-577	-6.27	1.56e-09	-0.29	-0.36	Optic disc area;	chr4:114492288	chr4:114656774~114656794:+
COAD	cis	rs7072216	0.763	rs8181292	MIMAT0005878	hsa-miR-1287-5p	6.26	1.59e-09	0.44	0.36	Metabolite levels;	chr10:98415720	chr10:98395271~98395292:-
COAD	cis	rs10021731	0.692	rs1599316	MIMAT0003242	hsa-miR-577	-6.26	1.59e-09	-0.29	-0.36	Optic disc area;	chr4:114490702	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs7689158	MIMAT0003242	hsa-miR-577	-6.26	1.6e-09	-0.28	-0.36	Optic disc area;	chr4:114495770	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs2054304	MIMAT0003242	hsa-miR-577	-6.26	1.6e-09	-0.28	-0.36	Optic disc area;	chr4:114495902	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs11724674	MIMAT0003242	hsa-miR-577	-6.26	1.62e-09	-0.28	-0.36	Optic disc area;	chr4:114482175	chr4:114656774~114656794:+
COAD	cis	rs7072216	0.763	rs7909822	MIMAT0005878	hsa-miR-1287-5p	6.26	1.64e-09	0.44	0.36	Metabolite levels;	chr10:98412278	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.763	rs942803	MIMAT0005878	hsa-miR-1287-5p	6.25	1.66e-09	0.44	0.36	Metabolite levels;	chr10:98408874	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.763	rs12259939	MIMAT0005878	hsa-miR-1287-5p	6.25	1.66e-09	0.44	0.36	Metabolite levels;	chr10:98409264	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.763	rs7923729	MIMAT0005878	hsa-miR-1287-5p	6.25	1.66e-09	0.44	0.36	Metabolite levels;	chr10:98409708	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.763	rs6584198	MIMAT0005878	hsa-miR-1287-5p	6.25	1.66e-09	0.44	0.36	Metabolite levels;	chr10:98410149	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.727	rs6584199	MIMAT0005878	hsa-miR-1287-5p	6.25	1.66e-09	0.44	0.36	Metabolite levels;	chr10:98410226	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.763	rs6584200	MIMAT0005878	hsa-miR-1287-5p	6.25	1.66e-09	0.44	0.36	Metabolite levels;	chr10:98410280	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.763	rs6584201	MIMAT0005878	hsa-miR-1287-5p	6.25	1.66e-09	0.44	0.36	Metabolite levels;	chr10:98410452	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.763	rs3814140	MIMAT0005878	hsa-miR-1287-5p	6.25	1.66e-09	0.44	0.36	Metabolite levels;	chr10:98411005	chr10:98395271~98395292:-
COAD	cis	rs10021731	0.644	rs7665675	MIMAT0003242	hsa-miR-577	-6.24	1.75e-09	-0.28	-0.36	Optic disc area;	chr4:114480704	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs7692571	MIMAT0003242	hsa-miR-577	-6.24	1.75e-09	-0.28	-0.36	Optic disc area;	chr4:114480792	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.809	rs35733223	MIMAT0003242	hsa-miR-577	6.24	1.8e-09	0.29	0.36	Optic disc area;	chr4:114566454	chr4:114656774~114656794:+
COAD	cis	rs7072216	0.763	rs2274243	MIMAT0005878	hsa-miR-1287-5p	6.24	1.83e-09	0.44	0.36	Metabolite levels;	chr10:98415510	chr10:98395271~98395292:-
COAD	cis	rs6841433	0.615	rs13136602	MIMAT0003242	hsa-miR-577	6.23	1.85e-09	0.4	0.36	Hemoglobin concentration;	chr4:114541864	chr4:114656774~114656794:+
COAD	cis	rs6841433	0.615	rs12649943	MIMAT0003242	hsa-miR-577	6.23	1.85e-09	0.4	0.36	Hemoglobin concentration;	chr4:114542460	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.521	rs116635794	MIMAT0003242	hsa-miR-577	-6.23	1.85e-09	-0.28	-0.36	Optic disc area;	chr4:114520865	chr4:114656774~114656794:+
COAD	cis	rs7072216	0.806	rs9804285	MIMAT0005878	hsa-miR-1287-5p	6.23	1.85e-09	0.44	0.36	Metabolite levels;	chr10:98409715	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.763	rs10732782	MIMAT0005878	hsa-miR-1287-5p	6.23	1.91e-09	0.43	0.36	Metabolite levels;	chr10:98406749	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.691	rs7910973	MIMAT0005878	hsa-miR-1287-5p	6.23	1.91e-09	0.43	0.36	Metabolite levels;	chr10:98406975	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.763	rs7911036	MIMAT0005878	hsa-miR-1287-5p	6.23	1.91e-09	0.43	0.36	Metabolite levels;	chr10:98407258	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.763	rs10883090	MIMAT0005878	hsa-miR-1287-5p	6.23	1.91e-09	0.43	0.36	Metabolite levels;	chr10:98407479	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.763	rs45523432	MIMAT0005878	hsa-miR-1287-5p	6.23	1.91e-09	0.43	0.36	Metabolite levels;	chr10:98407679	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.763	rs12763044	MIMAT0005878	hsa-miR-1287-5p	6.23	1.91e-09	0.43	0.36	Metabolite levels;	chr10:98407694	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.727	rs942808	MIMAT0005878	hsa-miR-1287-5p	6.23	1.91e-09	0.43	0.36	Metabolite levels;	chr10:98408345	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.727	rs942807	MIMAT0005878	hsa-miR-1287-5p	6.23	1.91e-09	0.43	0.36	Metabolite levels;	chr10:98408462	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.763	rs9787550	MIMAT0005878	hsa-miR-1287-5p	6.23	1.91e-09	0.43	0.36	Metabolite levels;	chr10:98409294	chr10:98395271~98395292:-
COAD	cis	rs10021731	0.809	rs12647519	MIMAT0003242	hsa-miR-577	6.23	1.94e-09	0.29	0.36	Optic disc area;	chr4:114594742	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.782	rs12650319	MIMAT0003242	hsa-miR-577	6.21	2.07e-09	0.29	0.36	Optic disc area;	chr4:114594734	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.782	rs7437569	MIMAT0003242	hsa-miR-577	-6.21	2.15e-09	-0.29	-0.36	Optic disc area;	chr4:114595431	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.867	rs12507591	MIMAT0003242	hsa-miR-577	6.2	2.21e-09	0.29	0.36	Optic disc area;	chr4:114574339	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.782	rs2388975	MIMAT0003242	hsa-miR-577	6.2	2.28e-09	0.29	0.36	Optic disc area;	chr4:114592899	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.692	rs12108281	MIMAT0003242	hsa-miR-577	-6.18	2.56e-09	-0.28	-0.36	Optic disc area;	chr4:114522147	chr4:114656774~114656794:+
COAD	cis	rs7072216	0.763	rs942804	MIMAT0005878	hsa-miR-1287-5p	6.16	2.73e-09	0.43	0.36	Metabolite levels;	chr10:98408742	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.763	rs10883091	MIMAT0005878	hsa-miR-1287-5p	6.13	3.29e-09	0.42	0.36	Metabolite levels;	chr10:98407482	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.763	rs10883092	MIMAT0005878	hsa-miR-1287-5p	6.13	3.29e-09	0.42	0.36	Metabolite levels;	chr10:98407519	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.763	rs6584202	MIMAT0005878	hsa-miR-1287-5p	6.12	3.45e-09	0.43	0.36	Metabolite levels;	chr10:98410626	chr10:98395271~98395292:-
COAD	cis	rs10021731	0.809	rs7655987	MIMAT0003242	hsa-miR-577	6.12	3.57e-09	0.29	0.36	Optic disc area;	chr4:114596146	chr4:114656774~114656794:+
COAD	cis	rs7255436	0.83	rs4350678	MIMAT0021017	hsa-miR-4999-5p	6.11	3.64e-09	0.47	0.36	HDL cholesterol;	chr19:8382482	chr19:8389340~8389360:-
COAD	cis	rs1163656	0.502	rs17007704	MIMAT0003287	hsa-miR-618	-6.1	3.93e-09	-0.54	-0.36	Dental caries;	chr12:80932218	chr12:80935796~80935818:-
COAD	cis	rs10021731	0.718	rs11724670	MIMAT0003242	hsa-miR-577	-6.1	3.96e-09	-0.28	-0.36	Optic disc area;	chr4:114482122	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs10002657	MIMAT0003242	hsa-miR-577	-6.1	3.96e-09	-0.28	-0.36	Optic disc area;	chr4:114483120	chr4:114656774~114656794:+
COAD	cis	rs7255436	0.931	rs7249520	MIMAT0021017	hsa-miR-4999-5p	6.09	4.2e-09	0.47	0.35	HDL cholesterol;	chr19:8381172	chr19:8389340~8389360:-
COAD	cis	rs7255436	0.965	rs7249624	MIMAT0021017	hsa-miR-4999-5p	6.09	4.2e-09	0.47	0.35	HDL cholesterol;	chr19:8381251	chr19:8389340~8389360:-
COAD	cis	rs6841433	0.511	rs36078253	MIMAT0003242	hsa-miR-577	6.07	4.66e-09	0.36	0.35	Hemoglobin concentration;	chr4:114538112	chr4:114656774~114656794:+
COAD	cis	rs75358501	0.901	rs76270461	MIMAT0014995	hsa-miR-3130-5p	-6.06	4.71e-09	-0.69	-0.35	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206788929	chr2:206783276~206783296:-
COAD	cis	rs75358501	0.901	rs76270461	MIMAT0014995_1	hsa-miR-3130-5p	-6.06	4.71e-09	-0.69	-0.35	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206788929	chr2:206783246~206783266:+
COAD	cis	rs10021731	0.718	rs12505597	MIMAT0003242	hsa-miR-577	-6.06	4.76e-09	-0.28	-0.35	Optic disc area;	chr4:114527954	chr4:114656774~114656794:+
COAD	cis	rs7255436	0.965	rs11668346	MIMAT0021017	hsa-miR-4999-5p	6.06	4.81e-09	0.46	0.35	HDL cholesterol;	chr19:8385970	chr19:8389340~8389360:-
COAD	cis	rs7255436	0.965	rs12981318	MIMAT0021017	hsa-miR-4999-5p	6.06	4.81e-09	0.46	0.35	HDL cholesterol;	chr19:8386546	chr19:8389340~8389360:-
COAD	cis	rs7255436	0.965	rs7351098	MIMAT0021017	hsa-miR-4999-5p	6.06	4.81e-09	0.46	0.35	HDL cholesterol;	chr19:8386787	chr19:8389340~8389360:-
COAD	cis	rs10021731	0.692	rs10021252	MIMAT0003242	hsa-miR-577	-6.06	4.87e-09	-0.28	-0.35	Optic disc area;	chr4:114515190	chr4:114656774~114656794:+
COAD	cis	rs1712517	0.526	rs113528138	MIMAT0005951	hsa-miR-1307-3p	-6.05	5.18e-09	-0.24	-0.35	Migraine;	chr10:103365694	chr10:103394301~103394322:-
COAD	cis	rs1712517	0.525	rs11191667	MIMAT0005951	hsa-miR-1307-3p	-6.05	5.18e-09	-0.24	-0.35	Migraine;	chr10:103369141	chr10:103394301~103394322:-
COAD	cis	rs7255436	0.965	rs11666003	MIMAT0021017	hsa-miR-4999-5p	6.04	5.47e-09	0.46	0.35	HDL cholesterol;	chr19:8387218	chr19:8389340~8389360:-
COAD	cis	rs1712517	1	rs1712517	MIMAT0005951	hsa-miR-1307-3p	-6.03	5.55e-09	-0.22	-0.35	Migraine;	chr10:103273258	chr10:103394301~103394322:-
COAD	cis	rs6841433	0.615	rs13114989	MIMAT0003242	hsa-miR-577	6.03	5.67e-09	0.38	0.35	Hemoglobin concentration;	chr4:114538869	chr4:114656774~114656794:+
COAD	cis	rs6753739	0.871	rs10174319	MIMAT0014996	hsa-miR-3131	-6.03	5.76e-09	-0.46	-0.35	Height;	chr2:219140586	chr2:219058725~219058747:-
COAD	cis	rs10021731	0.718	rs13104081	MIMAT0003242	hsa-miR-577	-5.99	7.23e-09	-0.28	-0.35	Optic disc area;	chr4:114532641	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.735	rs9995962	MIMAT0003242	hsa-miR-577	5.95	8.66e-09	0.28	0.35	Optic disc area;	chr4:114551671	chr4:114656774~114656794:+
COAD	cis	rs7072216	0.763	rs1061437	MIMAT0005878	hsa-miR-1287-5p	5.94	9.44e-09	0.42	0.35	Metabolite levels;	chr10:98416397	chr10:98395271~98395292:-
COAD	cis	rs7255436	0.965	rs11666233	MIMAT0021017	hsa-miR-4999-5p	5.93	9.76e-09	0.46	0.35	HDL cholesterol;	chr19:8387161	chr19:8389340~8389360:-
COAD	cis	rs1712517	0.873	rs1891292	MIMAT0005951	hsa-miR-1307-3p	5.91	1.09e-08	0.21	0.35	Migraine;	chr10:103241753	chr10:103394301~103394322:-
COAD	cis	rs7255436	0.965	rs62117510	MIMAT0021017	hsa-miR-4999-5p	5.9	1.14e-08	0.46	0.35	HDL cholesterol;	chr19:8387729	chr19:8389340~8389360:-
COAD	cis	rs7255436	0.965	rs28729307	MIMAT0021017	hsa-miR-4999-5p	5.9	1.14e-08	0.46	0.35	HDL cholesterol;	chr19:8387858	chr19:8389340~8389360:-
COAD	cis	rs7255436	0.894	rs10413136	MIMAT0021017	hsa-miR-4999-5p	5.9	1.14e-08	0.46	0.35	HDL cholesterol;	chr19:8387995	chr19:8389340~8389360:-
COAD	cis	rs7255436	1	rs7255436	MIMAT0021017	hsa-miR-4999-5p	5.9	1.17e-08	0.46	0.35	HDL cholesterol;	chr19:8368312	chr19:8389340~8389360:-
COAD	cis	rs1712517	1	rs3123794	MIMAT0005951	hsa-miR-1307-3p	-5.89	1.2e-08	-0.21	-0.34	Migraine;	chr10:103273985	chr10:103394301~103394322:-
COAD	cis	rs7072216	0.763	rs733345	MIMAT0005878	hsa-miR-1287-5p	5.82	1.78e-08	0.4	0.34	Metabolite levels;	chr10:98404458	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.763	rs733346	MIMAT0005878	hsa-miR-1287-5p	5.82	1.78e-08	0.4	0.34	Metabolite levels;	chr10:98404568	chr10:98395271~98395292:-
COAD	cis	rs7255436	0.965	rs7254882	MIMAT0021017	hsa-miR-4999-5p	5.8	1.91e-08	0.45	0.34	HDL cholesterol;	chr19:8388938	chr19:8389340~8389360:-
COAD	cis	rs6753739	0.871	rs4674360	MIMAT0014996	hsa-miR-3131	-5.8	1.93e-08	-0.45	-0.34	Height;	chr2:219144943	chr2:219058725~219058747:-
COAD	cis	rs12712135	0.709	rs10201184	MIMAT0019927	hsa-miR-4772-3p	-5.8	1.98e-08	-0.3	-0.34	Blood protein levels;	chr2:102472618	chr2:102432336~102432357:+
COAD	cis	rs7072216	0.763	rs7914401	MIMAT0005878	hsa-miR-1287-5p	5.79	2.01e-08	0.41	0.34	Metabolite levels;	chr10:98404171	chr10:98395271~98395292:-
COAD	cis	rs7255436	0.928	rs7250870	MIMAT0021017	hsa-miR-4999-5p	5.76	2.39e-08	0.44	0.34	HDL cholesterol;	chr19:8388798	chr19:8389340~8389360:-
COAD	cis	rs1163656	0.534	rs17007709	MIMAT0003287	hsa-miR-618	-5.74	2.62e-08	-0.43	-0.34	Dental caries;	chr12:80934267	chr12:80935796~80935818:-
COAD	cis	rs7072216	0.655	rs3830025	MIMAT0005878	hsa-miR-1287-5p	5.74	2.73e-08	0.41	0.34	Metabolite levels;	chr10:98416347	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.655	rs3830024	MIMAT0005878	hsa-miR-1287-5p	5.74	2.73e-08	0.41	0.34	Metabolite levels;	chr10:98416349	chr10:98395271~98395292:-
COAD	cis	rs10021731	0.577	rs34941812	MIMAT0003242	hsa-miR-577	-5.73	2.75e-08	-0.29	-0.34	Optic disc area;	chr4:114673260	chr4:114656774~114656794:+
COAD	cis	rs7072216	0.727	rs942809	MIMAT0005878	hsa-miR-1287-5p	5.73	2.78e-08	0.4	0.34	Metabolite levels;	chr10:98408244	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.763	rs7091709	MIMAT0005878	hsa-miR-1287-5p	5.73	2.87e-08	0.4	0.34	Metabolite levels;	chr10:98407848	chr10:98395271~98395292:-
COAD	cis	rs6841433	0.511	rs34534063	MIMAT0003242	hsa-miR-577	5.72	2.97e-08	0.34	0.34	Hemoglobin concentration;	chr4:114538077	chr4:114656774~114656794:+
COAD	cis	rs1712517	0.873	rs1163083	MIMAT0005951	hsa-miR-1307-3p	-5.71	3.08e-08	-0.21	-0.34	Migraine;	chr10:103278698	chr10:103394301~103394322:-
COAD	cis	rs10021731	0.668	rs28651771	MIMAT0003242	hsa-miR-577	-5.7	3.23e-08	-0.26	-0.34	Optic disc area;	chr4:114501291	chr4:114656774~114656794:+
COAD	cis	rs12712135	0.709	rs55664618	MIMAT0019927	hsa-miR-4772-3p	5.7	3.26e-08	0.29	0.34	Blood protein levels;	chr2:102399756	chr2:102432336~102432357:+
COAD	cis	rs10021731	0.756	rs1460782	MIMAT0003242	hsa-miR-577	-5.7	3.3e-08	-0.28	-0.33	Optic disc area;	chr4:114540002	chr4:114656774~114656794:+
COAD	cis	rs7072216	0.726	rs4474372	MIMAT0005878	hsa-miR-1287-5p	5.69	3.44e-08	0.4	0.33	Metabolite levels;	chr10:98404814	chr10:98395271~98395292:-
COAD	cis	rs10021731	0.668	rs62309894	MIMAT0003242	hsa-miR-577	-5.67	3.75e-08	-0.27	-0.33	Optic disc area;	chr4:114504575	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.706	rs1380931	MIMAT0003242	hsa-miR-577	-5.67	3.75e-08	-0.27	-0.33	Optic disc area;	chr4:114506853	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.668	rs2199313	MIMAT0003242	hsa-miR-577	-5.67	3.75e-08	-0.27	-0.33	Optic disc area;	chr4:114513488	chr4:114656774~114656794:+
COAD	cis	rs1712517	0.771	rs11191676	MIMAT0005951	hsa-miR-1307-3p	-5.67	3.88e-08	-0.21	-0.33	Migraine;	chr10:103395309	chr10:103394301~103394322:-
COAD	cis	rs1712517	1	rs1163084	MIMAT0005951	hsa-miR-1307-3p	-5.66	3.98e-08	-0.21	-0.33	Migraine;	chr10:103279291	chr10:103394301~103394322:-
COAD	cis	rs7072216	0.763	rs2147901	MIMAT0005878	hsa-miR-1287-5p	-5.65	4.18e-08	-0.39	-0.33	Metabolite levels;	chr10:98405739	chr10:98395271~98395292:-
COAD	cis	rs12712135	0.709	rs12463588	MIMAT0019927	hsa-miR-4772-3p	5.65	4.26e-08	0.29	0.33	Blood protein levels;	chr2:102468797	chr2:102432336~102432357:+
COAD	cis	rs12712135	0.709	rs2310302	MIMAT0019927	hsa-miR-4772-3p	5.65	4.26e-08	0.29	0.33	Blood protein levels;	chr2:102469589	chr2:102432336~102432357:+
COAD	cis	rs12712135	0.709	rs10195075	MIMAT0019927	hsa-miR-4772-3p	5.65	4.26e-08	0.29	0.33	Blood protein levels;	chr2:102471192	chr2:102432336~102432357:+
COAD	cis	rs12712135	0.709	rs1403553	MIMAT0019927	hsa-miR-4772-3p	5.65	4.26e-08	0.29	0.33	Blood protein levels;	chr2:102471202	chr2:102432336~102432357:+
COAD	cis	rs7072216	0.763	rs4475861	MIMAT0005878	hsa-miR-1287-5p	5.65	4.31e-08	0.39	0.33	Metabolite levels;	chr10:98405232	chr10:98395271~98395292:-
COAD	cis	rs6681460	0.625	rs6696812	MIMAT0014979	hsa-miR-3117-3p	-5.63	4.65e-08	-0.4	-0.33	Presence of antiphospholipid antibodies;	chr1:66634626	chr1:66628485~66628505:+
COAD	cis	rs1712517	0.503	rs72846198	MIMAT0005951	hsa-miR-1307-3p	-5.63	4.81e-08	-0.22	-0.33	Migraine;	chr10:103338267	chr10:103394301~103394322:-
COAD	cis	rs10021731	0.692	rs62309904	MIMAT0003242	hsa-miR-577	-5.62	4.92e-08	-0.26	-0.33	Optic disc area;	chr4:114514011	chr4:114656774~114656794:+
COAD	cis	rs12712135	0.709	rs12469887	MIMAT0019927	hsa-miR-4772-3p	5.62	5.07e-08	0.29	0.33	Blood protein levels;	chr2:102470298	chr2:102432336~102432357:+
COAD	cis	rs10021731	0.756	rs28787070	MIMAT0003242	hsa-miR-577	-5.61	5.22e-08	-0.27	-0.33	Optic disc area;	chr4:114556918	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.668	rs7676684	MIMAT0003242	hsa-miR-577	5.6	5.45e-08	0.26	0.33	Optic disc area;	chr4:114492371	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.597	rs12508215	MIMAT0003242	hsa-miR-577	-5.6	5.53e-08	-0.28	-0.33	Optic disc area;	chr4:114699103	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.597	rs11098263	MIMAT0003242	hsa-miR-577	-5.6	5.53e-08	-0.28	-0.33	Optic disc area;	chr4:114686481	chr4:114656774~114656794:+
COAD	cis	rs1867631	1	rs11208928	MIMAT0014979	hsa-miR-3117-3p	-5.59	5.79e-08	-0.41	-0.33	Menopause (age at onset);	chr1:66623879	chr1:66628485~66628505:+
COAD	cis	rs12712135	0.709	rs11465730	MIMAT0019927	hsa-miR-4772-3p	5.58	5.94e-08	0.29	0.33	Blood protein levels;	chr2:102450398	chr2:102432336~102432357:+
COAD	cis	rs10021731	0.668	rs13103537	MIMAT0003242	hsa-miR-577	-5.58	6.03e-08	-0.26	-0.33	Optic disc area;	chr4:114495092	chr4:114656774~114656794:+
COAD	cis	rs1712517	0.904	rs4918007	MIMAT0005951	hsa-miR-1307-3p	5.58	6.2e-08	0.21	0.33	Migraine;	chr10:103347713	chr10:103394301~103394322:-
COAD	cis	rs10021731	0.668	rs13112732	MIMAT0003242	hsa-miR-577	-5.57	6.26e-08	-0.26	-0.33	Optic disc area;	chr4:114483845	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.668	rs55968476	MIMAT0003242	hsa-miR-577	-5.57	6.57e-08	-0.26	-0.33	Optic disc area;	chr4:114532478	chr4:114656774~114656794:+
COAD	cis	rs1870653	0.516	rs73848142	MIMAT0003242	hsa-miR-577	5.56	6.67e-08	0.41	0.33	Exploratory eye movement dysfunction in schizophrenia (number of eye fixations);	chr4:114506178	chr4:114656774~114656794:+
COAD	cis	rs6681460	0.625	rs12138066	MIMAT0014979	hsa-miR-3117-3p	-5.55	7.03e-08	-0.39	-0.33	Presence of antiphospholipid antibodies;	chr1:66638133	chr1:66628485~66628505:+
COAD	cis	rs1712517	0.566	rs1163073	MIMAT0005951	hsa-miR-1307-3p	5.54	7.62e-08	0.22	0.33	Migraine;	chr10:103263177	chr10:103394301~103394322:-
COAD	cis	rs6724465	1	rs1052483	MIMAT0014996	hsa-miR-3131	5.53	7.71e-08	0.53	0.33	Height;	chr2:219069626	chr2:219058725~219058747:-
COAD	cis	rs10021731	0.718	rs1460779	MIMAT0003242	hsa-miR-577	5.52	8.29e-08	0.25	0.33	Optic disc area;	chr4:114528894	chr4:114656774~114656794:+
COAD	cis	rs6724465	1	rs868945	MIMAT0014996	hsa-miR-3131	-5.5	8.96e-08	-0.63	-0.32	Height;	chr2:219059717	chr2:219058725~219058747:-
COAD	cis	rs17027258	0.609	rs4851005	MIMAT0019926	hsa-miR-4772-5p	5.5	9.16e-08	0.38	0.32	White blood cell types;	chr2:102395092	chr2:102432300~102432321:+
COAD	cis	rs10021731	0.756	rs1460783	MIMAT0003242	hsa-miR-577	-5.5	9.18e-08	-0.27	-0.32	Optic disc area;	chr4:114540109	chr4:114656774~114656794:+
COAD	cis	rs1712517	0.844	rs1163081	MIMAT0005951	hsa-miR-1307-3p	-5.5	9.24e-08	-0.2	-0.32	Migraine;	chr10:103270083	chr10:103394301~103394322:-
COAD	cis	rs12712135	0.677	rs6705385	MIMAT0019927	hsa-miR-4772-3p	5.49	9.55e-08	0.28	0.32	Blood protein levels;	chr2:102460109	chr2:102432336~102432357:+
COAD	cis	rs10021731	0.756	rs35235288	MIMAT0003242	hsa-miR-577	-5.49	9.81e-08	-0.26	-0.32	Optic disc area;	chr4:114547620	chr4:114656774~114656794:+
COAD	cis	rs1870653	0.516	rs80050223	MIMAT0003242	hsa-miR-577	5.48	1.01e-07	0.41	0.32	Exploratory eye movement dysfunction in schizophrenia (number of eye fixations);	chr4:114503554	chr4:114656774~114656794:+
COAD	cis	rs1712517	0.588	rs12220267	MIMAT0005951	hsa-miR-1307-3p	-5.48	1.02e-07	-0.22	-0.32	Migraine;	chr10:103315955	chr10:103394301~103394322:-
COAD	cis	rs950880	0.56	rs66780767	MIMAT0019927	hsa-miR-4772-3p	5.48	1.02e-07	0.28	0.32	Serum protein levels (sST2);	chr2:102323249	chr2:102432336~102432357:+
COAD	cis	rs12712135	0.709	rs4140786	MIMAT0019927	hsa-miR-4772-3p	5.48	1.02e-07	0.28	0.32	Blood protein levels;	chr2:102471716	chr2:102432336~102432357:+
COAD	cis	rs950880	0.56	rs13020793	MIMAT0019927	hsa-miR-4772-3p	5.47	1.05e-07	0.28	0.32	Serum protein levels (sST2);	chr2:102315466	chr2:102432336~102432357:+
COAD	cis	rs950880	0.517	rs1968170	MIMAT0019927	hsa-miR-4772-3p	5.47	1.05e-07	0.28	0.32	Serum protein levels (sST2);	chr2:102317342	chr2:102432336~102432357:+
COAD	cis	rs950880	0.56	rs11123918	MIMAT0019927	hsa-miR-4772-3p	5.47	1.05e-07	0.28	0.32	Serum protein levels (sST2);	chr2:102318777	chr2:102432336~102432357:+
COAD	cis	rs950880	0.56	rs10182639	MIMAT0019927	hsa-miR-4772-3p	5.47	1.05e-07	0.28	0.32	Serum protein levels (sST2);	chr2:102319345	chr2:102432336~102432357:+
COAD	cis	rs950880	0.56	rs12712136	MIMAT0019927	hsa-miR-4772-3p	5.47	1.05e-07	0.28	0.32	Serum protein levels (sST2);	chr2:102319906	chr2:102432336~102432357:+
COAD	cis	rs1867631	1	rs10889640	MIMAT0014979	hsa-miR-3117-3p	-5.47	1.06e-07	-0.4	-0.32	Menopause (age at onset);	chr1:66662168	chr1:66628485~66628505:+
COAD	cis	rs1867631	1	rs10789212	MIMAT0014979	hsa-miR-3117-3p	-5.47	1.06e-07	-0.4	-0.32	Menopause (age at onset);	chr1:66662472	chr1:66628485~66628505:+
COAD	cis	rs1867631	1	rs10789213	MIMAT0014979	hsa-miR-3117-3p	-5.47	1.06e-07	-0.4	-0.32	Menopause (age at onset);	chr1:66662518	chr1:66628485~66628505:+
COAD	cis	rs1712517	0.771	rs2292807	MIMAT0005951	hsa-miR-1307-3p	-5.47	1.06e-07	-0.2	-0.32	Migraine;	chr10:103395888	chr10:103394301~103394322:-
COAD	cis	rs12712135	0.709	rs11676236	MIMAT0019927	hsa-miR-4772-3p	5.47	1.08e-07	0.28	0.32	Blood protein levels;	chr2:102465235	chr2:102432336~102432357:+
COAD	cis	rs12712135	0.677	rs11687013	MIMAT0019927	hsa-miR-4772-3p	5.47	1.08e-07	0.28	0.32	Blood protein levels;	chr2:102465261	chr2:102432336~102432357:+
COAD	cis	rs1712517	0.873	rs7894240	MIMAT0005951	hsa-miR-1307-3p	5.47	1.09e-07	0.2	0.32	Migraine;	chr10:103240612	chr10:103394301~103394322:-
COAD	cis	rs950880	0.56	rs11690443	MIMAT0019927	hsa-miR-4772-3p	5.46	1.1e-07	0.28	0.32	Serum protein levels (sST2);	chr2:102319671	chr2:102432336~102432357:+
COAD	cis	rs1867631	1	rs11208927	MIMAT0014979	hsa-miR-3117-3p	-5.46	1.11e-07	-0.4	-0.32	Menopause (age at onset);	chr1:66623878	chr1:66628485~66628505:+
COAD	cis	rs1712517	0.835	rs2506961	MIMAT0005951	hsa-miR-1307-3p	5.45	1.16e-07	0.2	0.32	Migraine;	chr10:103248169	chr10:103394301~103394322:-
COAD	cis	rs1712517	0.873	rs1712510	MIMAT0005951	hsa-miR-1307-3p	5.45	1.16e-07	0.2	0.32	Migraine;	chr10:103249329	chr10:103394301~103394322:-
COAD	cis	rs1712517	0.873	rs7903004	MIMAT0005951	hsa-miR-1307-3p	5.45	1.16e-07	0.2	0.32	Migraine;	chr10:103244344	chr10:103394301~103394322:-
COAD	cis	rs1712517	0.771	rs10883858	MIMAT0005951	hsa-miR-1307-3p	-5.45	1.21e-07	-0.2	-0.32	Migraine;	chr10:103367951	chr10:103394301~103394322:-
COAD	cis	rs6724465	1	rs72967954	MIMAT0014996	hsa-miR-3131	-5.43	1.28e-07	-0.62	-0.32	Height;	chr2:219057847	chr2:219058725~219058747:-
COAD	cis	rs7072216	0.727	rs7915108	MIMAT0005878	hsa-miR-1287-5p	5.43	1.31e-07	0.39	0.32	Metabolite levels;	chr10:98404684	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.727	rs7901577	MIMAT0005878	hsa-miR-1287-5p	5.43	1.31e-07	0.39	0.32	Metabolite levels;	chr10:98404685	chr10:98395271~98395292:-
COAD	cis	rs12712135	0.652	rs11465727	MIMAT0019927	hsa-miR-4772-3p	5.43	1.33e-07	0.28	0.32	Blood protein levels;	chr2:102448043	chr2:102432336~102432357:+
COAD	cis	rs1712517	0.566	rs7076274	MIMAT0005951	hsa-miR-1307-3p	-5.42	1.35e-07	-0.22	-0.32	Migraine;	chr10:103286250	chr10:103394301~103394322:-
COAD	cis	rs1712517	0.545	rs3740381	MIMAT0005951	hsa-miR-1307-3p	-5.42	1.35e-07	-0.22	-0.32	Migraine;	chr10:103286932	chr10:103394301~103394322:-
COAD	cis	rs1712517	0.566	rs7917388	MIMAT0005951	hsa-miR-1307-3p	-5.42	1.35e-07	-0.22	-0.32	Migraine;	chr10:103295206	chr10:103394301~103394322:-
COAD	cis	rs1712517	0.525	rs11191642	MIMAT0005951	hsa-miR-1307-3p	-5.42	1.35e-07	-0.22	-0.32	Migraine;	chr10:103296155	chr10:103394301~103394322:-
COAD	cis	rs6681460	0.604	rs7546825	MIMAT0014979	hsa-miR-3117-3p	-5.42	1.36e-07	-0.39	-0.32	Presence of antiphospholipid antibodies;	chr1:66636119	chr1:66628485~66628505:+
COAD	cis	rs6724465	0.929	rs7585868	MIMAT0014996	hsa-miR-3131	-5.41	1.42e-07	-0.61	-0.32	Height;	chr2:219117942	chr2:219058725~219058747:-
COAD	cis	rs950880	0.56	rs1997466	MIMAT0019927	hsa-miR-4772-3p	5.4	1.52e-07	0.28	0.32	Serum protein levels (sST2);	chr2:102335007	chr2:102432336~102432357:+
COAD	cis	rs950880	0.56	rs12712140	MIMAT0019927	hsa-miR-4772-3p	5.4	1.52e-07	0.28	0.32	Serum protein levels (sST2);	chr2:102334602	chr2:102432336~102432357:+
COAD	cis	rs950880	0.58	rs1997467	MIMAT0019927	hsa-miR-4772-3p	5.4	1.52e-07	0.28	0.32	Serum protein levels (sST2);	chr2:102334613	chr2:102432336~102432357:+
COAD	cis	rs12712135	0.709	rs11465729	MIMAT0019927	hsa-miR-4772-3p	5.39	1.58e-07	0.28	0.32	Blood protein levels;	chr2:102448052	chr2:102432336~102432357:+
COAD	cis	rs6724465	0.929	rs13410377	MIMAT0014996	hsa-miR-3131	-5.38	1.64e-07	-0.53	-0.32	Height;	chr2:219110326	chr2:219058725~219058747:-
COAD	cis	rs10021731	0.668	rs1599322	MIMAT0003242	hsa-miR-577	-5.38	1.71e-07	-0.25	-0.32	Optic disc area;	chr4:114531895	chr4:114656774~114656794:+
COAD	cis	rs950880	0.56	rs12466380	MIMAT0019927	hsa-miR-4772-3p	5.37	1.72e-07	0.28	0.32	Serum protein levels (sST2);	chr2:102332479	chr2:102432336~102432357:+
COAD	cis	rs950880	0.56	rs4142132	MIMAT0019927	hsa-miR-4772-3p	5.37	1.73e-07	0.28	0.32	Serum protein levels (sST2);	chr2:102321022	chr2:102432336~102432357:+
COAD	cis	rs950880	0.517	rs1420088	MIMAT0019927	hsa-miR-4772-3p	5.37	1.73e-07	0.28	0.32	Serum protein levels (sST2);	chr2:102322974	chr2:102432336~102432357:+
COAD	cis	rs950880	0.56	rs11123920	MIMAT0019927	hsa-miR-4772-3p	5.37	1.73e-07	0.28	0.32	Serum protein levels (sST2);	chr2:102323373	chr2:102432336~102432357:+
COAD	cis	rs950880	0.56	rs11676075	MIMAT0019927	hsa-miR-4772-3p	5.37	1.73e-07	0.28	0.32	Serum protein levels (sST2);	chr2:102324755	chr2:102432336~102432357:+
COAD	cis	rs950880	0.518	rs12996772	MIMAT0019927	hsa-miR-4772-3p	5.37	1.73e-07	0.28	0.32	Serum protein levels (sST2);	chr2:102330741	chr2:102432336~102432357:+
COAD	cis	rs10021731	0.546	rs12503437	MIMAT0003242	hsa-miR-577	-5.37	1.75e-07	-0.25	-0.32	Optic disc area;	chr4:114534955	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.546	rs12503481	MIMAT0003242	hsa-miR-577	-5.37	1.75e-07	-0.25	-0.32	Optic disc area;	chr4:114535080	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.546	rs7668023	MIMAT0003242	hsa-miR-577	-5.37	1.75e-07	-0.25	-0.32	Optic disc area;	chr4:114535366	chr4:114656774~114656794:+
COAD	cis	rs6681460	0.625	rs12127199	MIMAT0014979	hsa-miR-3117-3p	-5.36	1.86e-07	-0.38	-0.32	Presence of antiphospholipid antibodies;	chr1:66638059	chr1:66628485~66628505:+
COAD	cis	rs1712517	0.771	rs61871160	MIMAT0005951	hsa-miR-1307-3p	-5.34	2.04e-07	-0.2	-0.32	Migraine;	chr10:103384531	chr10:103394301~103394322:-
COAD	cis	rs1712517	0.771	rs10883857	MIMAT0005951	hsa-miR-1307-3p	5.33	2.14e-07	0.2	0.32	Migraine;	chr10:103367830	chr10:103394301~103394322:-
COAD	cis	rs950880	0.56	rs1362349	MIMAT0019927	hsa-miR-4772-3p	5.32	2.24e-07	0.27	0.32	Serum protein levels (sST2);	chr2:102335512	chr2:102432336~102432357:+
COAD	cis	rs1712517	0.836	rs7093039	MIMAT0005951	hsa-miR-1307-3p	-5.32	2.25e-07	-0.2	-0.31	Migraine;	chr10:103389790	chr10:103394301~103394322:-
COAD	cis	rs12712135	0.677	rs11678721	MIMAT0019927	hsa-miR-4772-3p	5.32	2.3e-07	0.28	0.31	Blood protein levels;	chr2:102456778	chr2:102432336~102432357:+
COAD	cis	rs12712135	0.709	rs11677555	MIMAT0019927	hsa-miR-4772-3p	5.32	2.3e-07	0.28	0.31	Blood protein levels;	chr2:102456833	chr2:102432336~102432357:+
COAD	cis	rs12712135	0.651	rs12712150	MIMAT0019927	hsa-miR-4772-3p	5.32	2.3e-07	0.28	0.31	Blood protein levels;	chr2:102458353	chr2:102432336~102432357:+
COAD	cis	rs12712135	0.709	rs6705498	MIMAT0019927	hsa-miR-4772-3p	5.32	2.3e-07	0.28	0.31	Blood protein levels;	chr2:102460210	chr2:102432336~102432357:+
COAD	cis	rs12712135	0.709	rs6719196	MIMAT0019927	hsa-miR-4772-3p	5.32	2.3e-07	0.28	0.31	Blood protein levels;	chr2:102460428	chr2:102432336~102432357:+
COAD	cis	rs6753739	0.673	rs17608747	MIMAT0014996	hsa-miR-3131	-5.31	2.37e-07	-0.44	-0.31	Height;	chr2:219117378	chr2:219058725~219058747:-
COAD	cis	rs1712517	0.844	rs1163075	MIMAT0005951	hsa-miR-1307-3p	5.31	2.4e-07	0.19	0.31	Migraine;	chr10:103261506	chr10:103394301~103394322:-
COAD	cis	rs7072216	0.843	rs4400721	MIMAT0005878	hsa-miR-1287-5p	5.3	2.47e-07	0.35	0.31	Metabolite levels;	chr10:98387340	chr10:98395271~98395292:-
COAD	cis	rs4917385	1	rs4917385	MIMAT0005951	hsa-miR-1307-3p	5.3	2.53e-07	0.21	0.31	Systemic lupus erythematosus;	chr10:103243964	chr10:103394301~103394322:-
COAD	cis	rs6681460	0.625	rs6680364	MIMAT0014979	hsa-miR-3117-3p	-5.29	2.59e-07	-0.38	-0.31	Presence of antiphospholipid antibodies;	chr1:66639151	chr1:66628485~66628505:+
COAD	cis	rs1712517	0.844	rs1163074	MIMAT0005951	hsa-miR-1307-3p	-5.29	2.61e-07	-0.19	-0.31	Migraine;	chr10:103262005	chr10:103394301~103394322:-
COAD	cis	rs1712517	0.838	rs6584543	MIMAT0005951	hsa-miR-1307-3p	5.28	2.7e-07	0.19	0.31	Migraine;	chr10:103237257	chr10:103394301~103394322:-
COAD	cis	rs1870653	0.516	rs115941533	MIMAT0003242	hsa-miR-577	5.27	2.82e-07	0.39	0.31	Exploratory eye movement dysfunction in schizophrenia (number of eye fixations);	chr4:114521099	chr4:114656774~114656794:+
COAD	cis	rs1712517	0.771	rs11191672	MIMAT0005951	hsa-miR-1307-3p	-5.27	2.85e-07	-0.19	-0.31	Migraine;	chr10:103379204	chr10:103394301~103394322:-
COAD	cis	rs950880	0.56	rs1362350	MIMAT0019927	hsa-miR-4772-3p	5.27	2.85e-07	0.27	0.31	Serum protein levels (sST2);	chr2:102335338	chr2:102432336~102432357:+
COAD	cis	rs950880	0.56	rs59247511	MIMAT0019927	hsa-miR-4772-3p	5.27	2.9e-07	0.27	0.31	Serum protein levels (sST2);	chr2:102337730	chr2:102432336~102432357:+
COAD	cis	rs1712517	0.873	rs1712516	MIMAT0005951	hsa-miR-1307-3p	-5.27	2.94e-07	-0.19	-0.31	Migraine;	chr10:103273871	chr10:103394301~103394322:-
COAD	cis	rs1712517	0.771	rs11191666	MIMAT0005951	hsa-miR-1307-3p	-5.25	3.13e-07	-0.19	-0.31	Migraine;	chr10:103367521	chr10:103394301~103394322:-
COAD	cis	rs1712517	0.524	rs1712509	MIMAT0005951	hsa-miR-1307-3p	-5.25	3.18e-07	-0.21	-0.31	Migraine;	chr10:103254113	chr10:103394301~103394322:-
COAD	cis	rs1867631	0.876	rs10889637	MIMAT0014979	hsa-miR-3117-3p	-5.25	3.24e-07	-0.38	-0.31	Menopause (age at onset);	chr1:66631782	chr1:66628485~66628505:+
COAD	cis	rs1870653	0.516	rs7671567	MIMAT0003242	hsa-miR-577	5.24	3.38e-07	0.38	0.31	Exploratory eye movement dysfunction in schizophrenia (number of eye fixations);	chr4:114517952	chr4:114656774~114656794:+
COAD	cis	rs950880	0.56	rs10183388	MIMAT0019927	hsa-miR-4772-3p	5.23	3.47e-07	0.27	0.31	Serum protein levels (sST2);	chr2:102315787	chr2:102432336~102432357:+
COAD	cis	rs7072216	0.65	rs10883089	MIMAT0005878	hsa-miR-1287-5p	5.23	3.51e-07	0.37	0.31	Metabolite levels;	chr10:98403363	chr10:98395271~98395292:-
COAD	cis	rs1870653	0.516	rs73848130	MIMAT0003242	hsa-miR-577	5.23	3.56e-07	0.38	0.31	Exploratory eye movement dysfunction in schizophrenia (number of eye fixations);	chr4:114489234	chr4:114656774~114656794:+
COAD	cis	rs6724465	1	rs56033548	MIMAT0014996	hsa-miR-3131	-5.22	3.66e-07	-0.61	-0.31	Height;	chr2:219071772	chr2:219058725~219058747:-
COAD	cis	rs1712517	0.771	rs61869827	MIMAT0005951	hsa-miR-1307-3p	-5.22	3.66e-07	-0.19	-0.31	Migraine;	chr10:103319682	chr10:103394301~103394322:-
COAD	cis	rs950880	0.56	rs1420102	MIMAT0019927	hsa-miR-4772-3p	5.22	3.72e-07	0.26	0.31	Serum protein levels (sST2);	chr2:102332359	chr2:102432336~102432357:+
COAD	cis	rs1712517	0.904	rs7905968	MIMAT0005951	hsa-miR-1307-3p	-5.21	3.8e-07	-0.19	-0.31	Migraine;	chr10:103375562	chr10:103394301~103394322:-
COAD	cis	rs950880	0.56	rs1558622	MIMAT0019927	hsa-miR-4772-3p	5.21	3.93e-07	0.26	0.31	Serum protein levels (sST2);	chr2:102313687	chr2:102432336~102432357:+
COAD	cis	rs950880	0.56	rs10189202	MIMAT0019927	hsa-miR-4772-3p	5.21	3.93e-07	0.26	0.31	Serum protein levels (sST2);	chr2:102313920	chr2:102432336~102432357:+
COAD	cis	rs950880	0.56	rs10191914	MIMAT0019927	hsa-miR-4772-3p	5.21	3.93e-07	0.26	0.31	Serum protein levels (sST2);	chr2:102314197	chr2:102432336~102432357:+
COAD	cis	rs950880	0.56	rs1558620	MIMAT0019927	hsa-miR-4772-3p	5.21	3.93e-07	0.26	0.31	Serum protein levels (sST2);	chr2:102314935	chr2:102432336~102432357:+
COAD	cis	rs950880	0.56	rs11685480	MIMAT0019927	hsa-miR-4772-3p	5.21	3.94e-07	0.26	0.31	Serum protein levels (sST2);	chr2:102310626	chr2:102432336~102432357:+
COAD	cis	rs1712517	0.771	rs59744322	MIMAT0005951	hsa-miR-1307-3p	-5.2	4.09e-07	-0.19	-0.31	Migraine;	chr10:103386935	chr10:103394301~103394322:-
COAD	cis	rs7894407	0.892	rs10883859	MIMAT0005951	hsa-miR-1307-3p	5.2	4.16e-07	0.2	0.31	White matter hyperintensity burden;	chr10:103368377	chr10:103394301~103394322:-
COAD	cis	rs6724465	1	rs10177466	MIMAT0014996	hsa-miR-3131	-5.19	4.29e-07	-0.5	-0.31	Height;	chr2:219046266	chr2:219058725~219058747:-
COAD	cis	rs75358501	0.636	rs7576591	MIMAT0014994	hsa-miR-3130-3p	5.19	4.34e-07	0.43	0.31	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784502	chr2:206783245~206783265:-
COAD	cis	rs75358501	0.636	rs7576591	MIMAT0014994_1	hsa-miR-3130-3p	5.19	4.34e-07	0.43	0.31	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784502	chr2:206783277~206783297:+
COAD	cis	rs75358501	0.636	rs2287628	MIMAT0014994	hsa-miR-3130-3p	5.19	4.34e-07	0.43	0.31	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785809	chr2:206783245~206783265:-
COAD	cis	rs75358501	0.636	rs2287628	MIMAT0014994_1	hsa-miR-3130-3p	5.19	4.34e-07	0.43	0.31	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785809	chr2:206783277~206783297:+
COAD	cis	rs6724465	1	rs72967942	MIMAT0014996	hsa-miR-3131	-5.19	4.36e-07	-0.5	-0.31	Height;	chr2:219052800	chr2:219058725~219058747:-
COAD	cis	rs76886731	1	rs76886731	MIMAT0019927	hsa-miR-4772-3p	5.18	4.43e-07	0.27	0.31	Leprosy;	chr2:102328956	chr2:102432336~102432357:+
COAD	cis	rs1712517	0.844	rs4918003	MIMAT0005951	hsa-miR-1307-3p	-5.18	4.49e-07	-0.19	-0.31	Migraine;	chr10:103284400	chr10:103394301~103394322:-
COAD	cis	rs75358501	0.636	rs11895370	MIMAT0014994	hsa-miR-3130-3p	5.17	4.8e-07	0.42	0.31	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206789990	chr2:206783245~206783265:-
COAD	cis	rs75358501	0.636	rs11895370	MIMAT0014994_1	hsa-miR-3130-3p	5.17	4.8e-07	0.42	0.31	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206789990	chr2:206783277~206783297:+
COAD	cis	rs12712135	0.709	rs11465728	MIMAT0019927	hsa-miR-4772-3p	5.16	4.97e-07	0.27	0.31	Blood protein levels;	chr2:102448051	chr2:102432336~102432357:+
COAD	cis	rs1867631	1	rs10889636	MIMAT0014979	hsa-miR-3117-3p	5.16	5e-07	0.37	0.31	Menopause (age at onset);	chr1:66624241	chr1:66628485~66628505:+
COAD	cis	rs6753739	0.625	rs359974	MIMAT0014996	hsa-miR-3131	5.16	5.05e-07	0.43	0.31	Height;	chr2:219065469	chr2:219058725~219058747:-
COAD	cis	rs75358501	0.636	rs16838834	MIMAT0014994	hsa-miR-3130-3p	5.15	5.23e-07	0.42	0.31	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765071	chr2:206783245~206783265:-
COAD	cis	rs75358501	0.636	rs16838834	MIMAT0014994_1	hsa-miR-3130-3p	5.15	5.23e-07	0.42	0.31	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765071	chr2:206783277~206783297:+
COAD	cis	rs6841433	0.615	rs17047236	MIMAT0003242	hsa-miR-577	5.15	5.26e-07	0.32	0.31	Hemoglobin concentration;	chr4:114564575	chr4:114656774~114656794:+
COAD	cis	rs10021731	0.718	rs7698391	MIMAT0003242	hsa-miR-577	-5.14	5.37e-07	-0.23	-0.31	Optic disc area;	chr4:114492457	chr4:114656774~114656794:+
COAD	cis	rs1712517	0.524	rs4917384	MIMAT0005951	hsa-miR-1307-3p	5.12	6.04e-07	0.21	0.3	Migraine;	chr10:103236031	chr10:103394301~103394322:-
COAD	cis	rs75358501	0.636	rs10199766	MIMAT0014994	hsa-miR-3130-3p	5.11	6.16e-07	0.42	0.3	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206777144	chr2:206783245~206783265:-
COAD	cis	rs75358501	0.636	rs10199766	MIMAT0014994_1	hsa-miR-3130-3p	5.11	6.16e-07	0.42	0.3	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206777144	chr2:206783277~206783297:+
COAD	cis	rs75358501	0.636	rs13427002	MIMAT0014994	hsa-miR-3130-3p	5.11	6.16e-07	0.42	0.3	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206778949	chr2:206783245~206783265:-
COAD	cis	rs75358501	0.636	rs13427002	MIMAT0014994_1	hsa-miR-3130-3p	5.11	6.16e-07	0.42	0.3	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206778949	chr2:206783277~206783297:+
COAD	cis	rs7072216	0.621	rs3750605	MIMAT0005878	hsa-miR-1287-5p	5.11	6.36e-07	0.39	0.3	Metabolite levels;	chr10:98415897	chr10:98395271~98395292:-
COAD	cis	rs1712517	0.873	rs1163086	MIMAT0005951	hsa-miR-1307-3p	-5.11	6.42e-07	-0.19	-0.3	Migraine;	chr10:103279822	chr10:103394301~103394322:-
COAD	cis	rs75358501	0.636	rs888621	MIMAT0014994	hsa-miR-3130-3p	-5.1	6.45e-07	-0.42	-0.3	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784626	chr2:206783245~206783265:-
COAD	cis	rs75358501	0.636	rs888621	MIMAT0014994_1	hsa-miR-3130-3p	-5.1	6.45e-07	-0.42	-0.3	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784626	chr2:206783277~206783297:+
COAD	cis	rs6755560	0.963	rs1862090	MIMAT0014995	hsa-miR-3130-5p	5.1	6.52e-07	0.35	0.3	QT interval (drug interaction);	chr2:206828016	chr2:206783276~206783296:-
COAD	cis	rs6755560	0.963	rs1862090	MIMAT0014995_1	hsa-miR-3130-5p	5.1	6.52e-07	0.35	0.3	QT interval (drug interaction);	chr2:206828016	chr2:206783246~206783266:+
COAD	cis	rs6543140	0.601	rs7558013	MIMAT0019927	hsa-miR-4772-3p	-5.1	6.65e-07	-0.33	-0.3	Blood protein levels;	chr2:102376346	chr2:102432336~102432357:+
COAD	cis	rs1712517	0.904	rs6584547	MIMAT0005951	hsa-miR-1307-3p	-5.09	6.8e-07	-0.19	-0.3	Migraine;	chr10:103305652	chr10:103394301~103394322:-
COAD	cis	rs1712517	0.787	rs1163089	MIMAT0005951	hsa-miR-1307-3p	-5.09	6.96e-07	-0.19	-0.3	Migraine;	chr10:103284207	chr10:103394301~103394322:-
COAD	cis	rs6724465	1	rs7598980	MIMAT0014996	hsa-miR-3131	-5.09	7.07e-07	-0.54	-0.3	Height;	chr2:219103700	chr2:219058725~219058747:-
COAD	cis	rs6724465	1	rs56388436	MIMAT0014996	hsa-miR-3131	-5.09	7.08e-07	-0.6	-0.3	Height;	chr2:219094181	chr2:219058725~219058747:-
COAD	cis	rs75358501	0.636	rs12471008	MIMAT0014994	hsa-miR-3130-3p	5.08	7.13e-07	0.41	0.3	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206775059	chr2:206783245~206783265:-
COAD	cis	rs75358501	0.636	rs12471008	MIMAT0014994_1	hsa-miR-3130-3p	5.08	7.13e-07	0.41	0.3	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206775059	chr2:206783277~206783297:+
COAD	cis	rs75358501	0.636	rs768533	MIMAT0014994	hsa-miR-3130-3p	5.08	7.13e-07	0.41	0.3	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776113	chr2:206783245~206783265:-
COAD	cis	rs75358501	0.636	rs768533	MIMAT0014994_1	hsa-miR-3130-3p	5.08	7.13e-07	0.41	0.3	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776113	chr2:206783277~206783297:+
COAD	cis	rs6724465	1	rs72951738	MIMAT0014996	hsa-miR-3131	-5.08	7.22e-07	-0.59	-0.3	Height;	chr2:219102079	chr2:219058725~219058747:-
COAD	cis	rs1712517	0.836	rs11191649	MIMAT0005951	hsa-miR-1307-3p	-5.06	8.11e-07	-0.19	-0.3	Migraine;	chr10:103307280	chr10:103394301~103394322:-
COAD	cis	rs950880	0.56	rs12712141	MIMAT0019927	hsa-miR-4772-3p	5.06	8.16e-07	0.26	0.3	Serum protein levels (sST2);	chr2:102336607	chr2:102432336~102432357:+
COAD	cis	rs6724465	1	rs10197172	MIMAT0014996	hsa-miR-3131	-5.06	8.16e-07	-0.59	-0.3	Height;	chr2:219091214	chr2:219058725~219058747:-
COAD	cis	rs1712517	0.771	rs11191654	MIMAT0005951	hsa-miR-1307-3p	-5.05	8.24e-07	-0.18	-0.3	Migraine;	chr10:103317367	chr10:103394301~103394322:-
COAD	cis	rs1712517	0.771	rs7074749	MIMAT0005951	hsa-miR-1307-3p	-5.05	8.32e-07	-0.19	-0.3	Migraine;	chr10:103356299	chr10:103394301~103394322:-
COAD	cis	rs1712517	0.74	rs11191663	MIMAT0005951	hsa-miR-1307-3p	-5.05	8.32e-07	-0.19	-0.3	Migraine;	chr10:103358705	chr10:103394301~103394322:-
COAD	cis	rs7072216	0.587	rs3814141	MIMAT0005878	hsa-miR-1287-5p	5.05	8.36e-07	0.38	0.3	Metabolite levels;	chr10:98411271	chr10:98395271~98395292:-
COAD	cis	rs75358501	0.636	rs725980	MIMAT0014994	hsa-miR-3130-3p	5.04	8.67e-07	0.42	0.3	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206773856	chr2:206783245~206783265:-
COAD	cis	rs75358501	0.636	rs725980	MIMAT0014994_1	hsa-miR-3130-3p	5.04	8.67e-07	0.42	0.3	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206773856	chr2:206783277~206783297:+
COAD	cis	rs950880	0.542	rs953934	MIMAT0019927	hsa-miR-4772-3p	5.04	8.77e-07	0.25	0.3	Serum protein levels (sST2);	chr2:102315833	chr2:102432336~102432357:+
COAD	cis	rs6543140	0.601	rs78178597	MIMAT0019927	hsa-miR-4772-3p	-5.04	8.92e-07	-0.33	-0.3	Blood protein levels;	chr2:102407136	chr2:102432336~102432357:+
COAD	cis	rs950880	0.542	rs12996505	MIMAT0019927	hsa-miR-4772-3p	5.03	9.13e-07	0.26	0.3	Serum protein levels (sST2);	chr2:102315342	chr2:102432336~102432357:+
COAD	cis	rs6753739	0.673	rs62191797	MIMAT0014996	hsa-miR-3131	-5.02	9.52e-07	-0.42	-0.3	Height;	chr2:219129221	chr2:219058725~219058747:-
COAD	cis	rs6724465	1	rs79986235	MIMAT0014996	hsa-miR-3131	-5.02	9.57e-07	-0.59	-0.3	Height;	chr2:219079413	chr2:219058725~219058747:-
COAD	cis	rs75358501	0.636	rs2241347	MIMAT0014994	hsa-miR-3130-3p	5.02	9.63e-07	0.41	0.3	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206783257	chr2:206783245~206783265:-
COAD	cis	rs75358501	0.636	rs2241347	MIMAT0014994_1	hsa-miR-3130-3p	5.02	9.63e-07	0.41	0.3	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206783257	chr2:206783277~206783297:+
COAD	cis	rs6724465	0.925	rs13408333	MIMAT0014996	hsa-miR-3131	-5.02	9.7e-07	-0.54	-0.3	Height;	chr2:219106795	chr2:219058725~219058747:-
COAD	cis	rs6724465	0.925	rs13408334	MIMAT0014996	hsa-miR-3131	-5.02	9.7e-07	-0.54	-0.3	Height;	chr2:219106796	chr2:219058725~219058747:-
COAD	cis	rs6724465	1	rs13408337	MIMAT0014996	hsa-miR-3131	-5.02	9.7e-07	-0.54	-0.3	Height;	chr2:219106804	chr2:219058725~219058747:-
COAD	cis	rs1870653	0.516	rs9995562	MIMAT0003242	hsa-miR-577	5.02	9.81e-07	0.36	0.3	Exploratory eye movement dysfunction in schizophrenia (number of eye fixations);	chr4:114491077	chr4:114656774~114656794:+
COAD	cis	rs6724465	1	rs72951729	MIMAT0014996	hsa-miR-3131	-5.02	9.86e-07	-0.59	-0.3	Height;	chr2:219095821	chr2:219058725~219058747:-
COAD	cis	rs950880	0.56	rs971764	MIMAT0019927	hsa-miR-4772-3p	5.01	1.01e-06	0.25	0.3	Serum protein levels (sST2);	chr2:102321875	chr2:102432336~102432357:+
COAD	cis	rs950880	0.56	rs6706844	MIMAT0019927	hsa-miR-4772-3p	5.01	1.01e-06	0.25	0.3	Serum protein levels (sST2);	chr2:102323952	chr2:102432336~102432357:+
COAD	cis	rs7072216	0.555	rs2296433	MIMAT0005878	hsa-miR-1287-5p	5.01	1.03e-06	0.39	0.3	Metabolite levels;	chr10:98424305	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.555	rs2296432	MIMAT0005878	hsa-miR-1287-5p	5.01	1.03e-06	0.39	0.3	Metabolite levels;	chr10:98424306	chr10:98395271~98395292:-
COAD	cis	rs1867631	1	rs7546090	MIMAT0014979	hsa-miR-3117-3p	-5	1.06e-06	-0.36	-0.3	Menopause (age at onset);	chr1:66618298	chr1:66628485~66628505:+
COAD	cis	rs6681460	0.625	rs2872079	MIMAT0014979	hsa-miR-3117-3p	-5	1.08e-06	-0.35	-0.3	Presence of antiphospholipid antibodies;	chr1:66664388	chr1:66628485~66628505:+
COAD	cis	rs6543140	0.601	rs6543135	MIMAT0019927	hsa-miR-4772-3p	-4.99	1.13e-06	-0.33	-0.3	Blood protein levels;	chr2:102445946	chr2:102432336~102432357:+
COAD	cis	rs1712517	0.844	rs1163087	MIMAT0005951	hsa-miR-1307-3p	-4.97	1.21e-06	-0.19	-0.3	Migraine;	chr10:103283532	chr10:103394301~103394322:-
COAD	cis	rs6724465	0.929	rs13410177	MIMAT0014996	hsa-miR-3131	-4.97	1.21e-06	-0.53	-0.3	Height;	chr2:219110130	chr2:219058725~219058747:-
COAD	cis	rs6724465	1	rs56345933	MIMAT0014996	hsa-miR-3131	-4.94	1.42e-06	-0.48	-0.29	Height;	chr2:219049013	chr2:219058725~219058747:-
COAD	cis	rs6724465	1	rs56006038	MIMAT0014996	hsa-miR-3131	-4.94	1.42e-06	-0.48	-0.29	Height;	chr2:219049115	chr2:219058725~219058747:-
COAD	cis	rs7072216	1	rs7072216	MIMAT0005878	hsa-miR-1287-5p	4.92	1.53e-06	0.33	0.29	Metabolite levels;	chr10:98397096	chr10:98395271~98395292:-
COAD	cis	rs1712517	0.771	rs7921655	MIMAT0005951	hsa-miR-1307-3p	-4.92	1.54e-06	-0.18	-0.29	Migraine;	chr10:103353944	chr10:103394301~103394322:-
COAD	cis	rs1867631	0.958	rs7536188	MIMAT0014979	hsa-miR-3117-3p	4.92	1.56e-06	0.36	0.29	Menopause (age at onset);	chr1:66622243	chr1:66628485~66628505:+
COAD	cis	rs6681460	0.625	rs4488004	MIMAT0014979	hsa-miR-3117-3p	-4.92	1.57e-06	-0.36	-0.29	Presence of antiphospholipid antibodies;	chr1:66607631	chr1:66628485~66628505:+
COAD	cis	rs6681460	0.584	rs7528182	MIMAT0014979	hsa-miR-3117-3p	-4.92	1.57e-06	-0.35	-0.29	Presence of antiphospholipid antibodies;	chr1:66601686	chr1:66628485~66628505:+
COAD	cis	rs6753739	0.54	rs394452	MIMAT0014996	hsa-miR-3131	4.92	1.58e-06	0.42	0.29	Height;	chr2:219055315	chr2:219058725~219058747:-
COAD	cis	rs1712517	0.771	rs11191645	MIMAT0005951	hsa-miR-1307-3p	-4.91	1.62e-06	-0.18	-0.29	Migraine;	chr10:103299551	chr10:103394301~103394322:-
COAD	cis	rs6755560	0.889	rs7597011	MIMAT0014995	hsa-miR-3130-5p	4.91	1.65e-06	0.35	0.29	QT interval (drug interaction);	chr2:206855115	chr2:206783276~206783296:-
COAD	cis	rs6755560	0.889	rs7597011	MIMAT0014995_1	hsa-miR-3130-5p	4.91	1.65e-06	0.35	0.29	QT interval (drug interaction);	chr2:206855115	chr2:206783246~206783266:+
COAD	cis	rs1867631	0.958	rs7520226	MIMAT0014979	hsa-miR-3117-3p	-4.9	1.72e-06	-0.36	-0.29	Menopause (age at onset);	chr1:66615312	chr1:66628485~66628505:+
COAD	cis	rs1712517	0.771	rs61350103	MIMAT0005951	hsa-miR-1307-3p	-4.89	1.75e-06	-0.18	-0.29	Migraine;	chr10:103309363	chr10:103394301~103394322:-
COAD	cis	rs1870653	0.516	rs28555162	MIMAT0003242	hsa-miR-577	4.88	1.87e-06	0.35	0.29	Exploratory eye movement dysfunction in schizophrenia (number of eye fixations);	chr4:114517408	chr4:114656774~114656794:+
COAD	cis	rs6543140	0.572	rs17027173	MIMAT0019927	hsa-miR-4772-3p	-4.87	1.97e-06	-0.32	-0.29	Blood protein levels;	chr2:102440583	chr2:102432336~102432357:+
COAD	cis	rs1712517	0.771	rs11191664	MIMAT0005951	hsa-miR-1307-3p	-4.87	1.99e-06	-0.18	-0.29	Migraine;	chr10:103358719	chr10:103394301~103394322:-
COAD	cis	rs7894407	0.76	rs1163085	MIMAT0005951	hsa-miR-1307-3p	-4.86	2.04e-06	-0.19	-0.29	White matter hyperintensity burden;	chr10:103279484	chr10:103394301~103394322:-
COAD	cis	rs75358501	0.688	rs2287629	MIMAT0014994	hsa-miR-3130-3p	-4.86	2.08e-06	-0.39	-0.29	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785690	chr2:206783245~206783265:-
COAD	cis	rs75358501	0.688	rs2287629	MIMAT0014994_1	hsa-miR-3130-3p	-4.86	2.08e-06	-0.39	-0.29	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785690	chr2:206783277~206783297:+
COAD	cis	rs6724465	1	rs7586856	MIMAT0014996	hsa-miR-3131	-4.86	2.08e-06	-0.49	-0.29	Height;	chr2:219103854	chr2:219058725~219058747:-
COAD	cis	rs7072216	0.621	rs3750604	MIMAT0005878	hsa-miR-1287-5p	4.84	2.27e-06	0.38	0.29	Metabolite levels;	chr10:98415824	chr10:98395271~98395292:-
COAD	cis	rs7894407	0.76	rs4917386	MIMAT0005951	hsa-miR-1307-3p	4.83	2.32e-06	0.19	0.29	White matter hyperintensity burden;	chr10:103247771	chr10:103394301~103394322:-
COAD	cis	rs1867631	1	rs6665859	MIMAT0014979	hsa-miR-3117-3p	-4.81	2.52e-06	-0.35	-0.29	Menopause (age at onset);	chr1:66611872	chr1:66628485~66628505:+
COAD	cis	rs1712517	0.873	rs7913461	MIMAT0005951	hsa-miR-1307-3p	-4.81	2.54e-06	-0.18	-0.29	Migraine;	chr10:103241568	chr10:103394301~103394322:-
COAD	cis	rs1712517	0.838	rs1891293	MIMAT0005951	hsa-miR-1307-3p	4.79	2.79e-06	0.18	0.29	Migraine;	chr10:103242040	chr10:103394301~103394322:-
COAD	cis	rs1712517	0.873	rs7916056	MIMAT0005951	hsa-miR-1307-3p	4.78	2.92e-06	0.18	0.29	Migraine;	chr10:103238157	chr10:103394301~103394322:-
COAD	cis	rs6724465	1	rs72967918	MIMAT0014996	hsa-miR-3131	-4.78	2.95e-06	-0.5	-0.29	Height;	chr2:219047122	chr2:219058725~219058747:-
COAD	cis	rs6724465	1	rs10172118	MIMAT0014996	hsa-miR-3131	-4.78	2.95e-06	-0.5	-0.29	Height;	chr2:219048790	chr2:219058725~219058747:-
COAD	cis	rs1712517	0.771	rs2008530	MIMAT0005951	hsa-miR-1307-3p	-4.78	2.95e-06	-0.18	-0.29	Migraine;	chr10:103299082	chr10:103394301~103394322:-
COAD	cis	rs75358501	0.636	rs3815686	MIMAT0014994	hsa-miR-3130-3p	4.77	3.06e-06	0.39	0.29	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206768278	chr2:206783245~206783265:-
COAD	cis	rs75358501	0.636	rs3815686	MIMAT0014994_1	hsa-miR-3130-3p	4.77	3.06e-06	0.39	0.29	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206768278	chr2:206783277~206783297:+
COAD	cis	rs7588654	0.793	rs422702	MIMAT0014996	hsa-miR-3131	-4.75	3.43e-06	-0.55	-0.28	Height;	chr2:219037931	chr2:219058725~219058747:-
COAD	cis	rs1712517	0.74	rs4917387	MIMAT0005951	hsa-miR-1307-3p	-4.74	3.6e-06	-0.18	-0.28	Migraine;	chr10:103348698	chr10:103394301~103394322:-
COAD	cis	rs6724465	1	rs6724465	MIMAT0014996	hsa-miR-3131	-4.73	3.71e-06	-0.51	-0.28	Height;	chr2:219079124	chr2:219058725~219058747:-
COAD	cis	rs950880	0.56	rs974389	MIMAT0019927	hsa-miR-4772-3p	-4.73	3.71e-06	-0.24	-0.28	Serum protein levels (sST2);	chr2:102320521	chr2:102432336~102432357:+
COAD	cis	rs6755560	1	rs4283403	MIMAT0014995	hsa-miR-3130-5p	4.72	3.83e-06	0.32	0.28	QT interval (drug interaction);	chr2:206829091	chr2:206783276~206783296:-
COAD	cis	rs6755560	1	rs4283403	MIMAT0014995_1	hsa-miR-3130-5p	4.72	3.83e-06	0.32	0.28	QT interval (drug interaction);	chr2:206829091	chr2:206783246~206783266:+
COAD	cis	rs6724465	1	rs13386793	MIMAT0014996	hsa-miR-3131	-4.72	3.94e-06	-0.47	-0.28	Height;	chr2:219107852	chr2:219058725~219058747:-
COAD	cis	rs6724465	0.929	rs12104660	MIMAT0014996	hsa-miR-3131	-4.72	3.94e-06	-0.47	-0.28	Height;	chr2:219108262	chr2:219058725~219058747:-
COAD	cis	rs75358501	0.584	rs11894165	MIMAT0014994	hsa-miR-3130-3p	4.71	4.14e-06	0.42	0.28	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206759688	chr2:206783245~206783265:-
COAD	cis	rs75358501	0.584	rs11894165	MIMAT0014994_1	hsa-miR-3130-3p	4.71	4.14e-06	0.42	0.28	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206759688	chr2:206783277~206783297:+
COAD	cis	rs950880	0.71	rs1474309	MIMAT0019927	hsa-miR-4772-3p	-4.7	4.26e-06	-0.5	-0.28	Serum protein levels (sST2);	chr2:102474542	chr2:102432336~102432357:+
COAD	cis	rs6724465	1	rs6752757	MIMAT0014996	hsa-miR-3131	-4.7	4.27e-06	-0.51	-0.28	Height;	chr2:219079079	chr2:219058725~219058747:-
COAD	cis	rs6724465	1	rs13396442	MIMAT0014996	hsa-miR-3131	-4.7	4.27e-06	-0.51	-0.28	Height;	chr2:219106808	chr2:219058725~219058747:-
COAD	cis	rs75358501	0.688	rs1862087	MIMAT0014994	hsa-miR-3130-3p	4.69	4.36e-06	0.41	0.28	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206760843	chr2:206783245~206783265:-
COAD	cis	rs75358501	0.688	rs1862087	MIMAT0014994_1	hsa-miR-3130-3p	4.69	4.36e-06	0.41	0.28	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206760843	chr2:206783277~206783297:+
COAD	cis	rs6724465	0.866	rs12185751	MIMAT0014996	hsa-miR-3131	-4.69	4.46e-06	-0.52	-0.28	Height;	chr2:219040186	chr2:219058725~219058747:-
COAD	cis	rs6681460	0.565	rs2147776	MIMAT0014979	hsa-miR-3117-3p	-4.67	4.78e-06	-0.34	-0.28	Presence of antiphospholipid antibodies;	chr1:66641720	chr1:66628485~66628505:+
COAD	cis	rs6724465	1	rs13394499	MIMAT0014996	hsa-miR-3131	-4.67	4.79e-06	-0.56	-0.28	Height;	chr2:219104363	chr2:219058725~219058747:-
COAD	cis	rs7072216	0.77	rs1061115	MIMAT0005878	hsa-miR-1287-5p	4.67	4.82e-06	0.33	0.28	Metabolite levels;	chr10:98417292	chr10:98395271~98395292:-
COAD	cis	rs6724465	0.929	rs77945941	MIMAT0014996	hsa-miR-3131	-4.67	4.88e-06	-0.56	-0.28	Height;	chr2:219109023	chr2:219058725~219058747:-
COAD	cis	rs6724465	1	rs55836193	MIMAT0014996	hsa-miR-3131	-4.66	5.03e-06	-0.53	-0.28	Height;	chr2:219042371	chr2:219058725~219058747:-
COAD	cis	rs7072216	0.621	rs11189595	MIMAT0005878	hsa-miR-1287-5p	4.64	5.54e-06	0.36	0.28	Metabolite levels;	chr10:98407565	chr10:98395271~98395292:-
COAD	cis	rs1870653	0.516	rs6852269	MIMAT0003242	hsa-miR-577	4.63	5.72e-06	0.35	0.28	Exploratory eye movement dysfunction in schizophrenia (number of eye fixations);	chr4:114481622	chr4:114656774~114656794:+
COAD	cis	rs6724465	1	rs72967917	MIMAT0014996	hsa-miR-3131	-4.63	5.73e-06	-0.56	-0.28	Height;	chr2:219046300	chr2:219058725~219058747:-
COAD	cis	rs6681460	0.966	rs10789214	MIMAT0014979	hsa-miR-3117-3p	-4.63	5.82e-06	-0.35	-0.28	Presence of antiphospholipid antibodies;	chr1:66681134	chr1:66628485~66628505:+
COAD	cis	rs1870653	0.516	rs7682565	MIMAT0003242	hsa-miR-577	4.62	6e-06	0.35	0.28	Exploratory eye movement dysfunction in schizophrenia (number of eye fixations);	chr4:114532315	chr4:114656774~114656794:+
COAD	cis	rs1870653	0.516	rs56228000	MIMAT0003242	hsa-miR-577	4.62	6e-06	0.35	0.28	Exploratory eye movement dysfunction in schizophrenia (number of eye fixations);	chr4:114533268	chr4:114656774~114656794:+
COAD	cis	rs6724465	1	rs13393738	MIMAT0014996	hsa-miR-3131	-4.62	6.11e-06	-0.5	-0.28	Height;	chr2:219049422	chr2:219058725~219058747:-
COAD	cis	rs10021731	1	rs11098258	MIMAT0003242	hsa-miR-577	4.61	6.26e-06	0.23	0.28	Optic disc area;	chr4:114564528	chr4:114656774~114656794:+
COAD	cis	rs7894407	0.856	rs7093667	MIMAT0005951	hsa-miR-1307-3p	-4.59	6.91e-06	-0.17	-0.28	White matter hyperintensity burden;	chr10:103320818	chr10:103394301~103394322:-
COAD	cis	rs10021731	1	rs10021731	MIMAT0003242	hsa-miR-577	4.59	6.97e-06	0.22	0.28	Optic disc area;	chr4:114560759	chr4:114656774~114656794:+
COAD	cis	rs7072216	0.922	rs4488133	MIMAT0005878	hsa-miR-1287-5p	-4.59	6.99e-06	-0.31	-0.28	Metabolite levels;	chr10:98399379	chr10:98395271~98395292:-
COAD	cis	rs6681460	0.565	rs6689755	MIMAT0014979	hsa-miR-3117-3p	-4.59	7.04e-06	-0.33	-0.28	Presence of antiphospholipid antibodies;	chr1:66647367	chr1:66628485~66628505:+
COAD	cis	rs6724465	1	rs17608677	MIMAT0014996	hsa-miR-3131	4.59	7.08e-06	0.42	0.28	Height;	chr2:219072149	chr2:219058725~219058747:-
COAD	cis	rs7072216	0.652	rs11189600	MIMAT0005878	hsa-miR-1287-5p	-4.58	7.16e-06	-0.32	-0.27	Metabolite levels;	chr10:98419517	chr10:98395271~98395292:-
COAD	cis	rs1712517	0.773	rs1063461	MIMAT0005951	hsa-miR-1307-3p	-4.58	7.23e-06	-0.17	-0.27	Migraine;	chr10:103289348	chr10:103394301~103394322:-
COAD	cis	rs1712517	0.74	rs4293062	MIMAT0005951	hsa-miR-1307-3p	-4.58	7.23e-06	-0.17	-0.27	Migraine;	chr10:103292867	chr10:103394301~103394322:-
COAD	cis	rs1712517	0.744	rs11191641	MIMAT0005951	hsa-miR-1307-3p	-4.58	7.23e-06	-0.17	-0.27	Migraine;	chr10:103293183	chr10:103394301~103394322:-
COAD	cis	rs1712517	0.744	rs4293063	MIMAT0005951	hsa-miR-1307-3p	-4.58	7.23e-06	-0.17	-0.27	Migraine;	chr10:103293219	chr10:103394301~103394322:-
COAD	cis	rs6724465	0.866	rs3736403	MIMAT0014996	hsa-miR-3131	-4.58	7.28e-06	-0.55	-0.27	Height;	chr2:219040525	chr2:219058725~219058747:-
COAD	cis	rs1870653	0.85	rs7687339	MIMAT0003242	hsa-miR-577	4.58	7.32e-06	0.32	0.27	Exploratory eye movement dysfunction in schizophrenia (number of eye fixations);	chr4:114450571	chr4:114656774~114656794:+
COAD	cis	rs6724465	0.714	rs72951802	MIMAT0014996	hsa-miR-3131	-4.58	7.38e-06	-0.42	-0.27	Height;	chr2:219141408	chr2:219058725~219058747:-
COAD	cis	rs7072216	0.77	rs1061123	MIMAT0005878	hsa-miR-1287-5p	4.57	7.6e-06	0.33	0.27	Metabolite levels;	chr10:98417240	chr10:98395271~98395292:-
COAD	cis	rs6681460	0.966	rs6588215	MIMAT0014979	hsa-miR-3117-3p	-4.56	7.83e-06	-0.34	-0.27	Presence of antiphospholipid antibodies;	chr1:66676266	chr1:66628485~66628505:+
COAD	cis	rs7072216	0.77	rs1739	MIMAT0005878	hsa-miR-1287-5p	4.55	8.25e-06	0.33	0.27	Metabolite levels;	chr10:98416582	chr10:98395271~98395292:-
COAD	cis	rs1014286	0.706	rs10202404	MIMAT0019926	hsa-miR-4772-5p	-4.55	8.31e-06	-0.29	-0.27	Serum protein levels (sST2);	chr2:102560955	chr2:102432300~102432321:+
COAD	cis	rs7072216	0.763	rs942804	MIMAT0026738	hsa-miR-1287-3p	4.55	8.45e-06	0.24	0.27	Metabolite levels;	chr10:98408742	chr10:98395232~98395253:-
COAD	cis	rs7072216	0.77	rs1737	MIMAT0005878	hsa-miR-1287-5p	4.54	8.65e-06	0.32	0.27	Metabolite levels;	chr10:98416609	chr10:98395271~98395292:-
COAD	cis	rs6755560	1	rs35311487	MIMAT0014995	hsa-miR-3130-5p	4.53	8.85e-06	0.31	0.27	QT interval (drug interaction);	chr2:206848647	chr2:206783276~206783296:-
COAD	cis	rs6755560	1	rs35311487	MIMAT0014995_1	hsa-miR-3130-5p	4.53	8.85e-06	0.31	0.27	QT interval (drug interaction);	chr2:206848647	chr2:206783246~206783266:+
COAD	cis	rs6724465	1	rs10201445	MIMAT0014996	hsa-miR-3131	-4.52	9.25e-06	-0.48	-0.27	Height;	chr2:219049995	chr2:219058725~219058747:-
COAD	cis	rs6724465	1	rs6719931	MIMAT0014996	hsa-miR-3131	-4.52	9.25e-06	-0.48	-0.27	Height;	chr2:219050217	chr2:219058725~219058747:-
COAD	cis	rs1014286	0.706	rs4851019	MIMAT0019926	hsa-miR-4772-5p	4.52	9.57e-06	0.28	0.27	Serum protein levels (sST2);	chr2:102561106	chr2:102432300~102432321:+
COAD	cis	rs950880	0.56	rs1558619	MIMAT0019927	hsa-miR-4772-3p	4.5	1.01e-05	0.23	0.27	Serum protein levels (sST2);	chr2:102315090	chr2:102432336~102432357:+
COAD	cis	rs7072216	0.727	rs7915108	MIMAT0026738	hsa-miR-1287-3p	4.5	1.01e-05	0.25	0.27	Metabolite levels;	chr10:98404684	chr10:98395232~98395253:-
COAD	cis	rs7072216	0.727	rs7901577	MIMAT0026738	hsa-miR-1287-3p	4.5	1.01e-05	0.25	0.27	Metabolite levels;	chr10:98404685	chr10:98395232~98395253:-
COAD	cis	rs1014286	0.706	rs6761291	MIMAT0019926	hsa-miR-4772-5p	4.5	1.02e-05	0.28	0.27	Serum protein levels (sST2);	chr2:102538610	chr2:102432300~102432321:+
COAD	cis	rs6755560	1	rs6755560	MIMAT0014995	hsa-miR-3130-5p	4.49	1.06e-05	0.31	0.27	QT interval (drug interaction);	chr2:206853059	chr2:206783276~206783296:-
COAD	cis	rs6755560	1	rs6755560	MIMAT0014995_1	hsa-miR-3130-5p	4.49	1.06e-05	0.31	0.27	QT interval (drug interaction);	chr2:206853059	chr2:206783246~206783266:+
COAD	cis	rs6724465	1	rs13404123	MIMAT0014996	hsa-miR-3131	4.49	1.06e-05	0.44	0.27	Height;	chr2:219052075	chr2:219058725~219058747:-
COAD	cis	rs7072216	0.843	rs2296441	MIMAT0005878	hsa-miR-1287-5p	4.49	1.07e-05	0.31	0.27	Metabolite levels;	chr10:98385025	chr10:98395271~98395292:-
COAD	cis	rs950880	0.56	rs4090473	MIMAT0019927	hsa-miR-4772-3p	4.49	1.1e-05	0.23	0.27	Serum protein levels (sST2);	chr2:102306527	chr2:102432336~102432357:+
COAD	cis	rs6681460	0.966	rs4655650	MIMAT0014979	hsa-miR-3117-3p	-4.48	1.1e-05	-0.34	-0.27	Presence of antiphospholipid antibodies;	chr1:66676603	chr1:66628485~66628505:+
COAD	cis	rs10021731	1	rs13104222	MIMAT0003242	hsa-miR-577	4.48	1.13e-05	0.23	0.27	Optic disc area;	chr4:114549757	chr4:114656774~114656794:+
COAD	cis	rs6681460	0.966	rs11208932	MIMAT0014979	hsa-miR-3117-3p	-4.47	1.15e-05	-0.35	-0.27	Presence of antiphospholipid antibodies;	chr1:66632170	chr1:66628485~66628505:+
COAD	cis	rs6681460	1	rs10889641	MIMAT0014979	hsa-miR-3117-3p	-4.47	1.19e-05	-0.34	-0.27	Presence of antiphospholipid antibodies;	chr1:66672684	chr1:66628485~66628505:+
COAD	cis	rs10021731	1	rs4834419	MIMAT0003242	hsa-miR-577	4.47	1.19e-05	0.22	0.27	Optic disc area;	chr4:114548870	chr4:114656774~114656794:+
COAD	cis	rs10021731	1	rs1599323	MIMAT0003242	hsa-miR-577	4.47	1.19e-05	0.22	0.27	Optic disc area;	chr4:114549176	chr4:114656774~114656794:+
COAD	cis	rs10021731	1	rs6533801	MIMAT0003242	hsa-miR-577	4.47	1.19e-05	0.22	0.27	Optic disc area;	chr4:114553199	chr4:114656774~114656794:+
COAD	cis	rs6724465	0.852	rs7561119	MIMAT0014996	hsa-miR-3131	-4.46	1.22e-05	-0.51	-0.27	Height;	chr2:219121531	chr2:219058725~219058747:-
COAD	cis	rs6724465	1	rs13419740	MIMAT0014996	hsa-miR-3131	-4.46	1.22e-05	-0.48	-0.27	Height;	chr2:219104375	chr2:219058725~219058747:-
COAD	cis	rs7072216	0.763	rs942805	MIMAT0026738	hsa-miR-1287-3p	4.46	1.22e-05	0.24	0.27	Metabolite levels;	chr10:98408615	chr10:98395232~98395253:-
COAD	cis	rs7588654	1	rs3100776	MIMAT0014996	hsa-miR-3131	-4.46	1.24e-05	-0.53	-0.27	Height;	chr2:219056478	chr2:219058725~219058747:-
COAD	cis	rs4072705	0.967	rs10120039	MIMAT0004558	hsa-miR-181a-2-3p	-4.45	1.25e-05	-0.29	-0.27	Menarche (age at onset);	chr9:124644682	chr9:124692518~124692539:+
COAD	cis	rs1014286	0.641	rs10172553	MIMAT0019926	hsa-miR-4772-5p	4.45	1.26e-05	0.28	0.27	Serum protein levels (sST2);	chr2:102536516	chr2:102432300~102432321:+
COAD	cis	rs6724465	1	rs13398898	MIMAT0014996	hsa-miR-3131	-4.45	1.3e-05	-0.56	-0.27	Height;	chr2:219063025	chr2:219058725~219058747:-
COAD	cis	rs12290811	0.572	rs12577328	MIMAT0004927	hsa-miR-708-3p	-4.44	1.31e-05	-0.3	-0.27	Bipolar disorder;	chr11:79382430	chr11:79402032~79402053:-
COAD	cis	rs6724465	0.673	rs2293081	MIMAT0014996	hsa-miR-3131	-4.44	1.32e-05	-0.4	-0.27	Height;	chr2:219146370	chr2:219058725~219058747:-
COAD	cis	rs1870653	0.516	rs76290069	MIMAT0003242	hsa-miR-577	4.44	1.35e-05	0.36	0.27	Exploratory eye movement dysfunction in schizophrenia (number of eye fixations);	chr4:114582168	chr4:114656774~114656794:+
COAD	cis	rs6724465	1	rs7600987	MIMAT0014996	hsa-miR-3131	-4.42	1.48e-05	-0.45	-0.27	Height;	chr2:219051149	chr2:219058725~219058747:-
COAD	cis	rs1163656	0.559	rs7136415	MIMAT0003287	hsa-miR-618	-4.41	1.5e-05	-0.55	-0.27	Dental caries;	chr12:80915511	chr12:80935796~80935818:-
COAD	cis	rs7072216	0.763	rs10732782	MIMAT0026738	hsa-miR-1287-3p	4.4	1.59e-05	0.24	0.26	Metabolite levels;	chr10:98406749	chr10:98395232~98395253:-
COAD	cis	rs7072216	0.691	rs7910973	MIMAT0026738	hsa-miR-1287-3p	4.4	1.59e-05	0.24	0.26	Metabolite levels;	chr10:98406975	chr10:98395232~98395253:-
COAD	cis	rs7072216	0.763	rs7911036	MIMAT0026738	hsa-miR-1287-3p	4.4	1.59e-05	0.24	0.26	Metabolite levels;	chr10:98407258	chr10:98395232~98395253:-
COAD	cis	rs7072216	0.763	rs10883090	MIMAT0026738	hsa-miR-1287-3p	4.4	1.59e-05	0.24	0.26	Metabolite levels;	chr10:98407479	chr10:98395232~98395253:-
COAD	cis	rs7072216	0.763	rs45523432	MIMAT0026738	hsa-miR-1287-3p	4.4	1.59e-05	0.24	0.26	Metabolite levels;	chr10:98407679	chr10:98395232~98395253:-
COAD	cis	rs7072216	0.763	rs12763044	MIMAT0026738	hsa-miR-1287-3p	4.4	1.59e-05	0.24	0.26	Metabolite levels;	chr10:98407694	chr10:98395232~98395253:-
COAD	cis	rs7072216	0.727	rs942808	MIMAT0026738	hsa-miR-1287-3p	4.4	1.59e-05	0.24	0.26	Metabolite levels;	chr10:98408345	chr10:98395232~98395253:-
COAD	cis	rs7072216	0.727	rs942807	MIMAT0026738	hsa-miR-1287-3p	4.4	1.59e-05	0.24	0.26	Metabolite levels;	chr10:98408462	chr10:98395232~98395253:-
COAD	cis	rs7072216	0.763	rs9787550	MIMAT0026738	hsa-miR-1287-3p	4.4	1.59e-05	0.24	0.26	Metabolite levels;	chr10:98409294	chr10:98395232~98395253:-
COAD	cis	rs6681460	1	rs4655647	MIMAT0014979	hsa-miR-3117-3p	-4.4	1.6e-05	-0.34	-0.26	Presence of antiphospholipid antibodies;	chr1:66640394	chr1:66628485~66628505:+
COAD	cis	rs7072216	0.77	rs3830020	MIMAT0005878	hsa-miR-1287-5p	-4.39	1.68e-05	-0.32	-0.26	Metabolite levels;	chr10:98416858	chr10:98395271~98395292:-
COAD	cis	rs7829975	0.54	rs2976909	MIMAT0019728	hsa-miR-4660	-4.39	1.69e-05	-0.3	-0.26	Mood instability;	chr8:8489180	chr8:9048453~9048475:+
COAD	cis	rs75358501	0.636	rs12473690	MIMAT0014995	hsa-miR-3130-5p	4.38	1.72e-05	0.4	0.26	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206734939	chr2:206783276~206783296:-
COAD	cis	rs75358501	0.636	rs12473690	MIMAT0014995_1	hsa-miR-3130-5p	4.38	1.72e-05	0.4	0.26	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206734939	chr2:206783246~206783266:+
COAD	cis	rs730566	1	rs4858819	MIMAT0001618	hsa-miR-191-3p	4.38	1.73e-05	0.23	0.26	Prion diseases;	chr3:48436678	chr3:49020631~49020652:-
COAD	cis	rs10021731	0.729	rs17047190	MIMAT0003242	hsa-miR-577	4.38	1.75e-05	0.21	0.26	Optic disc area;	chr4:114536699	chr4:114656774~114656794:+
COAD	cis	rs7072216	0.922	rs59667296	MIMAT0005878	hsa-miR-1287-5p	4.38	1.76e-05	0.3	0.26	Metabolite levels;	chr10:98386556	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.763	rs10883091	MIMAT0026738	hsa-miR-1287-3p	4.37	1.77e-05	0.23	0.26	Metabolite levels;	chr10:98407482	chr10:98395232~98395253:-
COAD	cis	rs7072216	0.763	rs10883092	MIMAT0026738	hsa-miR-1287-3p	4.37	1.77e-05	0.23	0.26	Metabolite levels;	chr10:98407519	chr10:98395232~98395253:-
COAD	cis	rs6724465	1	rs55973978	MIMAT0014996	hsa-miR-3131	-4.34	2.04e-05	-0.53	-0.26	Height;	chr2:219049092	chr2:219058725~219058747:-
COAD	cis	rs6681460	0.966	rs1325261	MIMAT0014979	hsa-miR-3117-3p	-4.33	2.13e-05	-0.33	-0.26	Presence of antiphospholipid antibodies;	chr1:66644833	chr1:66628485~66628505:+
COAD	cis	rs4851551	1	rs4851552	MIMAT0019927	hsa-miR-4772-3p	-4.33	2.17e-05	-0.47	-0.26	Blood protein levels;	chr2:102185873	chr2:102432336~102432357:+
COAD	cis	rs7072216	0.763	rs10736129	MIMAT0026738	hsa-miR-1287-3p	-4.32	2.2e-05	-0.24	-0.26	Metabolite levels;	chr10:98411814	chr10:98395232~98395253:-
COAD	cis	rs6681460	0.966	rs10889642	MIMAT0014979	hsa-miR-3117-3p	-4.32	2.22e-05	-0.33	-0.26	Presence of antiphospholipid antibodies;	chr1:66677651	chr1:66628485~66628505:+
COAD	cis	rs12290811	0.572	rs11237816	MIMAT0004927	hsa-miR-708-3p	4.32	2.25e-05	0.29	0.26	Bipolar disorder;	chr11:79380852	chr11:79402032~79402053:-
COAD	cis	rs8064299	0.967	rs3744208	MIMAT0017994	hsa-miR-3615	-4.32	2.25e-05	-0.25	-0.26	Monocyte count;	chr17:74771426	chr17:74748663~74748683:+
COAD	cis	rs7588654	0.826	rs10932795	MIMAT0014996	hsa-miR-3131	4.3	2.38e-05	0.5	0.26	Height;	chr2:219093740	chr2:219058725~219058747:-
COAD	cis	rs1712517	0.566	rs7076274	MIMAT0022727	hsa-miR-1307-5p	-4.3	2.38e-05	-0.19	-0.26	Migraine;	chr10:103286250	chr10:103394341~103394361:-
COAD	cis	rs1712517	0.545	rs3740381	MIMAT0022727	hsa-miR-1307-5p	-4.3	2.38e-05	-0.19	-0.26	Migraine;	chr10:103286932	chr10:103394341~103394361:-
COAD	cis	rs1712517	0.566	rs7917388	MIMAT0022727	hsa-miR-1307-5p	-4.3	2.38e-05	-0.19	-0.26	Migraine;	chr10:103295206	chr10:103394341~103394361:-
COAD	cis	rs1712517	0.525	rs11191642	MIMAT0022727	hsa-miR-1307-5p	-4.3	2.38e-05	-0.19	-0.26	Migraine;	chr10:103296155	chr10:103394341~103394361:-
COAD	cis	rs6681460	0.966	rs7519747	MIMAT0014979	hsa-miR-3117-3p	-4.3	2.38e-05	-0.33	-0.26	Presence of antiphospholipid antibodies;	chr1:66675040	chr1:66628485~66628505:+
COAD	cis	rs7072216	0.763	rs7914401	MIMAT0026738	hsa-miR-1287-3p	4.3	2.39e-05	0.23	0.26	Metabolite levels;	chr10:98404171	chr10:98395232~98395253:-
COAD	cis	rs1014286	0.706	rs10171438	MIMAT0019926	hsa-miR-4772-5p	-4.3	2.43e-05	-0.27	-0.26	Serum protein levels (sST2);	chr2:102558917	chr2:102432300~102432321:+
COAD	cis	rs1712517	0.588	rs12220267	MIMAT0022727	hsa-miR-1307-5p	-4.3	2.46e-05	-0.19	-0.26	Migraine;	chr10:103315955	chr10:103394341~103394361:-
COAD	cis	rs12290811	0.572	rs111460293	MIMAT0004927	hsa-miR-708-3p	4.3	2.46e-05	0.29	0.26	Bipolar disorder;	chr11:79386392	chr11:79402032~79402053:-
COAD	cis	rs12290811	0.508	rs79822078	MIMAT0004927	hsa-miR-708-3p	4.3	2.46e-05	0.29	0.26	Bipolar disorder;	chr11:79386980	chr11:79402032~79402053:-
COAD	cis	rs7072216	0.922	rs4539242	MIMAT0005878	hsa-miR-1287-5p	4.29	2.48e-05	0.29	0.26	Metabolite levels;	chr10:98388301	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.881	rs2147896	MIMAT0005878	hsa-miR-1287-5p	4.29	2.48e-05	0.29	0.26	Metabolite levels;	chr10:98388419	chr10:98395271~98395292:-
COAD	cis	rs6681460	0.565	rs1536112	MIMAT0014979	hsa-miR-3117-3p	4.29	2.5e-05	0.32	0.26	Presence of antiphospholipid antibodies;	chr1:66641542	chr1:66628485~66628505:+
COAD	cis	rs1014286	0.706	rs4851615	MIMAT0019926	hsa-miR-4772-5p	-4.29	2.54e-05	-0.27	-0.26	Serum protein levels (sST2);	chr2:102530540	chr2:102432300~102432321:+
COAD	cis	rs7072216	0.691	rs10786419	MIMAT0005878	hsa-miR-1287-5p	4.28	2.61e-05	0.31	0.26	Metabolite levels;	chr10:98421183	chr10:98395271~98395292:-
COAD	cis	rs11792861	0.53	rs1772047	MIMAT0000090	hsa-miR-32-5p	-4.28	2.66e-05	-0.21	-0.26	Menarche (age at onset);	chr9:108916732	chr9:109046272~109046293:-
COAD	cis	rs7829975	0.564	rs2976855	MIMAT0019728	hsa-miR-4660	4.28	2.7e-05	0.27	0.26	Mood instability;	chr8:8444284	chr8:9048453~9048475:+
COAD	cis	rs7072216	0.763	rs733345	MIMAT0026738	hsa-miR-1287-3p	4.27	2.71e-05	0.23	0.26	Metabolite levels;	chr10:98404458	chr10:98395232~98395253:-
COAD	cis	rs7072216	0.763	rs733346	MIMAT0026738	hsa-miR-1287-3p	4.27	2.71e-05	0.23	0.26	Metabolite levels;	chr10:98404568	chr10:98395232~98395253:-
COAD	cis	rs8064299	0.967	rs880827	MIMAT0017994	hsa-miR-3615	4.27	2.73e-05	0.25	0.26	Monocyte count;	chr17:74771296	chr17:74748663~74748683:+
COAD	cis	rs7072216	0.922	rs10786415	MIMAT0005878	hsa-miR-1287-5p	4.27	2.78e-05	0.29	0.26	Metabolite levels;	chr10:98391509	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.922	rs942814	MIMAT0005878	hsa-miR-1287-5p	4.27	2.78e-05	0.29	0.26	Metabolite levels;	chr10:98391548	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.922	rs6584191	MIMAT0005878	hsa-miR-1287-5p	4.27	2.78e-05	0.29	0.26	Metabolite levels;	chr10:98392298	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.69	rs113195335	MIMAT0026738	hsa-miR-1287-3p	4.27	2.8e-05	0.23	0.26	Metabolite levels;	chr10:98415775	chr10:98395232~98395253:-
COAD	cis	rs7072216	0.727	rs3750603	MIMAT0026738	hsa-miR-1287-3p	4.27	2.8e-05	0.23	0.26	Metabolite levels;	chr10:98415779	chr10:98395232~98395253:-
COAD	cis	rs8064299	0.967	rs878905	MIMAT0017994	hsa-miR-3615	-4.27	2.81e-05	-0.25	-0.26	Monocyte count;	chr17:74773272	chr17:74748663~74748683:+
COAD	cis	rs6681460	0.625	rs6679568	MIMAT0014979	hsa-miR-3117-3p	-4.26	2.82e-05	-0.31	-0.26	Presence of antiphospholipid antibodies;	chr1:66608494	chr1:66628485~66628505:+
COAD	cis	rs1014286	0.706	rs10194822	MIMAT0019926	hsa-miR-4772-5p	-4.26	2.83e-05	-0.26	-0.26	Serum protein levels (sST2);	chr2:102549045	chr2:102432300~102432321:+
COAD	cis	rs6681460	0.901	rs1570815	MIMAT0014979	hsa-miR-3117-3p	-4.26	2.85e-05	-0.33	-0.26	Presence of antiphospholipid antibodies;	chr1:66673984	chr1:66628485~66628505:+
COAD	cis	rs6681460	1	rs7524818	MIMAT0014979	hsa-miR-3117-3p	-4.26	2.92e-05	-0.32	-0.26	Presence of antiphospholipid antibodies;	chr1:66606348	chr1:66628485~66628505:+
COAD	cis	rs7588654	1	rs7588654	MIMAT0014996	hsa-miR-3131	4.25	2.99e-05	0.46	0.26	Height;	chr2:219118308	chr2:219058725~219058747:-
COAD	cis	rs7072216	0.763	rs2147901	MIMAT0026738	hsa-miR-1287-3p	-4.25	2.99e-05	-0.23	-0.26	Metabolite levels;	chr10:98405739	chr10:98395232~98395253:-
COAD	cis	rs1712517	0.526	rs113528138	MIMAT0022727	hsa-miR-1307-5p	-4.25	3.02e-05	-0.19	-0.26	Migraine;	chr10:103365694	chr10:103394341~103394361:-
COAD	cis	rs1712517	0.525	rs11191667	MIMAT0022727	hsa-miR-1307-5p	-4.25	3.02e-05	-0.19	-0.26	Migraine;	chr10:103369141	chr10:103394341~103394361:-
COAD	cis	rs7072216	0.763	rs3814142	MIMAT0026738	hsa-miR-1287-3p	4.25	3.04e-05	0.23	0.26	Metabolite levels;	chr10:98411347	chr10:98395232~98395253:-
COAD	cis	rs7072216	0.691	rs3829853	MIMAT0026738	hsa-miR-1287-3p	4.25	3.04e-05	0.23	0.26	Metabolite levels;	chr10:98411417	chr10:98395232~98395253:-
COAD	cis	rs7072216	0.727	rs10748728	MIMAT0026738	hsa-miR-1287-3p	4.25	3.04e-05	0.23	0.26	Metabolite levels;	chr10:98411441	chr10:98395232~98395253:-
COAD	cis	rs7072216	0.763	rs10748729	MIMAT0026738	hsa-miR-1287-3p	4.25	3.04e-05	0.23	0.26	Metabolite levels;	chr10:98411614	chr10:98395232~98395253:-
COAD	cis	rs7072216	0.763	rs10748730	MIMAT0026738	hsa-miR-1287-3p	4.25	3.04e-05	0.23	0.26	Metabolite levels;	chr10:98411683	chr10:98395232~98395253:-
COAD	cis	rs7072216	0.763	rs7910014	MIMAT0026738	hsa-miR-1287-3p	4.25	3.04e-05	0.23	0.26	Metabolite levels;	chr10:98412353	chr10:98395232~98395253:-
COAD	cis	rs7072216	0.763	rs7910247	MIMAT0026738	hsa-miR-1287-3p	4.25	3.04e-05	0.23	0.26	Metabolite levels;	chr10:98412495	chr10:98395232~98395253:-
COAD	cis	rs7072216	0.727	rs7913541	MIMAT0026738	hsa-miR-1287-3p	4.25	3.04e-05	0.23	0.26	Metabolite levels;	chr10:98412722	chr10:98395232~98395253:-
COAD	cis	rs7072216	0.763	rs6584204	MIMAT0026738	hsa-miR-1287-3p	4.25	3.04e-05	0.23	0.26	Metabolite levels;	chr10:98413823	chr10:98395232~98395253:-
COAD	cis	rs7072216	0.763	rs6584205	MIMAT0026738	hsa-miR-1287-3p	4.25	3.04e-05	0.23	0.26	Metabolite levels;	chr10:98414049	chr10:98395232~98395253:-
COAD	cis	rs7072216	0.763	rs3750601	MIMAT0026738	hsa-miR-1287-3p	4.25	3.04e-05	0.23	0.26	Metabolite levels;	chr10:98414804	chr10:98395232~98395253:-
COAD	cis	rs7072216	0.763	rs2147900	MIMAT0026738	hsa-miR-1287-3p	4.25	3.04e-05	0.23	0.26	Metabolite levels;	chr10:98414964	chr10:98395232~98395253:-
COAD	cis	rs7072216	0.763	rs2274246	MIMAT0026738	hsa-miR-1287-3p	4.25	3.04e-05	0.23	0.26	Metabolite levels;	chr10:98415303	chr10:98395232~98395253:-
COAD	cis	rs7072216	0.763	rs2274245	MIMAT0026738	hsa-miR-1287-3p	4.25	3.04e-05	0.23	0.26	Metabolite levels;	chr10:98415325	chr10:98395232~98395253:-
COAD	cis	rs7072216	0.763	rs2274244	MIMAT0026738	hsa-miR-1287-3p	4.25	3.04e-05	0.23	0.26	Metabolite levels;	chr10:98415461	chr10:98395232~98395253:-
COAD	cis	rs6681460	1	rs4655648	MIMAT0014979	hsa-miR-3117-3p	-4.24	3.1e-05	-0.32	-0.26	Presence of antiphospholipid antibodies;	chr1:66648626	chr1:66628485~66628505:+
COAD	cis	rs1712517	0.503	rs72846198	MIMAT0022727	hsa-miR-1307-5p	-4.24	3.1e-05	-0.19	-0.26	Migraine;	chr10:103338267	chr10:103394341~103394361:-
COAD	cis	rs7894407	0.856	rs10883855	MIMAT0005951	hsa-miR-1307-3p	-4.24	3.16e-05	-0.16	-0.26	White matter hyperintensity burden;	chr10:103332690	chr10:103394301~103394322:-
COAD	cis	rs7072216	0.763	rs4475861	MIMAT0026738	hsa-miR-1287-3p	4.23	3.2e-05	0.23	0.26	Metabolite levels;	chr10:98405232	chr10:98395232~98395253:-
COAD	cis	rs74233809	1	rs11191499	MIMAT0005951	hsa-miR-1307-3p	-4.23	3.22e-05	-0.25	-0.26	Birth weight;	chr10:103004514	chr10:103394301~103394322:-
COAD	cis	rs6681460	1	rs1325263	MIMAT0014979	hsa-miR-3117-3p	-4.23	3.23e-05	-0.33	-0.26	Presence of antiphospholipid antibodies;	chr1:66664108	chr1:66628485~66628505:+
COAD	cis	rs7072216	0.763	rs12763326	MIMAT0026738	hsa-miR-1287-3p	-4.23	3.26e-05	-0.23	-0.26	Metabolite levels;	chr10:98407639	chr10:98395232~98395253:-
COAD	cis	rs7072216	0.763	rs942803	MIMAT0026738	hsa-miR-1287-3p	4.23	3.29e-05	0.23	0.25	Metabolite levels;	chr10:98408874	chr10:98395232~98395253:-
COAD	cis	rs7072216	0.763	rs12259939	MIMAT0026738	hsa-miR-1287-3p	4.23	3.29e-05	0.23	0.25	Metabolite levels;	chr10:98409264	chr10:98395232~98395253:-
COAD	cis	rs7072216	0.763	rs7923729	MIMAT0026738	hsa-miR-1287-3p	4.23	3.29e-05	0.23	0.25	Metabolite levels;	chr10:98409708	chr10:98395232~98395253:-
COAD	cis	rs7072216	0.763	rs6584198	MIMAT0026738	hsa-miR-1287-3p	4.23	3.29e-05	0.23	0.25	Metabolite levels;	chr10:98410149	chr10:98395232~98395253:-
COAD	cis	rs7072216	0.727	rs6584199	MIMAT0026738	hsa-miR-1287-3p	4.23	3.29e-05	0.23	0.25	Metabolite levels;	chr10:98410226	chr10:98395232~98395253:-
COAD	cis	rs7072216	0.763	rs6584200	MIMAT0026738	hsa-miR-1287-3p	4.23	3.29e-05	0.23	0.25	Metabolite levels;	chr10:98410280	chr10:98395232~98395253:-
COAD	cis	rs7072216	0.763	rs6584201	MIMAT0026738	hsa-miR-1287-3p	4.23	3.29e-05	0.23	0.25	Metabolite levels;	chr10:98410452	chr10:98395232~98395253:-
COAD	cis	rs7072216	0.763	rs3814140	MIMAT0026738	hsa-miR-1287-3p	4.23	3.29e-05	0.23	0.25	Metabolite levels;	chr10:98411005	chr10:98395232~98395253:-
COAD	cis	rs6681460	1	rs6670378	MIMAT0014979	hsa-miR-3117-3p	-4.23	3.3e-05	-0.32	-0.25	Presence of antiphospholipid antibodies;	chr1:66660902	chr1:66628485~66628505:+
COAD	cis	rs6681460	1	rs2147777	MIMAT0014979	hsa-miR-3117-3p	-4.23	3.3e-05	-0.32	-0.25	Presence of antiphospholipid antibodies;	chr1:66663571	chr1:66628485~66628505:+
COAD	cis	rs6681460	1	rs6680876	MIMAT0014979	hsa-miR-3117-3p	-4.23	3.3e-05	-0.32	-0.25	Presence of antiphospholipid antibodies;	chr1:66663799	chr1:66628485~66628505:+
COAD	cis	rs7072216	0.726	rs4474372	MIMAT0026738	hsa-miR-1287-3p	4.23	3.31e-05	0.23	0.25	Metabolite levels;	chr10:98404814	chr10:98395232~98395253:-
COAD	cis	rs1014286	0.73	rs2215998	MIMAT0019926	hsa-miR-4772-5p	4.22	3.33e-05	0.26	0.25	Serum protein levels (sST2);	chr2:102549584	chr2:102432300~102432321:+
COAD	cis	rs1014286	0.706	rs10196579	MIMAT0019926	hsa-miR-4772-5p	4.22	3.46e-05	0.27	0.25	Serum protein levels (sST2);	chr2:102553722	chr2:102432300~102432321:+
COAD	cis	rs1014286	0.706	rs2310295	MIMAT0019926	hsa-miR-4772-5p	4.22	3.46e-05	0.27	0.25	Serum protein levels (sST2);	chr2:102554607	chr2:102432300~102432321:+
COAD	cis	rs7072216	0.763	rs8181292	MIMAT0026738	hsa-miR-1287-3p	4.21	3.47e-05	0.23	0.25	Metabolite levels;	chr10:98415720	chr10:98395232~98395253:-
COAD	cis	rs950880	0.56	rs10189711	MIMAT0019927	hsa-miR-4772-3p	4.21	3.48e-05	0.21	0.25	Serum protein levels (sST2);	chr2:102314421	chr2:102432336~102432357:+
COAD	cis	rs12290811	0.63	rs12277834	MIMAT0004927	hsa-miR-708-3p	4.21	3.5e-05	0.29	0.25	Bipolar disorder;	chr11:79389112	chr11:79402032~79402053:-
COAD	cis	rs12290811	0.63	rs79406027	MIMAT0004927	hsa-miR-708-3p	4.21	3.5e-05	0.29	0.25	Bipolar disorder;	chr11:79390059	chr11:79402032~79402053:-
COAD	cis	rs7072216	0.806	rs9804285	MIMAT0026738	hsa-miR-1287-3p	4.21	3.59e-05	0.23	0.25	Metabolite levels;	chr10:98409715	chr10:98395232~98395253:-
COAD	cis	rs7072216	0.555	rs2296433	MIMAT0026738	hsa-miR-1287-3p	4.21	3.6e-05	0.25	0.25	Metabolite levels;	chr10:98424305	chr10:98395232~98395253:-
COAD	cis	rs7072216	0.555	rs2296432	MIMAT0026738	hsa-miR-1287-3p	4.21	3.6e-05	0.25	0.25	Metabolite levels;	chr10:98424306	chr10:98395232~98395253:-
COAD	cis	rs7894407	0.76	rs1163072	MIMAT0005951	hsa-miR-1307-3p	4.2	3.61e-05	0.16	0.25	White matter hyperintensity burden;	chr10:103264621	chr10:103394301~103394322:-
COAD	cis	rs11792861	0.541	rs838824	MIMAT0000090	hsa-miR-32-5p	-4.2	3.62e-05	-0.21	-0.25	Menarche (age at onset);	chr9:108908427	chr9:109046272~109046293:-
COAD	cis	rs6724465	1	rs72967946	MIMAT0014996	hsa-miR-3131	-4.2	3.62e-05	-0.52	-0.25	Height;	chr2:219053257	chr2:219058725~219058747:-
COAD	cis	rs6681460	1	rs1562217	MIMAT0014979	hsa-miR-3117-3p	4.2	3.68e-05	0.32	0.25	Presence of antiphospholipid antibodies;	chr1:66607883	chr1:66628485~66628505:+
COAD	cis	rs75358501	0.636	rs1862089	MIMAT0014994	hsa-miR-3130-3p	4.2	3.71e-05	0.37	0.25	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206755794	chr2:206783245~206783265:-
COAD	cis	rs75358501	0.636	rs1862089	MIMAT0014994_1	hsa-miR-3130-3p	4.2	3.71e-05	0.37	0.25	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206755794	chr2:206783277~206783297:+
COAD	cis	rs7072216	0.727	rs942809	MIMAT0026738	hsa-miR-1287-3p	4.2	3.71e-05	0.23	0.25	Metabolite levels;	chr10:98408244	chr10:98395232~98395253:-
COAD	cis	rs7072216	0.763	rs7909822	MIMAT0026738	hsa-miR-1287-3p	4.2	3.73e-05	0.23	0.25	Metabolite levels;	chr10:98412278	chr10:98395232~98395253:-
COAD	cis	rs330203	0.574	rs7730715	MIMAT0022500	hsa-miR-5706	-4.18	3.94e-05	-0.31	-0.25	Iris color (a* coordinate);Iris color (b* coordinate);	chr5:119671259	chr5:119154646~119154667:+
COAD	cis	rs7072216	0.763	rs6584202	MIMAT0026738	hsa-miR-1287-3p	4.18	4e-05	0.23	0.25	Metabolite levels;	chr10:98410626	chr10:98395232~98395253:-
COAD	cis	rs6681460	0.966	rs4655646	MIMAT0014979	hsa-miR-3117-3p	-4.18	4.02e-05	-0.34	-0.25	Presence of antiphospholipid antibodies;	chr1:66628653	chr1:66628485~66628505:+
COAD	cis	rs1867631	0.585	rs11208940	MIMAT0014979	hsa-miR-3117-3p	4.18	4.06e-05	0.3	0.25	Menopause (age at onset);	chr1:66661559	chr1:66628485~66628505:+
COAD	cis	rs1712517	0.525	rs7911488	MIMAT0022727	hsa-miR-1307-5p	-4.17	4.13e-05	-0.19	-0.25	Migraine;	chr10:103394332	chr10:103394341~103394361:-
COAD	cis	rs75358501	0.636	rs7580138	MIMAT0014994	hsa-miR-3130-3p	4.17	4.14e-05	0.38	0.25	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206750560	chr2:206783245~206783265:-
COAD	cis	rs75358501	0.636	rs7580138	MIMAT0014994_1	hsa-miR-3130-3p	4.17	4.14e-05	0.38	0.25	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206750560	chr2:206783277~206783297:+
COAD	cis	rs7072216	0.922	rs942813	MIMAT0005878	hsa-miR-1287-5p	4.17	4.22e-05	0.29	0.25	Metabolite levels;	chr10:98393851	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.763	rs1061437	MIMAT0026738	hsa-miR-1287-3p	4.17	4.24e-05	0.23	0.25	Metabolite levels;	chr10:98416397	chr10:98395232~98395253:-
COAD	cis	rs7072216	0.881	rs11189591	MIMAT0005878	hsa-miR-1287-5p	4.16	4.37e-05	0.28	0.25	Metabolite levels;	chr10:98395539	chr10:98395271~98395292:-
COAD	cis	rs6681460	1	rs6659968	MIMAT0014979	hsa-miR-3117-3p	-4.15	4.5e-05	-0.31	-0.25	Presence of antiphospholipid antibodies;	chr1:66657776	chr1:66628485~66628505:+
COAD	cis	rs6681460	1	rs2031478	MIMAT0014979	hsa-miR-3117-3p	-4.15	4.5e-05	-0.31	-0.25	Presence of antiphospholipid antibodies;	chr1:66658059	chr1:66628485~66628505:+
COAD	cis	rs7072216	0.763	rs2274243	MIMAT0026738	hsa-miR-1287-3p	4.15	4.56e-05	0.23	0.25	Metabolite levels;	chr10:98415510	chr10:98395232~98395253:-
COAD	cis	rs6681460	0.604	rs11208920	MIMAT0014979	hsa-miR-3117-3p	-4.15	4.57e-05	-0.3	-0.25	Presence of antiphospholipid antibodies;	chr1:66609629	chr1:66628485~66628505:+
COAD	cis	rs7072216	0.881	rs2274247	MIMAT0005878	hsa-miR-1287-5p	4.15	4.6e-05	0.28	0.25	Metabolite levels;	chr10:98390391	chr10:98395271~98395292:-
COAD	cis	rs6681460	0.932	rs2044399	MIMAT0014979	hsa-miR-3117-3p	-4.14	4.62e-05	-0.33	-0.25	Presence of antiphospholipid antibodies;	chr1:66588397	chr1:66628485~66628505:+
COAD	cis	rs6681460	0.932	rs2044400	MIMAT0014979	hsa-miR-3117-3p	-4.14	4.62e-05	-0.33	-0.25	Presence of antiphospholipid antibodies;	chr1:66588398	chr1:66628485~66628505:+
COAD	cis	rs8064299	0.967	rs878906	MIMAT0017994	hsa-miR-3615	-4.14	4.67e-05	-0.24	-0.25	Monocyte count;	chr17:74773195	chr17:74748663~74748683:+
COAD	cis	rs8064299	0.967	rs878907	MIMAT0017994	hsa-miR-3615	-4.14	4.67e-05	-0.24	-0.25	Monocyte count;	chr17:74773555	chr17:74748663~74748683:+
COAD	cis	rs1867631	0.585	rs6694782	MIMAT0014979	hsa-miR-3117-3p	4.14	4.68e-05	0.3	0.25	Menopause (age at onset);	chr1:66661079	chr1:66628485~66628505:+
COAD	cis	rs950880	0.56	rs11685424	MIMAT0019927	hsa-miR-4772-3p	4.14	4.79e-05	0.21	0.25	Serum protein levels (sST2);	chr2:102310521	chr2:102432336~102432357:+
COAD	cis	rs6681460	1	rs1329978	MIMAT0014979	hsa-miR-3117-3p	-4.13	4.85e-05	-0.32	-0.25	Presence of antiphospholipid antibodies;	chr1:66650548	chr1:66628485~66628505:+
COAD	cis	rs12290811	0.63	rs77749926	MIMAT0004927	hsa-miR-708-3p	4.13	4.88e-05	0.28	0.25	Bipolar disorder;	chr11:79391873	chr11:79402032~79402053:-
COAD	cis	rs12290811	0.63	rs11237820	MIMAT0004927	hsa-miR-708-3p	4.13	4.88e-05	0.28	0.25	Bipolar disorder;	chr11:79393621	chr11:79402032~79402053:-
COAD	cis	rs12290811	0.63	rs4433593	MIMAT0004927	hsa-miR-708-3p	4.13	4.88e-05	0.28	0.25	Bipolar disorder;	chr11:79395571	chr11:79402032~79402053:-
COAD	cis	rs6584202	0.589	rs10883094	MIMAT0005878	hsa-miR-1287-5p	4.13	4.99e-05	0.31	0.25	Obesity-related traits;	chr10:98428349	chr10:98395271~98395292:-
COAD	cis	rs1867631	0.585	rs12094526	MIMAT0014979	hsa-miR-3117-3p	-4.13	5.01e-05	-0.3	-0.25	Menopause (age at onset);	chr1:66660431	chr1:66628485~66628505:+
COAD	cis	rs1867631	0.585	rs6670827	MIMAT0014979	hsa-miR-3117-3p	-4.13	5.01e-05	-0.3	-0.25	Menopause (age at onset);	chr1:66661323	chr1:66628485~66628505:+
COAD	cis	rs950880	0.542	rs1558621	MIMAT0019927	hsa-miR-4772-3p	4.12	5.07e-05	0.21	0.25	Serum protein levels (sST2);	chr2:102313847	chr2:102432336~102432357:+
COAD	cis	rs7072216	0.881	rs2147895	MIMAT0005878	hsa-miR-1287-5p	4.12	5.1e-05	0.28	0.25	Metabolite levels;	chr10:98388551	chr10:98395271~98395292:-
COAD	cis	rs6681460	1	rs2872078	MIMAT0014979	hsa-miR-3117-3p	-4.12	5.14e-05	-0.32	-0.25	Presence of antiphospholipid antibodies;	chr1:66661684	chr1:66628485~66628505:+
COAD	cis	rs1014286	0.706	rs4851612	MIMAT0019926	hsa-miR-4772-5p	4.12	5.2e-05	0.26	0.25	Serum protein levels (sST2);	chr2:102521421	chr2:102432300~102432321:+
COAD	cis	rs1014286	0.706	rs2058656	MIMAT0019926	hsa-miR-4772-5p	4.12	5.21e-05	0.26	0.25	Serum protein levels (sST2);	chr2:102520567	chr2:102432300~102432321:+
COAD	cis	rs950880	0.56	rs6733174	MIMAT0019927	hsa-miR-4772-3p	4.11	5.35e-05	0.21	0.25	Serum protein levels (sST2);	chr2:102312552	chr2:102432336~102432357:+
COAD	cis	rs6724465	1	rs6436106	MIMAT0014996	hsa-miR-3131	-4.11	5.39e-05	-0.47	-0.25	Height;	chr2:219062191	chr2:219058725~219058747:-
COAD	cis	rs6724465	1	rs7595949	MIMAT0014996	hsa-miR-3131	-4.11	5.39e-05	-0.47	-0.25	Height;	chr2:219062496	chr2:219058725~219058747:-
COAD	cis	rs6681460	1	rs6656550	MIMAT0014979	hsa-miR-3117-3p	-4.11	5.41e-05	-0.32	-0.25	Presence of antiphospholipid antibodies;	chr1:66656869	chr1:66628485~66628505:+
COAD	cis	rs1014286	0.706	rs4851608	MIMAT0019926	hsa-miR-4772-5p	4.1	5.63e-05	0.25	0.25	Serum protein levels (sST2);	chr2:102509525	chr2:102432300~102432321:+
COAD	cis	rs1014286	0.66	rs1476999	MIMAT0019926	hsa-miR-4772-5p	4.1	5.63e-05	0.25	0.25	Serum protein levels (sST2);	chr2:102515220	chr2:102432300~102432321:+
COAD	cis	rs1014286	0.665	rs1523204	MIMAT0019926	hsa-miR-4772-5p	4.09	5.67e-05	0.25	0.25	Serum protein levels (sST2);	chr2:102519178	chr2:102432300~102432321:+
COAD	cis	rs1014286	0.706	rs2216000	MIMAT0019926	hsa-miR-4772-5p	4.09	5.68e-05	0.25	0.25	Serum protein levels (sST2);	chr2:102516181	chr2:102432300~102432321:+
COAD	cis	rs7894407	0.634	rs755577	MIMAT0005951	hsa-miR-1307-3p	4.09	5.81e-05	0.19	0.25	White matter hyperintensity burden;	chr10:103464309	chr10:103394301~103394322:-
COAD	cis	rs6724465	1	rs17655003	MIMAT0014996	hsa-miR-3131	-4.09	5.83e-05	-0.47	-0.25	Height;	chr2:219065759	chr2:219058725~219058747:-
COAD	cis	rs6724465	1	rs10208728	MIMAT0014996	hsa-miR-3131	-4.09	5.84e-05	-0.38	-0.25	Height;	chr2:219052581	chr2:219058725~219058747:-
COAD	cis	rs12290811	0.63	rs7108878	MIMAT0004927	hsa-miR-708-3p	4.07	6.31e-05	0.28	0.25	Bipolar disorder;	chr11:79396763	chr11:79402032~79402053:-
COAD	cis	rs953387	0.666	rs10180515	MIMAT0026477	hsa-miR-128-1-5p	-4.06	6.45e-05	-0.22	-0.25	Arthritis (juvenile idiopathic);	chr2:136164133	chr2:135665411~135665433:+
COAD	cis	rs6681460	0.966	rs7524851	MIMAT0014979	hsa-miR-3117-3p	-4.06	6.62e-05	-0.33	-0.25	Presence of antiphospholipid antibodies;	chr1:66627335	chr1:66628485~66628505:+
COAD	cis	rs7072216	0.666	rs11598689	MIMAT0005878	hsa-miR-1287-5p	4.06	6.65e-05	0.3	0.25	Metabolite levels;	chr10:98396270	chr10:98395271~98395292:-
COAD	cis	rs6724465	0.673	rs6751232	MIMAT0014996	hsa-miR-3131	-4.05	6.71e-05	-0.38	-0.25	Height;	chr2:219151208	chr2:219058725~219058747:-
COAD	cis	rs6724465	0.636	rs6436119	MIMAT0014996	hsa-miR-3131	-4.05	6.71e-05	-0.38	-0.25	Height;	chr2:219154306	chr2:219058725~219058747:-
COAD	cis	rs6681460	0.546	rs1998716	MIMAT0014979	hsa-miR-3117-3p	-4.05	6.76e-05	-0.3	-0.24	Presence of antiphospholipid antibodies;	chr1:66651423	chr1:66628485~66628505:+
COAD	cis	rs6681460	1	rs9662962	MIMAT0014979	hsa-miR-3117-3p	-4.05	6.83e-05	-0.31	-0.24	Presence of antiphospholipid antibodies;	chr1:66655681	chr1:66628485~66628505:+
COAD	cis	rs6681460	0.966	rs9659879	MIMAT0014979	hsa-miR-3117-3p	-4.05	6.83e-05	-0.31	-0.24	Presence of antiphospholipid antibodies;	chr1:66655751	chr1:66628485~66628505:+
COAD	cis	rs6681460	1	rs7521111	MIMAT0014979	hsa-miR-3117-3p	-4.05	6.83e-05	-0.31	-0.24	Presence of antiphospholipid antibodies;	chr1:66655951	chr1:66628485~66628505:+
COAD	cis	rs6681460	1	rs7521123	MIMAT0014979	hsa-miR-3117-3p	-4.05	6.83e-05	-0.31	-0.24	Presence of antiphospholipid antibodies;	chr1:66655980	chr1:66628485~66628505:+
COAD	cis	rs6681460	1	rs6680944	MIMAT0014979	hsa-miR-3117-3p	-4.05	6.83e-05	-0.31	-0.24	Presence of antiphospholipid antibodies;	chr1:66656882	chr1:66628485~66628505:+
COAD	cis	rs6681460	1	rs4655636	MIMAT0014979	hsa-miR-3117-3p	-4.04	7.13e-05	-0.3	-0.24	Presence of antiphospholipid antibodies;	chr1:66602854	chr1:66628485~66628505:+
COAD	cis	rs10021731	0.798	rs34581144	MIMAT0003242	hsa-miR-577	4.03	7.22e-05	0.22	0.24	Optic disc area;	chr4:114583571	chr4:114656774~114656794:+
COAD	cis	rs6681460	1	rs964574	MIMAT0014979	hsa-miR-3117-3p	-4.03	7.22e-05	-0.31	-0.24	Presence of antiphospholipid antibodies;	chr1:66597202	chr1:66628485~66628505:+
COAD	cis	rs6681460	0.966	rs10889643	MIMAT0014979	hsa-miR-3117-3p	-4.03	7.24e-05	-0.31	-0.24	Presence of antiphospholipid antibodies;	chr1:66677685	chr1:66628485~66628505:+
COAD	cis	rs6724465	1	rs3731878	MIMAT0014996	hsa-miR-3131	-4.03	7.41e-05	-0.46	-0.24	Height;	chr2:219055843	chr2:219058725~219058747:-
COAD	cis	rs3915499	0.63	rs216160	MIMAT0002174	hsa-miR-484	4.03	7.45e-05	0.17	0.24	Resting heart rate;	chr16:15825103	chr16:15643301~15643322:+
COAD	cis	rs6724465	1	rs55838820	MIMAT0014996	hsa-miR-3131	-4.02	7.52e-05	-0.52	-0.24	Height;	chr2:219082963	chr2:219058725~219058747:-
COAD	cis	rs6724465	1	rs72951747	MIMAT0014996	hsa-miR-3131	-4.02	7.52e-05	-0.52	-0.24	Height;	chr2:219107321	chr2:219058725~219058747:-
COAD	cis	rs12290811	0.572	rs12289486	MIMAT0004927	hsa-miR-708-3p	4.02	7.55e-05	0.27	0.24	Bipolar disorder;	chr11:79381483	chr11:79402032~79402053:-
COAD	cis	rs6681460	1	rs1445575	MIMAT0014979	hsa-miR-3117-3p	-4.02	7.7e-05	-0.31	-0.24	Presence of antiphospholipid antibodies;	chr1:66586481	chr1:66628485~66628505:+
COAD	cis	rs6681460	0.934	rs4655628	MIMAT0014979	hsa-miR-3117-3p	-4.02	7.7e-05	-0.31	-0.24	Presence of antiphospholipid antibodies;	chr1:66586926	chr1:66628485~66628505:+
COAD	cis	rs216303	0.642	rs216315	MIMAT0000432	hsa-miR-141-3p	-4.01	7.82e-05	-0.2	-0.24	Low vWF levels;	chr12:6027748	chr12:6964155~6964176:+
COAD	cis	rs75358501	0.636	rs10932164	MIMAT0014994	hsa-miR-3130-3p	4.01	7.82e-05	0.35	0.24	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206751601	chr2:206783245~206783265:-
COAD	cis	rs75358501	0.636	rs10932164	MIMAT0014994_1	hsa-miR-3130-3p	4.01	7.82e-05	0.35	0.24	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206751601	chr2:206783277~206783297:+
COAD	cis	rs7072216	0.881	rs6584192	MIMAT0005878	hsa-miR-1287-5p	4.01	7.93e-05	0.28	0.24	Metabolite levels;	chr10:98392616	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.881	rs10883084	MIMAT0005878	hsa-miR-1287-5p	4.01	7.99e-05	0.28	0.24	Metabolite levels;	chr10:98391432	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.922	rs7097824	MIMAT0005878	hsa-miR-1287-5p	4.01	7.99e-05	0.28	0.24	Metabolite levels;	chr10:98392042	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.763	rs7091709	MIMAT0026738	hsa-miR-1287-3p	4.01	8.04e-05	0.22	0.24	Metabolite levels;	chr10:98407848	chr10:98395232~98395253:-
COAD	cis	rs7072216	0.881	rs2182169	MIMAT0005878	hsa-miR-1287-5p	4.01	8.04e-05	0.27	0.24	Metabolite levels;	chr10:98388247	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.881	rs1079179	MIMAT0005878	hsa-miR-1287-5p	4.01	8.04e-05	0.27	0.24	Metabolite levels;	chr10:98389589	chr10:98395271~98395292:-
COAD	cis	rs6681460	1	rs6681460	MIMAT0014979	hsa-miR-3117-3p	4.01	8.05e-05	0.3	0.24	Presence of antiphospholipid antibodies;	chr1:66657374	chr1:66628485~66628505:+
COAD	cis	rs1712517	0.873	rs1712516	MIMAT0022727	hsa-miR-1307-5p	-4	8.29e-05	-0.16	-0.24	Migraine;	chr10:103273871	chr10:103394341~103394361:-
COAD	cis	rs10231759	0.617	rs11982695	MIMAT0004819	hsa-miR-671-3p	-4	8.42e-05	-0.35	-0.24	Height;	chr7:150815012	chr7:151238488~151238508:+
COAD	cis	rs7072216	0.881	rs2182168	MIMAT0005878	hsa-miR-1287-5p	4	8.43e-05	0.27	0.24	Metabolite levels;	chr10:98388596	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.881	rs7916469	MIMAT0005878	hsa-miR-1287-5p	4	8.43e-05	0.27	0.24	Metabolite levels;	chr10:98388896	chr10:98395271~98395292:-
COAD	cis	rs7072216	0.881	rs755126	MIMAT0005878	hsa-miR-1287-5p	4	8.43e-05	0.27	0.24	Metabolite levels;	chr10:98389194	chr10:98395271~98395292:-
COAD	cis	rs2303282	0.933	rs4784670	MIMAT0000430	hsa-miR-138-5p	-3.99	8.46e-05	-0.28	-0.24	Breast cancer;	chr16:56464599	chr16:56858527~56858549:+
COAD	cis	rs2303282	0.933	rs4784670	MIMAT0000430_1	hsa-miR-138-5p	-3.99	8.46e-05	-0.28	-0.24	Breast cancer;	chr16:56464599	chr3:44114234~44114256:+
COAD	cis	rs6681460	0.966	rs10749763	MIMAT0014979	hsa-miR-3117-3p	-3.98	8.84e-05	-0.32	-0.24	Presence of antiphospholipid antibodies;	chr1:66596443	chr1:66628485~66628505:+
COAD	cis	rs6681460	0.932	rs4655640	MIMAT0014979	hsa-miR-3117-3p	-3.98	9.12e-05	-0.32	-0.24	Presence of antiphospholipid antibodies;	chr1:66623537	chr1:66628485~66628505:+
COAD	cis	rs6543140	0.964	rs2080288	MIMAT0019927	hsa-miR-4772-3p	-3.98	9.14e-05	-0.23	-0.24	Blood protein levels;	chr2:102405706	chr2:102432336~102432357:+
COAD	cis	rs16960773	0.609	rs16960833	MIMAT0018358	hsa-miR-3942-5p	-3.97	9.25e-05	-0.36	-0.24	Optic nerve measurement (cup-to-disc ratio);	chr15:35374528	chr15:35372321~35372342:-
COAD	cis	rs2456930	0.676	rs2471038	MIMAT0000458	hsa-miR-190a-5p	3.97	9.27e-05	0.27	0.24	Brain structure (temporal lobe volume);	chr15:62382642	chr15:62823971~62823992:+
COAD	cis	rs4851551	0.867	rs3917299	MIMAT0019927	hsa-miR-4772-3p	-3.97	9.36e-05	-0.42	-0.24	Blood protein levels;	chr2:102169626	chr2:102432336~102432357:+
COAD	cis	rs7072216	0.77	rs7909131	MIMAT0005878	hsa-miR-1287-5p	3.96	9.56e-05	0.28	0.24	Metabolite levels;	chr10:98411714	chr10:98395271~98395292:-
COAD	cis	rs10231759	0.617	rs11982701	MIMAT0004819	hsa-miR-671-3p	-3.96	9.65e-05	-0.35	-0.24	Height;	chr7:150815068	chr7:151238488~151238508:+
COAD	cis	rs10021731	0.628	rs6533791	MIMAT0003242	hsa-miR-577	-3.96	9.77e-05	-0.2	-0.24	Optic disc area;	chr4:114491869	chr4:114656774~114656794:+
COAD	cis	rs950880	0.542	rs6543118	MIMAT0019927	hsa-miR-4772-3p	3.95	1e-04	0.2	0.24	Serum protein levels (sST2);	chr2:102313009	chr2:102432336~102432357:+
COAD	cis	rs6681460	0.934	rs4655631	MIMAT0014979	hsa-miR-3117-3p	-3.95	1e-04	-0.3	-0.24	Presence of antiphospholipid antibodies;	chr1:66589224	chr1:66628485~66628505:+
COAD	cis	rs6681460	1	rs6689864	MIMAT0014979	hsa-miR-3117-3p	-3.95	0.000101	-0.31	-0.24	Presence of antiphospholipid antibodies;	chr1:66602429	chr1:66628485~66628505:+
COAD	cis	rs6681460	0.901	rs1373911	MIMAT0014979	hsa-miR-3117-3p	-3.95	0.000102	-0.32	-0.24	Presence of antiphospholipid antibodies;	chr1:66575382	chr1:66628485~66628505:+
COAD	cis	rs6681460	0.966	rs10889644	MIMAT0014979	hsa-miR-3117-3p	-3.95	0.000102	-0.29	-0.24	Presence of antiphospholipid antibodies;	chr1:66679639	chr1:66628485~66628505:+
COAD	cis	rs950880	0.542	rs12712135	MIMAT0019927	hsa-miR-4772-3p	3.95	0.000103	0.2	0.24	Serum protein levels (sST2);	chr2:102314488	chr2:102432336~102432357:+
COAD	cis	rs7072216	0.77	rs1061115	MIMAT0026738	hsa-miR-1287-3p	3.94	0.000104	0.21	0.24	Metabolite levels;	chr10:98417292	chr10:98395232~98395253:-
COAD	cis	rs6681460	1	rs1536115	MIMAT0014979	hsa-miR-3117-3p	-3.94	0.000105	-0.3	-0.24	Presence of antiphospholipid antibodies;	chr1:66655318	chr1:66628485~66628505:+
COAD	cis	rs6981523	0.553	rs11989369	MIMAT0003266	hsa-miR-598-3p	3.94	0.000106	0.3	0.24	Neuroticism;	chr8:11197876	chr8:11035221~11035242:-
COAD	cis	rs6543140	0.89	rs61122764	MIMAT0019927	hsa-miR-4772-3p	-3.94	0.000107	-0.23	-0.24	Blood protein levels;	chr2:102383060	chr2:102432336~102432357:+
COAD	cis	rs10021731	0.793	rs12650568	MIMAT0003242	hsa-miR-577	3.93	0.000109	0.21	0.24	Optic disc area;	chr4:114578461	chr4:114656774~114656794:+
COAD	cis	rs4851551	1	rs4851551	MIMAT0019927	hsa-miR-4772-3p	-3.93	0.000109	-0.42	-0.24	Blood protein levels;	chr2:102183770	chr2:102432336~102432357:+
COAD	cis	rs6681460	1	rs10789210	MIMAT0014979	hsa-miR-3117-3p	-3.93	0.00011	-0.3	-0.24	Presence of antiphospholipid antibodies;	chr1:66600347	chr1:66628485~66628505:+
COAD	cis	rs7072216	0.691	rs10786419	MIMAT0026738	hsa-miR-1287-3p	3.93	0.00011	0.21	0.24	Metabolite levels;	chr10:98421183	chr10:98395232~98395253:-
COAD	cis	rs6543140	0.964	rs1035126	MIMAT0019927	hsa-miR-4772-3p	-3.92	0.000112	-0.23	-0.24	Blood protein levels;	chr2:102403521	chr2:102432336~102432357:+
COAD	cis	rs6724465	0.673	rs77397607	MIMAT0014996	hsa-miR-3131	-3.92	0.000112	-0.38	-0.24	Height;	chr2:219157074	chr2:219058725~219058747:-
COAD	cis	rs113401313	0.541	rs79480054	MIMAT0000090	hsa-miR-32-5p	3.92	0.000112	0.23	0.24	CTACK levels;	chr9:109362271	chr9:109046272~109046293:-
COAD	cis	rs3915499	0.591	rs2733854	MIMAT0002174	hsa-miR-484	3.92	0.000113	0.17	0.24	Resting heart rate;	chr16:15824841	chr16:15643301~15643322:+
COAD	cis	rs4713675	0.584	rs9368776	MIMAT0022975	hsa-miR-3934-3p	-3.92	0.000114	-0.25	-0.24	Plateletcrit;	chr6:33728628	chr6:33698191~33698212:+
COAD	cis	rs4711336	0.527	rs28651968	MIMAT0022975	hsa-miR-3934-3p	-3.92	0.000115	-0.25	-0.24	Height;	chr6:33749647	chr6:33698191~33698212:+
COAD	cis	rs6724465	0.673	rs7596389	MIMAT0014996	hsa-miR-3131	3.91	0.000117	0.37	0.24	Height;	chr2:219150495	chr2:219058725~219058747:-
COAD	cis	rs4865762	0.686	rs6867917	MIMAT0003246	hsa-miR-581	-3.91	0.000118	-0.25	-0.24	Intraocular pressure;	chr5:53130776	chr5:53951564~53951584:-
COAD	cis	rs12290811	0.572	rs77165503	MIMAT0004927	hsa-miR-708-3p	3.91	0.000118	0.27	0.24	Bipolar disorder;	chr11:79419350	chr11:79402032~79402053:-
COAD	cis	rs12612435	0.869	rs67150460	MIMAT0000424	hsa-miR-128-3p	3.91	0.000119	0.21	0.24	Takotsubo syndrome;	chr2:136370631	chr2:135665446~135665466:+
COAD	cis	rs12612435	0.869	rs67150460	MIMAT0000424_1	hsa-miR-128-3p	3.91	0.000119	0.21	0.24	Takotsubo syndrome;	chr2:136370631	chr3:35744527~35744547:+
COAD	cis	rs12612435	0.793	rs59951306	MIMAT0000424	hsa-miR-128-3p	3.91	0.000119	0.21	0.24	Takotsubo syndrome;	chr2:136374497	chr2:135665446~135665466:+
COAD	cis	rs12612435	0.793	rs59951306	MIMAT0000424_1	hsa-miR-128-3p	3.91	0.000119	0.21	0.24	Takotsubo syndrome;	chr2:136374497	chr3:35744527~35744547:+
COAD	cis	rs950880	0.553	rs2241116	MIMAT0019927	hsa-miR-4772-3p	3.91	0.00012	0.26	0.24	Serum protein levels (sST2);	chr2:102386805	chr2:102432336~102432357:+
COAD	cis	rs6543140	0.964	rs4851578	MIMAT0019927	hsa-miR-4772-3p	-3.91	0.00012	-0.23	-0.24	Blood protein levels;	chr2:102412491	chr2:102432336~102432357:+
COAD	cis	rs6681460	0.625	rs2312154	MIMAT0014979	hsa-miR-3117-3p	3.91	0.00012	0.28	0.24	Presence of antiphospholipid antibodies;	chr1:66607293	chr1:66628485~66628505:+
COAD	cis	rs950880	0.767	rs6710885	MIMAT0019927	hsa-miR-4772-3p	-3.9	0.000122	-0.21	-0.24	Serum protein levels (sST2);	chr2:102361077	chr2:102432336~102432357:+
COAD	cis	rs330203	0.519	rs17145639	MIMAT0022500	hsa-miR-5706	-3.9	0.000123	-0.31	-0.24	Iris color (a* coordinate);Iris color (b* coordinate);	chr5:119661069	chr5:119154646~119154667:+
COAD	cis	rs12290811	0.506	rs968369	MIMAT0004927	hsa-miR-708-3p	3.9	0.000124	0.25	0.24	Bipolar disorder;	chr11:79442036	chr11:79402032~79402053:-
COAD	cis	rs7527798	0.577	rs34883952	MIMAT0004515	hsa-miR-29b-2-5p	3.9	0.000124	0.23	0.24	Erythrocyte sedimentation rate;	chr1:207567523	chr1:207802492~207802513:-
COAD	cis	rs1712517	0.873	rs7913461	MIMAT0022727	hsa-miR-1307-5p	-3.9	0.000124	-0.16	-0.24	Migraine;	chr10:103241568	chr10:103394341~103394361:-
COAD	cis	rs6681460	0.932	rs523188	MIMAT0014979	hsa-miR-3117-3p	-3.9	0.000125	-0.28	-0.24	Presence of antiphospholipid antibodies;	chr1:66708739	chr1:66628485~66628505:+
COAD	cis	rs330203	0.574	rs330215	MIMAT0022500	hsa-miR-5706	-3.9	0.000125	-0.3	-0.24	Iris color (a* coordinate);Iris color (b* coordinate);	chr5:119671335	chr5:119154646~119154667:+
COAD	cis	rs3771180	0.505	rs2160203	MIMAT0019926	hsa-miR-4772-5p	3.9	0.000125	0.29	0.24	Asthma;	chr2:102344364	chr2:102432300~102432321:+
COAD	cis	rs11792861	0.962	rs72607161	MIMAT0000090	hsa-miR-32-5p	3.89	0.000126	0.2	0.24	Menarche (age at onset);	chr9:109030360	chr9:109046272~109046293:-
COAD	cis	rs114034759	0.655	rs73726303	MIMAT0000086	hsa-miR-29a-3p	-3.89	0.000129	-0.34	-0.24	Bipolar disorder (early onset);	chr7:131124556	chr7:130876748~130876769:-
COAD	cis	rs11792861	0.926	rs7470160	MIMAT0000090	hsa-miR-32-5p	3.89	0.00013	0.2	0.24	Menarche (age at onset);	chr9:109081966	chr9:109046272~109046293:-
COAD	cis	rs11792861	0.926	rs1051474	MIMAT0000090	hsa-miR-32-5p	3.88	0.00013	0.2	0.24	Menarche (age at onset);	chr9:109119576	chr9:109046272~109046293:-
COAD	cis	rs35847492	1	rs35847492	MIMAT0019728	hsa-miR-4660	3.88	0.000131	0.28	0.24	Neuroticism;	chr8:9418515	chr8:9048453~9048475:+
COAD	cis	rs1712517	0.873	rs1163086	MIMAT0022727	hsa-miR-1307-5p	-3.88	0.000133	-0.16	-0.24	Migraine;	chr10:103279822	chr10:103394341~103394361:-
COAD	cis	rs7072216	0.587	rs2296435	MIMAT0026738	hsa-miR-1287-3p	-3.88	0.000133	-0.22	-0.24	Metabolite levels;	chr10:98422528	chr10:98395232~98395253:-
COAD	cis	rs6681460	1	rs10889634	MIMAT0014979	hsa-miR-3117-3p	3.88	0.000134	0.3	0.24	Presence of antiphospholipid antibodies;	chr1:66600228	chr1:66628485~66628505:+
COAD	cis	rs7735249	0.53	rs9686938	MIMAT0003246	hsa-miR-581	3.88	0.000134	0.5	0.24	Glomerular filtration rate (creatinine);	chr5:54083472	chr5:53951564~53951584:-
COAD	cis	rs7894407	0.629	rs11598702	MIMAT0005951	hsa-miR-1307-3p	3.88	0.000135	0.16	0.24	White matter hyperintensity burden;	chr10:103138228	chr10:103394301~103394322:-
COAD	cis	rs6543140	0.929	rs11465700	MIMAT0019927	hsa-miR-4772-3p	-3.87	0.000135	-0.23	-0.23	Blood protein levels;	chr2:102441208	chr2:102432336~102432357:+
COAD	cis	rs7072216	0.77	rs1061123	MIMAT0026738	hsa-miR-1287-3p	3.87	0.000136	0.21	0.23	Metabolite levels;	chr10:98417240	chr10:98395232~98395253:-
COAD	cis	rs7072216	0.587	rs2296435	MIMAT0005878	hsa-miR-1287-5p	-3.87	0.000137	-0.29	-0.23	Metabolite levels;	chr10:98422528	chr10:98395271~98395292:-
COAD	cis	rs2456930	0.648	rs2261443	MIMAT0000458	hsa-miR-190a-5p	3.87	0.000138	0.26	0.23	Brain structure (temporal lobe volume);	chr15:62387973	chr15:62823971~62823992:+
COAD	cis	rs17783634	0.509	rs11775489	MIMAT0003266	hsa-miR-598-3p	-3.87	0.000138	-0.29	-0.23	Subjective well-being;	chr8:11179334	chr8:11035221~11035242:-
COAD	cis	rs4865762	0.514	rs2547526	MIMAT0003246	hsa-miR-581	-3.87	0.000138	-0.25	-0.23	Intraocular pressure;	chr5:53141038	chr5:53951564~53951584:-
COAD	cis	rs953387	0.628	rs2176716	MIMAT0026477	hsa-miR-128-1-5p	3.87	0.00014	0.21	0.23	Arthritis (juvenile idiopathic);	chr2:136166123	chr2:135665411~135665433:+
COAD	cis	rs953387	0.666	rs11684458	MIMAT0026477	hsa-miR-128-1-5p	3.87	0.00014	0.21	0.23	Arthritis (juvenile idiopathic);	chr2:136166586	chr2:135665411~135665433:+
COAD	cis	rs8064299	0.967	rs7420	MIMAT0017994	hsa-miR-3615	3.87	0.000141	0.23	0.23	Monocyte count;	chr17:74769076	chr17:74748663~74748683:+
COAD	cis	rs6681460	1	rs6588207	MIMAT0014979	hsa-miR-3117-3p	-3.86	0.000142	-0.29	-0.23	Presence of antiphospholipid antibodies;	chr1:66600872	chr1:66628485~66628505:+
COAD	cis	rs950880	0.553	rs3755272	MIMAT0019927	hsa-miR-4772-3p	3.86	0.000142	0.25	0.23	Serum protein levels (sST2);	chr2:102417365	chr2:102432336~102432357:+
COAD	cis	rs330203	0.574	rs1597713	MIMAT0022500	hsa-miR-5706	-3.86	0.000143	-0.29	-0.23	Iris color (a* coordinate);Iris color (b* coordinate);	chr5:119666652	chr5:119154646~119154667:+
COAD	cis	rs7894407	0.623	rs10883846	MIMAT0005951	hsa-miR-1307-3p	3.86	0.000143	0.16	0.23	White matter hyperintensity burden;	chr10:103198487	chr10:103394301~103394322:-
COAD	cis	rs950880	0.56	rs11679191	MIMAT0019927	hsa-miR-4772-3p	3.86	0.000143	0.2	0.23	Serum protein levels (sST2);	chr2:102310340	chr2:102432336~102432357:+
COAD	cis	rs79387448	0.638	rs74731686	MIMAT0019926	hsa-miR-4772-5p	-3.86	0.000145	-0.36	-0.23	Gut microbiota (bacterial taxa);	chr2:102427521	chr2:102432300~102432321:+
COAD	cis	rs7735249	0.618	rs7709659	MIMAT0003246	hsa-miR-581	3.86	0.000145	0.52	0.23	Glomerular filtration rate (creatinine);	chr5:54086609	chr5:53951564~53951584:-
COAD	cis	rs6681460	0.933	rs7554101	MIMAT0014979	hsa-miR-3117-3p	3.86	0.000145	0.28	0.23	Presence of antiphospholipid antibodies;	chr1:66690789	chr1:66628485~66628505:+
COAD	cis	rs1712517	0.773	rs1063461	MIMAT0022727	hsa-miR-1307-5p	-3.86	0.000145	-0.16	-0.23	Migraine;	chr10:103289348	chr10:103394341~103394361:-
COAD	cis	rs1712517	0.74	rs4293062	MIMAT0022727	hsa-miR-1307-5p	-3.86	0.000145	-0.16	-0.23	Migraine;	chr10:103292867	chr10:103394341~103394361:-
COAD	cis	rs1712517	0.744	rs11191641	MIMAT0022727	hsa-miR-1307-5p	-3.86	0.000145	-0.16	-0.23	Migraine;	chr10:103293183	chr10:103394341~103394361:-
COAD	cis	rs1712517	0.744	rs4293063	MIMAT0022727	hsa-miR-1307-5p	-3.86	0.000145	-0.16	-0.23	Migraine;	chr10:103293219	chr10:103394341~103394361:-
COAD	cis	rs1712517	0.525	rs2271751	MIMAT0022727	hsa-miR-1307-5p	-3.86	0.000146	-0.17	-0.23	Migraine;	chr10:103415374	chr10:103394341~103394361:-
COAD	cis	rs6681460	0.966	rs4655506	MIMAT0014979	hsa-miR-3117-3p	-3.86	0.000146	-0.29	-0.23	Presence of antiphospholipid antibodies;	chr1:66685128	chr1:66628485~66628505:+
COAD	cis	rs4917385	1	rs4917385	MIMAT0022727	hsa-miR-1307-5p	3.85	0.000147	0.17	0.23	Systemic lupus erythematosus;	chr10:103243964	chr10:103394341~103394361:-
COAD	cis	rs6981523	0.553	rs2409730	MIMAT0003266	hsa-miR-598-3p	-3.85	0.000148	-0.3	-0.23	Neuroticism;	chr8:11203129	chr8:11035221~11035242:-
COAD	cis	rs6681460	0.837	rs6669023	MIMAT0014979	hsa-miR-3117-3p	-3.85	0.00015	-0.28	-0.23	Presence of antiphospholipid antibodies;	chr1:66706185	chr1:66628485~66628505:+
COAD	cis	rs6681460	0.932	rs492109	MIMAT0014979	hsa-miR-3117-3p	3.85	0.000151	0.29	0.23	Presence of antiphospholipid antibodies;	chr1:66721450	chr1:66628485~66628505:+
COAD	cis	rs4713675	0.546	rs10947435	MIMAT0022975	hsa-miR-3934-3p	-3.84	0.000154	-0.24	-0.23	Plateletcrit;	chr6:33750298	chr6:33698191~33698212:+
COAD	cis	rs950880	0.767	rs12999364	MIMAT0019927	hsa-miR-4772-3p	3.84	0.000155	0.21	0.23	Serum protein levels (sST2);	chr2:102357669	chr2:102432336~102432357:+
COAD	cis	rs950880	0.767	rs12998521	MIMAT0019927	hsa-miR-4772-3p	3.84	0.000155	0.21	0.23	Serum protein levels (sST2);	chr2:102357957	chr2:102432336~102432357:+
COAD	cis	rs950880	0.796	rs12987977	MIMAT0019927	hsa-miR-4772-3p	3.84	0.000155	0.21	0.23	Serum protein levels (sST2);	chr2:102358876	chr2:102432336~102432357:+
COAD	cis	rs4072705	0.967	rs4144630	MIMAT0004558	hsa-miR-181a-2-3p	-3.84	0.000156	-0.26	-0.23	Menarche (age at onset);	chr9:124676921	chr9:124692518~124692539:+
COAD	cis	rs7588654	1	rs2293072	MIMAT0014996	hsa-miR-3131	3.84	0.000158	0.54	0.23	Height;	chr2:219180732	chr2:219058725~219058747:-
COAD	cis	rs330203	0.574	rs55714737	MIMAT0022500	hsa-miR-5706	-3.83	0.000162	-0.3	-0.23	Iris color (a* coordinate);Iris color (b* coordinate);	chr5:119662587	chr5:119154646~119154667:+
COAD	cis	rs330203	0.574	rs55977325	MIMAT0022500	hsa-miR-5706	-3.83	0.000162	-0.3	-0.23	Iris color (a* coordinate);Iris color (b* coordinate);	chr5:119662723	chr5:119154646~119154667:+
COAD	cis	rs330203	0.574	rs56329994	MIMAT0022500	hsa-miR-5706	-3.83	0.000162	-0.3	-0.23	Iris color (a* coordinate);Iris color (b* coordinate);	chr5:119663741	chr5:119154646~119154667:+
COAD	cis	rs330203	0.547	rs1823665	MIMAT0022500	hsa-miR-5706	-3.83	0.000162	-0.3	-0.23	Iris color (a* coordinate);Iris color (b* coordinate);	chr5:119664058	chr5:119154646~119154667:+
COAD	cis	rs6681460	0.932	rs523956	MIMAT0014979	hsa-miR-3117-3p	3.83	0.000162	0.29	0.23	Presence of antiphospholipid antibodies;	chr1:66722593	chr1:66628485~66628505:+
COAD	cis	rs216303	0.642	rs216314	MIMAT0000432	hsa-miR-141-3p	-3.82	0.000165	-0.2	-0.23	Low vWF levels;	chr12:6027414	chr12:6964155~6964176:+
COAD	cis	rs6543140	0.964	rs6761350	MIMAT0019927	hsa-miR-4772-3p	-3.82	0.000165	-0.23	-0.23	Blood protein levels;	chr2:102414316	chr2:102432336~102432357:+
COAD	cis	rs6543140	0.929	rs7602207	MIMAT0019927	hsa-miR-4772-3p	-3.82	0.000165	-0.23	-0.23	Blood protein levels;	chr2:102415906	chr2:102432336~102432357:+
COAD	cis	rs6543140	0.964	rs2160200	MIMAT0019927	hsa-miR-4772-3p	-3.82	0.000165	-0.23	-0.23	Blood protein levels;	chr2:102417503	chr2:102432336~102432357:+
COAD	cis	rs113401313	0.541	rs12551180	MIMAT0000090	hsa-miR-32-5p	3.82	0.000166	0.23	0.23	CTACK levels;	chr9:109371131	chr9:109046272~109046293:-
COAD	cis	rs12034383	0.783	rs11576522	MIMAT0004515	hsa-miR-29b-2-5p	-3.82	0.000166	-0.2	-0.23	Erythrocyte sedimentation rate;	chr1:207615924	chr1:207802492~207802513:-
COAD	cis	rs4865762	0.692	rs1374058	MIMAT0003246	hsa-miR-581	3.82	0.000169	0.25	0.23	Intraocular pressure;	chr5:53131816	chr5:53951564~53951584:-
COAD	cis	rs6681460	0.899	rs502690	MIMAT0014979	hsa-miR-3117-3p	-3.82	0.000169	-0.28	-0.23	Presence of antiphospholipid antibodies;	chr1:66716720	chr1:66628485~66628505:+
COAD	cis	rs1163656	0.527	rs1402347	MIMAT0003287	hsa-miR-618	3.82	0.000169	0.46	0.23	Dental caries;	chr12:80913217	chr12:80935796~80935818:-
COAD	cis	rs6543140	0.964	rs6543136	MIMAT0019927	hsa-miR-4772-3p	-3.82	0.00017	-0.22	-0.23	Blood protein levels;	chr2:102449087	chr2:102432336~102432357:+
COAD	cis	rs1712517	0.873	rs7916056	MIMAT0022727	hsa-miR-1307-5p	3.82	0.00017	0.16	0.23	Migraine;	chr10:103238157	chr10:103394341~103394361:-
COAD	cis	rs12290811	0.515	rs12286448	MIMAT0004927	hsa-miR-708-3p	3.81	0.000172	0.26	0.23	Bipolar disorder;	chr11:79410298	chr11:79402032~79402053:-
COAD	cis	rs2871473	0.951	rs1030025	MIMAT0019926	hsa-miR-4772-5p	-3.81	0.000174	-0.27	-0.23	Blood protein levels;	chr2:102489152	chr2:102432300~102432321:+
COAD	cis	rs6681460	0.934	rs10889635	MIMAT0014979	hsa-miR-3117-3p	-3.81	0.000174	-0.3	-0.23	Presence of antiphospholipid antibodies;	chr1:66609892	chr1:66628485~66628505:+
COAD	cis	rs6543140	0.964	rs62154972	MIMAT0019927	hsa-miR-4772-3p	-3.8	0.000177	-0.22	-0.23	Blood protein levels;	chr2:102432278	chr2:102432336~102432357:+
COAD	cis	rs6681460	0.932	rs523132	MIMAT0014979	hsa-miR-3117-3p	3.8	0.000178	0.28	0.23	Presence of antiphospholipid antibodies;	chr1:66708757	chr1:66628485~66628505:+
COAD	cis	rs7072216	0.65	rs10883089	MIMAT0026738	hsa-miR-1287-3p	3.8	0.000179	0.2	0.23	Metabolite levels;	chr10:98403363	chr10:98395232~98395253:-
COAD	cis	rs4713675	0.546	rs9348925	MIMAT0022975	hsa-miR-3934-3p	-3.8	0.000179	-0.24	-0.23	Plateletcrit;	chr6:33742919	chr6:33698191~33698212:+
COAD	cis	rs2456930	0.714	rs2261472	MIMAT0000458	hsa-miR-190a-5p	-3.8	0.00018	-0.25	-0.23	Brain structure (temporal lobe volume);	chr15:62388751	chr15:62823971~62823992:+
COAD	cis	rs1712517	0.524	rs4917384	MIMAT0022727	hsa-miR-1307-5p	3.8	0.00018	0.17	0.23	Migraine;	chr10:103236031	chr10:103394341~103394361:-
COAD	cis	rs7527798	0.577	rs10127904	MIMAT0004515	hsa-miR-29b-2-5p	3.8	0.00018	0.23	0.23	Erythrocyte sedimentation rate;	chr1:207574762	chr1:207802492~207802513:-
COAD	cis	rs1867631	0.585	rs5008753	MIMAT0014979	hsa-miR-3117-3p	-3.8	0.00018	-0.27	-0.23	Menopause (age at onset);	chr1:66626565	chr1:66628485~66628505:+
COAD	cis	rs4713675	0.565	rs60704560	MIMAT0022975	hsa-miR-3934-3p	-3.8	0.00018	-0.24	-0.23	Plateletcrit;	chr6:33745523	chr6:33698191~33698212:+
COAD	cis	rs12368653	0.641	rs11172300	MIMAT0004681	hsa-miR-26a-2-3p	3.8	0.000182	0.22	0.23	Multiple sclerosis;	chr12:57682732	chr12:57824620~57824641:-
COAD	cis	rs453301	0.653	rs11784393	MIMAT0019728	hsa-miR-4660	3.8	0.000184	0.25	0.23	Joint mobility (Beighton score);	chr8:9045624	chr8:9048453~9048475:+
COAD	cis	rs75358501	0.901	rs79499040	MIMAT0014994	hsa-miR-3130-3p	3.79	0.000186	0.48	0.23	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776206	chr2:206783245~206783265:-
COAD	cis	rs75358501	0.901	rs79499040	MIMAT0014994_1	hsa-miR-3130-3p	3.79	0.000186	0.48	0.23	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776206	chr2:206783277~206783297:+
COAD	cis	rs7072216	0.621	rs3750604	MIMAT0026738	hsa-miR-1287-3p	3.79	0.000187	0.23	0.23	Metabolite levels;	chr10:98415824	chr10:98395232~98395253:-
COAD	cis	rs6543140	0.964	rs6736135	MIMAT0019927	hsa-miR-4772-3p	-3.79	0.000188	-0.22	-0.23	Blood protein levels;	chr2:102448464	chr2:102432336~102432357:+
COAD	cis	rs6681460	0.932	rs2146904	MIMAT0014979	hsa-miR-3117-3p	3.79	0.000189	0.28	0.23	Presence of antiphospholipid antibodies;	chr1:66694653	chr1:66628485~66628505:+
COAD	cis	rs113401313	0.573	rs74519113	MIMAT0000090	hsa-miR-32-5p	3.79	0.000189	0.22	0.23	CTACK levels;	chr9:109383920	chr9:109046272~109046293:-
COAD	cis	rs11792861	0.962	rs72607162	MIMAT0000090	hsa-miR-32-5p	3.79	0.00019	0.19	0.23	Menarche (age at onset);	chr9:109031439	chr9:109046272~109046293:-
COAD	cis	rs11792861	0.962	rs11789624	MIMAT0000090	hsa-miR-32-5p	3.79	0.00019	0.19	0.23	Menarche (age at onset);	chr9:109033951	chr9:109046272~109046293:-
COAD	cis	rs6681460	1	rs9662943	MIMAT0014979	hsa-miR-3117-3p	3.79	0.000191	0.3	0.23	Presence of antiphospholipid antibodies;	chr1:66655449	chr1:66628485~66628505:+
COAD	cis	rs4713675	0.584	rs9394163	MIMAT0022975	hsa-miR-3934-3p	-3.79	0.000191	-0.24	-0.23	Plateletcrit;	chr6:33714637	chr6:33698191~33698212:+
COAD	cis	rs11792861	0.816	rs17792434	MIMAT0000090	hsa-miR-32-5p	3.78	0.000193	0.2	0.23	Menarche (age at onset);	chr9:108905039	chr9:109046272~109046293:-
COAD	cis	rs4865762	0.901	rs153618	MIMAT0003246	hsa-miR-581	3.78	0.000194	0.25	0.23	Intraocular pressure;	chr5:53254409	chr5:53951564~53951584:-
COAD	cis	rs113401313	0.512	rs75396397	MIMAT0000090	hsa-miR-32-5p	3.78	0.000196	0.22	0.23	CTACK levels;	chr9:109348663	chr9:109046272~109046293:-
COAD	cis	rs113401313	0.512	rs12685074	MIMAT0000090	hsa-miR-32-5p	3.78	0.000196	0.22	0.23	CTACK levels;	chr9:109353407	chr9:109046272~109046293:-
COAD	cis	rs12612435	0.869	rs16833899	MIMAT0000424	hsa-miR-128-3p	3.78	0.000196	0.19	0.23	Takotsubo syndrome;	chr2:136362752	chr2:135665446~135665466:+
COAD	cis	rs12612435	0.869	rs16833899	MIMAT0000424_1	hsa-miR-128-3p	3.78	0.000196	0.19	0.23	Takotsubo syndrome;	chr2:136362752	chr3:35744527~35744547:+
COAD	cis	rs6681460	1	rs6696927	MIMAT0014979	hsa-miR-3117-3p	-3.78	0.000197	-0.29	-0.23	Presence of antiphospholipid antibodies;	chr1:66604698	chr1:66628485~66628505:+
COAD	cis	rs7819412	0.595	rs10503416	MIMAT0003266	hsa-miR-598-3p	3.78	0.000197	0.27	0.23	Triglycerides;	chr8:11130043	chr8:11035221~11035242:-
COAD	cis	rs12290811	0.515	rs7127580	MIMAT0004927	hsa-miR-708-3p	3.78	0.000198	0.24	0.23	Bipolar disorder;	chr11:79433812	chr11:79402032~79402053:-
COAD	cis	rs6681460	0.966	rs10789215	MIMAT0014979	hsa-miR-3117-3p	3.78	0.000198	0.28	0.23	Presence of antiphospholipid antibodies;	chr1:66685502	chr1:66628485~66628505:+
COAD	cis	rs10021731	0.725	rs1460770	MIMAT0003242	hsa-miR-577	-3.77	0.000199	-0.19	-0.23	Optic disc area;	chr4:114484189	chr4:114656774~114656794:+
COAD	cis	rs7072216	0.666	rs11598689	MIMAT0026738	hsa-miR-1287-3p	3.77	0.000199	0.21	0.23	Metabolite levels;	chr10:98396270	chr10:98395232~98395253:-
COAD	cis	rs1712517	0.844	rs1163087	MIMAT0022727	hsa-miR-1307-5p	-3.77	0.000202	-0.16	-0.23	Migraine;	chr10:103283532	chr10:103394341~103394361:-
COAD	cis	rs950880	0.56	rs10178436	MIMAT0019927	hsa-miR-4772-3p	3.77	0.000204	0.19	0.23	Serum protein levels (sST2);	chr2:102310051	chr2:102432336~102432357:+
COAD	cis	rs1712517	0.524	rs1712509	MIMAT0022727	hsa-miR-1307-5p	-3.77	0.000205	-0.17	-0.23	Migraine;	chr10:103254113	chr10:103394341~103394361:-
COAD	cis	rs6981523	0.553	rs11783045	MIMAT0003266	hsa-miR-598-3p	-3.77	0.000206	-0.29	-0.23	Neuroticism;	chr8:11198666	chr8:11035221~11035242:-
COAD	cis	rs2303282	0.933	rs34793257	MIMAT0000430	hsa-miR-138-5p	-3.76	0.000207	-0.26	-0.23	Breast cancer;	chr16:56460159	chr16:56858527~56858549:+
COAD	cis	rs2303282	0.933	rs34793257	MIMAT0000430_1	hsa-miR-138-5p	-3.76	0.000207	-0.26	-0.23	Breast cancer;	chr16:56460159	chr3:44114234~44114256:+
COAD	cis	rs4713675	0.565	rs9368773	MIMAT0022975	hsa-miR-3934-3p	-3.76	0.000208	-0.24	-0.23	Plateletcrit;	chr6:33714764	chr6:33698191~33698212:+
COAD	cis	rs1712517	0.771	rs2008530	MIMAT0022727	hsa-miR-1307-5p	-3.76	0.000209	-0.15	-0.23	Migraine;	chr10:103299082	chr10:103394341~103394361:-
COAD	cis	rs7527798	0.577	rs10127904	MIMAT0004673	hsa-miR-29c-5p	3.76	0.000209	0.19	0.23	Erythrocyte sedimentation rate;	chr1:207574762	chr1:207801903~207801924:-
COAD	cis	rs6681460	1	rs6697088	MIMAT0014979	hsa-miR-3117-3p	3.76	0.000209	0.3	0.23	Presence of antiphospholipid antibodies;	chr1:66579041	chr1:66628485~66628505:+
COAD	cis	rs79387448	0.638	rs11465670	MIMAT0019926	hsa-miR-4772-5p	-3.76	0.00021	-0.34	-0.23	Gut microbiota (bacterial taxa);	chr2:102417980	chr2:102432300~102432321:+
COAD	cis	rs216303	0.554	rs216320	MIMAT0000432	hsa-miR-141-3p	-3.76	0.00021	-0.2	-0.23	Low vWF levels;	chr12:6034190	chr12:6964155~6964176:+
COAD	cis	rs216303	0.57	rs216321	MIMAT0000432	hsa-miR-141-3p	-3.76	0.00021	-0.2	-0.23	Low vWF levels;	chr12:6034818	chr12:6964155~6964176:+
COAD	cis	rs216303	0.642	rs216324	MIMAT0000432	hsa-miR-141-3p	-3.76	0.00021	-0.2	-0.23	Low vWF levels;	chr12:6036059	chr12:6964155~6964176:+
COAD	cis	rs7072216	0.77	rs7896828	MIMAT0005878	hsa-miR-1287-5p	3.76	0.000212	0.27	0.23	Metabolite levels;	chr10:98410750	chr10:98395271~98395292:-
COAD	cis	rs4713675	0.565	rs4713668	MIMAT0022975	hsa-miR-3934-3p	-3.76	0.000212	-0.24	-0.23	Plateletcrit;	chr6:33723019	chr6:33698191~33698212:+
COAD	cis	rs4713675	0.546	rs10947434	MIMAT0022975	hsa-miR-3934-3p	-3.76	0.000212	-0.24	-0.23	Plateletcrit;	chr6:33723724	chr6:33698191~33698212:+
COAD	cis	rs6543140	0.964	rs6748390	MIMAT0019927	hsa-miR-4772-3p	-3.76	0.000214	-0.22	-0.23	Blood protein levels;	chr2:102445715	chr2:102432336~102432357:+
COAD	cis	rs4865762	0.514	rs30093	MIMAT0003246	hsa-miR-581	3.76	0.000214	0.24	0.23	Intraocular pressure;	chr5:53127408	chr5:53951564~53951584:-
COAD	cis	rs4713675	0.584	rs9380375	MIMAT0022975	hsa-miR-3934-3p	-3.76	0.000214	-0.24	-0.23	Plateletcrit;	chr6:33714614	chr6:33698191~33698212:+
COAD	cis	rs11792861	0.926	rs58795279	MIMAT0000090	hsa-miR-32-5p	3.75	0.000217	0.19	0.23	Menarche (age at onset);	chr9:109089622	chr9:109046272~109046293:-
COAD	cis	rs11657269	0.518	rs8070021	MIMAT0000761	hsa-miR-324-5p	3.75	0.000217	0.18	0.23	TRAIL levels;	chr17:6422894	chr17:7223343~7223364:-
COAD	cis	rs1712517	0.771	rs7921655	MIMAT0022727	hsa-miR-1307-5p	-3.75	0.000221	-0.15	-0.23	Migraine;	chr10:103353944	chr10:103394341~103394361:-
COAD	cis	rs7819412	0.521	rs10100660	MIMAT0003266	hsa-miR-598-3p	-3.75	0.000222	-0.28	-0.23	Triglycerides;	chr8:11181376	chr8:11035221~11035242:-
COAD	cis	rs11792861	0.816	rs3763643	MIMAT0000090	hsa-miR-32-5p	3.74	0.000223	0.2	0.23	Menarche (age at onset);	chr9:108933327	chr9:109046272~109046293:-
COAD	cis	rs11792861	0.816	rs2275637	MIMAT0000090	hsa-miR-32-5p	3.74	0.000223	0.2	0.23	Menarche (age at onset);	chr9:108933763	chr9:109046272~109046293:-
COAD	cis	rs4713675	0.565	rs9348924	MIMAT0022975	hsa-miR-3934-3p	-3.74	0.000224	-0.23	-0.23	Plateletcrit;	chr6:33737659	chr6:33698191~33698212:+
COAD	cis	rs950880	1	rs950880	MIMAT0019927	hsa-miR-4772-3p	3.74	0.000227	0.21	0.23	Serum protein levels (sST2);	chr2:102316102	chr2:102432336~102432357:+
COAD	cis	rs11792861	0.926	rs72607170	MIMAT0000090	hsa-miR-32-5p	3.74	0.000228	0.19	0.23	Menarche (age at onset);	chr9:109074661	chr9:109046272~109046293:-
COAD	cis	rs1712517	0.566	rs1163073	MIMAT0022727	hsa-miR-1307-5p	3.74	0.000228	0.17	0.23	Migraine;	chr10:103263177	chr10:103394341~103394361:-
COAD	cis	rs6681460	0.932	rs602513	MIMAT0014979	hsa-miR-3117-3p	-3.74	0.00023	-0.27	-0.23	Presence of antiphospholipid antibodies;	chr1:66711587	chr1:66628485~66628505:+
COAD	cis	rs10021731	0.725	rs72676244	MIMAT0003242	hsa-miR-577	3.74	0.00023	0.18	0.23	Optic disc area;	chr4:114479168	chr4:114656774~114656794:+
COAD	cis	rs950880	0.56	rs6721346	MIMAT0019927	hsa-miR-4772-3p	3.73	0.000232	0.19	0.23	Serum protein levels (sST2);	chr2:102309860	chr2:102432336~102432357:+
COAD	cis	rs730570	1	rs10141733	MIMAT0000453	hsa-miR-154-3p	-3.73	0.000233	-0.27	-0.23	Type 2 diabetes;	chr14:100676314	chr14:101059805~101059826:+
COAD	cis	rs1712517	0.771	rs11191676	MIMAT0022727	hsa-miR-1307-5p	-3.73	0.000234	-0.15	-0.23	Migraine;	chr10:103395309	chr10:103394341~103394361:-
COAD	cis	rs953387	0.58	rs1519527	MIMAT0026477	hsa-miR-128-1-5p	3.73	0.000234	0.21	0.23	Arthritis (juvenile idiopathic);	chr2:136210847	chr2:135665411~135665433:+
COAD	cis	rs7105056	1	rs4936054	MIMAT0000686	hsa-miR-34c-5p	3.73	0.000235	0.45	0.23	Immune reponse to smallpox (secreted IL-12p40);	chr11:112386156	chr11:111513451~111513473:+
COAD	cis	rs11792861	0.855	rs72607165	MIMAT0000090	hsa-miR-32-5p	3.73	0.000237	0.19	0.23	Menarche (age at onset);	chr9:109052218	chr9:109046272~109046293:-
COAD	cis	rs6703335	0.687	rs4658560	MIMAT0019761	hsa-miR-4677-3p	3.72	0.000241	0.2	0.23	Schizophrenia;Schizophrenia, schizoaffective disorder or bipolar disorder;	chr1:243355389	chr1:243346225~243346246:+
COAD	cis	rs2456930	0.714	rs2456932	MIMAT0000458	hsa-miR-190a-5p	3.72	0.000242	0.25	0.23	Brain structure (temporal lobe volume);	chr15:62390947	chr15:62823971~62823992:+
COAD	cis	rs2456930	0.714	rs1850573	MIMAT0000458	hsa-miR-190a-5p	3.72	0.000242	0.25	0.23	Brain structure (temporal lobe volume);	chr15:62391976	chr15:62823971~62823992:+
COAD	cis	rs12758548	0.624	rs12760161	MIMAT0004564	hsa-miR-214-5p	3.72	0.000242	0.14	0.23	Erythrocyte cadmium concentration in never smokers;	chr1:172528734	chr1:172138857~172138878:-
COAD	cis	rs10021731	0.725	rs6850121	MIMAT0003242	hsa-miR-577	-3.72	0.000242	-0.18	-0.23	Optic disc area;	chr4:114484294	chr4:114656774~114656794:+
COAD	cis	rs75358501	0.901	rs76270461	MIMAT0014994	hsa-miR-3130-3p	3.72	0.000243	0.49	0.23	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206788929	chr2:206783245~206783265:-
COAD	cis	rs75358501	0.901	rs76270461	MIMAT0014994_1	hsa-miR-3130-3p	3.72	0.000243	0.49	0.23	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206788929	chr2:206783277~206783297:+
COAD	cis	rs11792861	0.89	rs57387569	MIMAT0000090	hsa-miR-32-5p	3.72	0.000245	0.19	0.23	Menarche (age at onset);	chr9:109158112	chr9:109046272~109046293:-
COAD	cis	rs7829975	0.774	rs11775523	MIMAT0019728	hsa-miR-4660	3.72	0.000245	0.26	0.23	Mood instability;	chr8:8821666	chr8:9048453~9048475:+
COAD	cis	rs6543140	0.964	rs6543138	MIMAT0019927	hsa-miR-4772-3p	-3.72	0.000246	-0.21	-0.23	Blood protein levels;	chr2:102449672	chr2:102432336~102432357:+
COAD	cis	rs7072216	0.77	rs942810	MIMAT0005878	hsa-miR-1287-5p	3.72	0.000246	0.27	0.23	Metabolite levels;	chr10:98408103	chr10:98395271~98395292:-
COAD	cis	rs6681460	0.932	rs603750	MIMAT0014979	hsa-miR-3117-3p	-3.72	0.000246	-0.27	-0.23	Presence of antiphospholipid antibodies;	chr1:66711805	chr1:66628485~66628505:+
COAD	cis	rs7072216	0.621	rs11189595	MIMAT0026738	hsa-miR-1287-3p	3.72	0.000249	0.22	0.23	Metabolite levels;	chr10:98407565	chr10:98395232~98395253:-
COAD	cis	rs79387448	0.638	rs7600961	MIMAT0019926	hsa-miR-4772-5p	-3.71	0.00025	-0.34	-0.23	Gut microbiota (bacterial taxa);	chr2:102418995	chr2:102432300~102432321:+
COAD	cis	rs10021731	0.691	rs6849064	MIMAT0003242	hsa-miR-577	-3.71	0.00025	-0.18	-0.23	Optic disc area;	chr4:114483807	chr4:114656774~114656794:+
COAD	cis	rs216303	0.642	rs216335	MIMAT0000432	hsa-miR-141-3p	-3.71	0.000251	-0.19	-0.23	Low vWF levels;	chr12:6038839	chr12:6964155~6964176:+
COAD	cis	rs11792861	0.926	rs11788904	MIMAT0000090	hsa-miR-32-5p	3.71	0.000252	0.19	0.23	Menarche (age at onset);	chr9:109102772	chr9:109046272~109046293:-
COAD	cis	rs11792861	0.926	rs11787878	MIMAT0000090	hsa-miR-32-5p	3.71	0.000252	0.19	0.23	Menarche (age at onset);	chr9:109104469	chr9:109046272~109046293:-
COAD	cis	rs11792861	0.926	rs56899598	MIMAT0000090	hsa-miR-32-5p	3.71	0.000252	0.19	0.23	Menarche (age at onset);	chr9:109104991	chr9:109046272~109046293:-
COAD	cis	rs11792861	0.926	rs12683988	MIMAT0000090	hsa-miR-32-5p	3.71	0.000252	0.19	0.23	Menarche (age at onset);	chr9:109105010	chr9:109046272~109046293:-
COAD	cis	rs11792861	0.855	rs116127510	MIMAT0000090	hsa-miR-32-5p	3.71	0.000252	0.19	0.23	Menarche (age at onset);	chr9:109106064	chr9:109046272~109046293:-
COAD	cis	rs11792861	0.926	rs2271878	MIMAT0000090	hsa-miR-32-5p	3.71	0.000252	0.19	0.23	Menarche (age at onset);	chr9:109106605	chr9:109046272~109046293:-
COAD	cis	rs11792861	0.926	rs7870597	MIMAT0000090	hsa-miR-32-5p	3.71	0.000252	0.19	0.23	Menarche (age at onset);	chr9:109109584	chr9:109046272~109046293:-
COAD	cis	rs216303	0.57	rs216339	MIMAT0000432	hsa-miR-141-3p	-3.71	0.000253	-0.22	-0.23	Low vWF levels;	chr12:6040118	chr12:6964155~6964176:+
COAD	cis	rs950880	0.767	rs2287037	MIMAT0019927	hsa-miR-4772-3p	3.71	0.000253	0.2	0.23	Serum protein levels (sST2);	chr2:102362568	chr2:102432336~102432357:+
COAD	cis	rs12758548	0.601	rs2227189	MIMAT0004564	hsa-miR-214-5p	-3.71	0.000253	-0.15	-0.23	Erythrocyte cadmium concentration in never smokers;	chr1:172614412	chr1:172138857~172138878:-
COAD	cis	rs11792861	0.816	rs11790105	MIMAT0000090	hsa-miR-32-5p	3.71	0.000253	0.19	0.23	Menarche (age at onset);	chr9:108969505	chr9:109046272~109046293:-
COAD	cis	rs1712517	0.787	rs1163089	MIMAT0022727	hsa-miR-1307-5p	-3.71	0.000254	-0.16	-0.23	Migraine;	chr10:103284207	chr10:103394341~103394361:-
COAD	cis	rs7072216	0.881	rs7082192	MIMAT0005878	hsa-miR-1287-5p	3.71	0.000254	0.26	0.23	Metabolite levels;	chr10:98392087	chr10:98395271~98395292:-
COAD	cis	rs7527798	0.535	rs34070762	MIMAT0004515	hsa-miR-29b-2-5p	3.71	0.000255	0.22	0.23	Erythrocyte sedimentation rate;	chr1:207599263	chr1:207802492~207802513:-
COAD	cis	rs7527798	0.535	rs17259038	MIMAT0004515	hsa-miR-29b-2-5p	3.71	0.000255	0.22	0.23	Erythrocyte sedimentation rate;	chr1:207600557	chr1:207802492~207802513:-
COAD	cis	rs7072216	0.77	rs1739	MIMAT0026738	hsa-miR-1287-3p	3.71	0.000255	0.2	0.23	Metabolite levels;	chr10:98416582	chr10:98395232~98395253:-
COAD	cis	rs950880	0.767	rs4851569	MIMAT0019927	hsa-miR-4772-3p	3.71	0.000255	0.2	0.23	Serum protein levels (sST2);	chr2:102366787	chr2:102432336~102432357:+
COAD	cis	rs950880	0.767	rs1420098	MIMAT0019927	hsa-miR-4772-3p	3.71	0.000255	0.2	0.23	Serum protein levels (sST2);	chr2:102367819	chr2:102432336~102432357:+
COAD	cis	rs950880	0.699	rs1882348	MIMAT0019927	hsa-miR-4772-3p	3.71	0.000255	0.2	0.23	Serum protein levels (sST2);	chr2:102368211	chr2:102432336~102432357:+
COAD	cis	rs11792861	0.926	rs12686736	MIMAT0000090	hsa-miR-32-5p	3.71	0.000256	0.19	0.23	Menarche (age at onset);	chr9:109126459	chr9:109046272~109046293:-
COAD	cis	rs4865762	0.904	rs254198	MIMAT0003246	hsa-miR-581	3.71	0.000257	0.23	0.23	Intraocular pressure;	chr5:53204982	chr5:53951564~53951584:-
COAD	cis	rs4713675	0.565	rs942640	MIMAT0022975	hsa-miR-3934-3p	-3.71	0.000258	-0.24	-0.23	Plateletcrit;	chr6:33718665	chr6:33698191~33698212:+
COAD	cis	rs4713675	0.584	rs2966	MIMAT0022975	hsa-miR-3934-3p	-3.71	0.000258	-0.24	-0.23	Plateletcrit;	chr6:33721743	chr6:33698191~33698212:+
COAD	cis	rs4713675	0.565	rs4711341	MIMAT0022975	hsa-miR-3934-3p	-3.71	0.000258	-0.24	-0.23	Plateletcrit;	chr6:33723020	chr6:33698191~33698212:+
COAD	cis	rs6681460	0.932	rs618093	MIMAT0014979	hsa-miR-3117-3p	-3.71	0.000258	-0.27	-0.23	Presence of antiphospholipid antibodies;	chr1:66712745	chr1:66628485~66628505:+
COAD	cis	rs9646944	0.501	rs10202813	MIMAT0019927	hsa-miR-4772-3p	-3.71	0.000259	-0.23	-0.23	Blood protein levels;	chr2:102403280	chr2:102432336~102432357:+
COAD	cis	rs7527798	0.577	rs34883952	MIMAT0004673	hsa-miR-29c-5p	3.7	0.000259	0.18	0.23	Erythrocyte sedimentation rate;	chr1:207567523	chr1:207801903~207801924:-
COAD	cis	rs2456930	0.714	rs2459893	MIMAT0000458	hsa-miR-190a-5p	3.7	0.000262	0.24	0.23	Brain structure (temporal lobe volume);	chr15:62393915	chr15:62823971~62823992:+
COAD	cis	rs4713675	0.565	rs4711343	MIMAT0022975	hsa-miR-3934-3p	-3.7	0.000262	-0.23	-0.22	Plateletcrit;	chr6:33746771	chr6:33698191~33698212:+
COAD	cis	rs11792861	0.888	rs75543406	MIMAT0000090	hsa-miR-32-5p	3.7	0.000263	0.19	0.22	Menarche (age at onset);	chr9:109054623	chr9:109046272~109046293:-
COAD	cis	rs11792861	0.926	rs3750451	MIMAT0000090	hsa-miR-32-5p	3.7	0.000263	0.19	0.22	Menarche (age at onset);	chr9:109060586	chr9:109046272~109046293:-
COAD	cis	rs35847492	1	rs17730481	MIMAT0019728	hsa-miR-4660	-3.7	0.000263	-0.27	-0.22	Neuroticism;	chr8:9418653	chr8:9048453~9048475:+
COAD	cis	rs1712517	0.771	rs10883858	MIMAT0022727	hsa-miR-1307-5p	-3.7	0.000267	-0.15	-0.22	Migraine;	chr10:103367951	chr10:103394341~103394361:-
COAD	cis	rs11792861	0.926	rs75128146	MIMAT0000090	hsa-miR-32-5p	3.7	0.000267	0.19	0.22	Menarche (age at onset);	chr9:109071511	chr9:109046272~109046293:-
COAD	cis	rs11792861	0.926	rs76689835	MIMAT0000090	hsa-miR-32-5p	3.7	0.000267	0.19	0.22	Menarche (age at onset);	chr9:109071512	chr9:109046272~109046293:-
COAD	cis	rs950880	0.961	rs13020553	MIMAT0019927	hsa-miR-4772-3p	3.69	0.000269	0.21	0.22	Serum protein levels (sST2);	chr2:102315366	chr2:102432336~102432357:+
COAD	cis	rs7941030	1	rs1945390	MIMAT0010195	hsa-let-7a-2-3p	3.69	0.000269	0.17	0.22	HDL cholesterol;Cholesterol, total;	chr11:122649545	chr11:122146523~122146544:-
COAD	cis	rs4713675	0.565	rs4713670	MIMAT0022975	hsa-miR-3934-3p	3.69	0.000269	0.23	0.22	Plateletcrit;	chr6:33732105	chr6:33698191~33698212:+
COAD	cis	rs4072705	0.967	rs10818984	MIMAT0004558	hsa-miR-181a-2-3p	-3.69	0.000269	-0.24	-0.22	Menarche (age at onset);	chr9:124651272	chr9:124692518~124692539:+
COAD	cis	rs11792861	0.781	rs28361152	MIMAT0000090	hsa-miR-32-5p	3.69	0.00027	0.19	0.22	Menarche (age at onset);	chr9:108965249	chr9:109046272~109046293:-
COAD	cis	rs2456930	0.714	rs2471028	MIMAT0000458	hsa-miR-190a-5p	3.69	0.00027	0.25	0.22	Brain structure (temporal lobe volume);	chr15:62393995	chr15:62823971~62823992:+
COAD	cis	rs11792861	0.926	rs59904140	MIMAT0000090	hsa-miR-32-5p	3.69	0.000271	0.18	0.22	Menarche (age at onset);	chr9:109147771	chr9:109046272~109046293:-
COAD	cis	rs2871473	1	rs2871473	MIMAT0019926	hsa-miR-4772-5p	-3.69	0.000272	-0.26	-0.22	Blood protein levels;	chr2:102490821	chr2:102432300~102432321:+
COAD	cis	rs4713675	0.546	rs2296739	MIMAT0022975	hsa-miR-3934-3p	-3.69	0.000273	-0.25	-0.22	Plateletcrit;	chr6:33689192	chr6:33698191~33698212:+
COAD	cis	rs7527798	0.535	rs10158414	MIMAT0004515	hsa-miR-29b-2-5p	3.69	0.000274	0.22	0.22	Erythrocyte sedimentation rate;	chr1:207597507	chr1:207802492~207802513:-
COAD	cis	rs950880	1	rs13001325	MIMAT0019927	hsa-miR-4772-3p	3.69	0.000276	0.21	0.22	Serum protein levels (sST2);	chr2:102322576	chr2:102432336~102432357:+
COAD	cis	rs7819412	0.521	rs10110684	MIMAT0003266	hsa-miR-598-3p	-3.69	0.000277	-0.28	-0.22	Triglycerides;	chr8:11181650	chr8:11035221~11035242:-
COAD	cis	rs4072705	1	rs2067791	MIMAT0004558	hsa-miR-181a-2-3p	-3.69	0.000277	-0.24	-0.22	Menarche (age at onset);	chr9:124676015	chr9:124692518~124692539:+
COAD	cis	rs6981523	0.553	rs11783890	MIMAT0003266	hsa-miR-598-3p	-3.68	0.000281	-0.3	-0.22	Neuroticism;	chr8:11198879	chr8:11035221~11035242:-
COAD	trans	rs1120787	0.793	rs625661	MIMAT0002817	hsa-miR-495-3p	-6.29	1.35e-09	-0.4	-0.37	HIV-1 control;	chr18:57347192	chr14:101033804~101033825:+
COAD	trans	rs6546537	0.91	rs10779953	MIMAT0003339	hsa-miR-421	-6.09	4.05e-09	-0.32	-0.36	Serum thyroid-stimulating hormone levels;	chr2:69659625	chrX:74218392~74218414:-
COAD	trans	rs1875517	0.518	rs1501869	MIMAT0003257	hsa-miR-550a-3p	-6.09	4.13e-09	-0.31	-0.36	Waist circumference;	chr3:117583190	chr7:29680748~29680769:-
COAD	trans	rs1875517	0.518	rs1501869	MIMAT0003257_1	hsa-miR-550a-3p	-6.09	4.13e-09	-0.31	-0.36	Waist circumference;	chr3:117583190	chr7:30289854~30289875:+
COAD	trans	rs1875517	0.518	rs1501869	MIMAT0003257_2	hsa-miR-550a-3p	-6.09	4.13e-09	-0.31	-0.36	Waist circumference;	chr3:117583190	chr7:32733041~32733062:+
COAD	trans	rs488628	0.518	rs705265	MIMAT0004784	hsa-miR-455-3p	6.07	4.63e-09	0.41	0.35	White matter integrity (bipolar disorder risk interaction);	chr3:118343939	chr9:114209487~114209507:+
COAD	trans	rs1875517	0.518	rs2036397	MIMAT0003257	hsa-miR-550a-3p	6.03	5.66e-09	0.31	0.35	Waist circumference;	chr3:117581616	chr7:29680748~29680769:-
COAD	trans	rs1875517	0.518	rs2036397	MIMAT0003257_1	hsa-miR-550a-3p	6.03	5.66e-09	0.31	0.35	Waist circumference;	chr3:117581616	chr7:30289854~30289875:+
COAD	trans	rs1875517	0.518	rs2036397	MIMAT0003257_2	hsa-miR-550a-3p	6.03	5.66e-09	0.31	0.35	Waist circumference;	chr3:117581616	chr7:32733041~32733062:+
COAD	trans	rs6546537	0.955	rs1396798	MIMAT0003339	hsa-miR-421	-6	6.78e-09	-0.33	-0.35	Serum thyroid-stimulating hormone levels;	chr2:69660705	chrX:74218392~74218414:-
COAD	trans	rs1155750	0.564	rs980823	MIMAT0000687	hsa-miR-299-3p	5.84	1.54e-08	0.58	0.34	Colorectal cancer;	chr6:54989873	chr14:101023832~101023853:+
COAD	trans	rs10502386	0.716	rs12956492	MIMAT0019208	hsa-miR-3074-5p	5.83	1.7e-08	0.37	0.34	Obesity-related traits;	chr18:8950562	chr9:95086063~95086083:-
COAD	trans	rs2790232	1	rs78532356	MIMAT0004774	hsa-miR-501-3p	-5.82	1.74e-08	-0.5	-0.34	Obesity-related traits;	chr10:58333016	chrX:50009772~50009793:+
COAD	trans	rs2882834	0.597	rs1549862	MIMAT0003233	hsa-miR-551b-3p	5.81	1.81e-08	0.4	0.34	Capecitabine sensitivity;	chr7:10350685	chr3:168551914~168551934:+
COAD	trans	rs2882834	0.597	rs2352102	MIMAT0003233	hsa-miR-551b-3p	5.81	1.81e-08	0.4	0.34	Capecitabine sensitivity;	chr7:10350882	chr3:168551914~168551934:+
COAD	trans	rs2882834	0.607	rs35011145	MIMAT0003233	hsa-miR-551b-3p	5.81	1.81e-08	0.4	0.34	Capecitabine sensitivity;	chr7:10351052	chr3:168551914~168551934:+
COAD	trans	rs2882834	0.597	rs13247104	MIMAT0003233	hsa-miR-551b-3p	5.81	1.81e-08	0.4	0.34	Capecitabine sensitivity;	chr7:10351805	chr3:168551914~168551934:+
COAD	trans	rs2882834	0.633	rs6967157	MIMAT0003233	hsa-miR-551b-3p	-5.8	1.91e-08	-0.41	-0.34	Capecitabine sensitivity;	chr7:10396073	chr3:168551914~168551934:+
COAD	trans	rs11743006	0.626	rs1072158	MIMAT0018191	hsa-miR-3917	-5.75	2.46e-08	-0.45	-0.34	Mathematical ability;	chr5:137168977	chr1:25906384~25906403:-
COAD	trans	rs6922269	0.847	rs4869959	MIMAT0005924	hsa-miR-1270	5.75	2.57e-08	0.47	0.34	Coronary heart disease;	chr6:150940403	chr19:20399320~20399342:-
COAD	trans	rs2882834	0.597	rs10263548	MIMAT0003233	hsa-miR-551b-3p	-5.74	2.63e-08	-0.39	-0.34	Capecitabine sensitivity;	chr7:10366934	chr3:168551914~168551934:+